Staphylococcus epidermidis biofilms : new insights in their formation and development of control strategies by Vanzieleghem, Thomas
Available at:
http://hdl.handle.net/2078.1/160970
[Downloaded 2019/04/19 at 05:25:21 ]
"Staphylococcus epidermidis biofilms : new insights in
their formation and development of control strategies"
Vanzieleghem, Thomas
Abstract
Bacterial biofilms are the root cause of most chronic infections as- sociated with
implanted materials. For the opportunistic pathogen Staphylococcus epidermidis,
the development of biofilms is considered as a major virulence factor, responsible
for its resilience in hospitals and in patients. There is a clear need to improve
our understanding of the influences of the environment on S. epidermidis
biofilm formation to propose more adapted clinical treatments to biofilms. This
study aimed to gather more insights on the mechanisms of bacterial adhesion
and aggregation, two essential phases of biofilm development and to develop
methods to detect and control S. epidermidis in biofilms. First, the adhesion of
S. epidermidis to Fibrinogen-coated surfaces was investigated. In particular, the
contribution of SdrG, a cell surface adhesin, in the modulation of the adhesion
of S. epidermidis to adsorbed fibrinogen was assessed. Secondly, a method to
detect adhering bacteria by means of a impedi...
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3Abstract
Bacterial bioﬁlms are the root cause of most chronic infections as-
sociated with implanted materials. For the opportunistic pathogen
Staphylococcus epidermidis, the development of bioﬁlms is considered as
a major virulence factor, responsible for its resilience in hospitals and
in patients. There is a clear need to improve our understanding of the
inﬂuences of the environment on S. epidermidis bioﬁlm formation to
propose more adapted clinical treatments to bioﬁlms. This study aimed
to gather more insights on the mechanisms of bacterial adhesion and
aggregation, two essential phases of bioﬁlm development and to develop
methods to detect and control S. epidermidis in bioﬁlms.
First, the adhesion of S. epidermidis to ﬁbrinogen-coated surfaces was
investigated. In particular, the contribution of SdrG, a cell surface
adhesin, in the modulation of the adhesion of S. epidermidis to adsorbed
ﬁbrinogen was assessed. Secondly, a method to detect adhering bacteria
by means of a impedimetric biosensor was developed. An original
combination of optical and electrical measurements allowed to conﬁrm
the detection selectivity towards Staphylococci.
Then, a novel type of aggregation was reported. Several isolates of
Staphylococcus aureus and S. epidermidis were found to rapidly form
large cell clumps in a reversible fashion. The implications of this
phenotype on bioﬁlm formation was also demonstrated.
Finally, enzymes were used to challenge matureS. epidermidis bioﬁlms.
Lysostaphin, lysins of phage K and Twort and an analog of dispersin
B were identiﬁed as potent candidates with anti-bioﬁlm activity.
Lysostaphin and lysin K could also cause signiﬁcant cell lysis. These
enzymes represent alternatives to the failure of antibiotics and disinfec-
tants to eradicate bioﬁlms.
4Keywords: adhesion, aggregation, bioﬁlms, detection, ﬁbrinogen, ionic
strength, lysins, nosocomial infections, Staphylococcus epidermidis.
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Introduction and Objectives
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1.1 Historic context
Bioﬁlms result from the natural organisation of micro-organisms as a
community [Costerton 1995] [Westall 2006]. Bacteria and archaea have
colonized almost all available natural habitats, and in about 90% of the
cases, they live in the form of a bioﬁlm [Costerton 1987]. The ﬁrst
observation of bioﬁlm was made in the late 17th century by Antonie Van
Leeuwenhoek (1632-1723), a dutch tradesman passionate about science.
He conceived rudimentary microscopes and could observe what he called
"animalculi", a word he used to describe micro-organisms isolated from
his dental plaque. He said "The number of these animalcules in the
scurf of a man's teeth are so many that I believe they exceed the number
of men in a kingdom.". The scurf he mentioned is, in fact, what we
now call a bioﬁlm. Unfortunately, his reports were welcomed with much
scepticism amongst scientist of that time. The leads he proposed to
pursue were left aside and his publications did not receive the echo they
deserved in the scientiﬁc community.
On the impulsion of Robert Koch (1841-1910), the paradigm of
microbiology was centered on a gold standard : the pure culture of
planktonic bacteria. Indeed, he put pure culture at the core of its
strategy to establish his four postulates to link an etiological agent to
a diseases. He stated that: the etiological agent of a disease should be
present in high numbers in the patients, should be cultivated in vitro,
should provoke the disease when reinoculated in a healthy individual and
should be isolated again from the contaminated body [Loeer 1884].
Still profoundly anchored in mentalities, this pure culture paradigm
occulted, almost totally, important questions regarding the ecology of
bacteria in their natural environments. In 1930's and 1940's though,
some voices arose to reinstate the essence of Van Leeuwenhoek obser-
vations : "Surfaces enable bacteria to develop in substrates otherwise
too dilute for growth. Development takes place either as bacterial slime
or colonial growth attached to surfaces." [Heukelekian 1940]. Their
statements were supported by experimental evidences that in sea water
metabolic activity and growth increased close to surfaces upon which
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bacteria develop [Henrici 1933] [Zobell 1943] [Allen 1949].
From then to the 1970's, the number and the relevance of such
observations on "surface-bound" life of bacteria were numerous: at
air-water, air-soil, water-soil, water-rocks interfaces [Geesey 1977]
[Characklis 1983] [Costerton 1995]. More recently, some forms of
bioﬁlms such as granules were shown to grow without the need for an
external interface, thriving on their own extracellular polymeric sub-
stance (EPS) matrix [Barr 2010]. Based on the pioneering works of Bill
Costerton and Bill Characklis, the ﬁrst center for the study of bioﬁlms
was created in Montana in 1990. Ever since, bioﬁlm research has grown
immensely popular, as indicated by the exponentially increasing number
of publications related to the topic.
1.2 Deﬁnition of a bioﬁlm
Nowadays, a commonly admitted deﬁnition for a bioﬁlm can be put
as follows: a community of aggregating microorganisms, dwelling
on biotic or abiotic interfaces, engulfed in a self produced matrix of
EPS [Costerton 1995]. This matrix of polymers, a feature speciﬁc
to bioﬁlms, is generally composed of polysaccharides, proteins, eDNA
(extracellular DNA) and minor components such as minerals and lipids
[Flemming 2010]. Due to its intrinsic properties, the EPS matrix plays
various roles in the growth and maturation of a bioﬁlm (as explained in
details later). In nature, several species are commonly present in these
sessile populations called multi-species bioﬁlms. They thrive together
as an organized consortium. In some rarer cases, monospecies bioﬁlms
are encountered.
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1.3 A paradigm for the development of bacterial
bioﬁlms
The following section is dedicated to detailing the bioﬁlm life cycle as it
is commonly accepted today.
1.3.1 Four steps to the bioﬁlm life cycle
The development of a bioﬁlm involves four four mains steps
[Monds 2009]. First, free-ﬂoating or planktonic bacteria come in
contact with a surface (either biotic or abiotic). Upon contact, adhesion
may occur and bacterial cells anchor themselves, reversibly. Over
time, two scenarii are then possible. In the ﬁrst case, the cell-surface
interaction weakens and the bacterium is set free from the surface.
In the second case, reversible adhesion is fastened, turning into irre-
versible adhesion [Marshall 1971] [Hermansson 1999] [Hinsa 2003]
[Boks 2008b].
Second, the adhered bacterial cells, in the presence of nutrients, can
grow and divide to form microcolonies. This step is called accumulation.
It is mainly supported by the production of the EPS matrix, a biological
glue that keeps cells together thanks to electrostatic, Van der Waals
and acid-base interactions [Flemming 2010]. Depending on the species,
alterations of the EPS with, for example, acetyl residues can modulate
the aggregative properties of the matrix [Tielen 2005]. In many species,
speciﬁc cell surface proteins also play a role in cell-cell interactions, as
it is the case by Lactobacilli with the Cfp protein [Schachtsiek 2004] or
for Enterococci with the Asc10 and Asa1 proteins [Paganelli 2012].
Third, comes a maturation process while micro-colonies undergo
dramatic changes in their structure and, if their density is high enough,
they can merge. At this stage, quorum sensing (QS), a mechanism of
bacterial communication based on the recognition of with self-emitted
small molecules [Waters 2005], plays an important role in the organ-
isation of bacteria in the micro- and macro-colonies. The impact of
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quorum sensing on the development of staphylococcal bioﬁlms will be
thoroughly explained in Section 3.5.2. The build up of micro-colonies
into macro-colonies usually involve the development of towers or
mushrooms shapes, but not always [Claessen 2014]. On the contrary,
some micro-colonies partly disaggregate to allow water channels to
form into the bioﬁlm core [Monds 2009]. It results in a complex
heterogeneous three-dimensional architecture comprising a variety of
micro-environments [Stewart 2008] [Periasamy 2012]. As a consequence
of its heterogeneity, a bioﬁlm is composed of cells in diﬀerent metabolic
and physiological states, the most famous of which are persister cells
[Keren 2004a] [Lewis 2010].
Finally, mature bioﬁlms come to release planktonic cells during
a stage commonly called dispersal. The mechanisms for detachment
are extrinsic as well as intrinsic. Extrinsic factors are, for example,
shear forces from the liquid moving on the surface of the bioﬁlm
[Purevdorj 2002], tearing oﬀ bits of the bacterial community, nutrient
starvation [Hunt 2004], oxygen depletion [Thormann 2005], or temper-
ature ﬂuctuations [Kaplan 2002]. Intrinsic factors are, among others,
the release of EPS degrading enzymes by bioﬁlm bacteria, like nuclease
[Chaignon 2007], polysaccharide degrading enzymes [Allison 1998]
and genetic down regulation of EPS production. The latter is notably
inﬂuenced by environmental stimuli. Gradients of nutrients, gases, i.e.
nitric oxide (NO), and metabolic wastes occuring in bioﬁlms can be
sensed by bioﬁlm bacteria and interpreted as a signal to initiate the
dispersal phase [McDougald 2012].
The life cycle of a bioﬁlm is represented in Fig. 1.1.
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Figure 1.1: The 4 steps of bioﬁlm development. Planktonic (or free-ﬂoating)
cells (i) come in contact with a substratum (in blue). Attachement (ii) occurs
ﬁrst in a reversible, then in an irreversible fashion through bond strenghtening.
Bacteria anchored on the substratum divide and accumulate to form micro-
colonies (iii). During maturation, microcolonies turn into macrocolonies (iv)
which shapes and architecture may be diverse. Finally, macrocolonies release
planktonic cells in the surrounding environment, a phenomenon called dispersal
(v). Source : [Monds 2009].
1.4 The bioﬁlm - the genuine lifestyle of bacteria
The ubiquity of bioﬁlms in nature has led scientists to question the former
paradigm of microbiology based on the assumption that the majority of
bacteria were living in free-ﬂoating forms. Jeﬀerson argued that bioﬁlms
could well be the "default" lifestyle of bacteria [Jeﬀerson 2004]. Based
on the increased ﬁtness of bioﬁlms compared to planktonic cells, the lat-
ter can be regarded as "seeds" of bioﬁlms being carried along to a new
substrate to colonize. In the next sections, several arguments demon-
strating the increased ﬁtness provided by the bioﬁlm to bacteria will be
presented.
1.4.1 The bioﬁlms : a defense against environmental
threats
Firstly, a bioﬁlm is a stronghold, an eﬃcient mechanism of defense.
Indeed, bioﬁlms provide increased protection against all types of envi-
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ronmental threats such as pH variation, dessication, oxidative stress, UV
radiations or predation [Flemming 1993] [Davey 2000] [Tamaru 2005]
[Flemming 2010]. Faced with such adverse conditions, a planktonic
population will systematically suﬀer a much larger decrease in viability.
In most species, bioﬁlm formation is even genetically triggered as a
response to stresses. In Escherichia coli for instance, the starvation
stress induces the expression of the YcfR protein that decreases cell
hydrophobicity and regulates bioﬁlm buildup [Zhang 2007]. Similarly,
in Bacillus subtilis, the stress-response pathway YwcC-SlrA strongly
inﬂuences bioﬁlm formation [Chai 2009] [Vlamakis 2013] and, in
Vibrio cholerae, the bioﬁlm production increases under the inﬂuence
of stringent response (bacterial reaction to low nutrient availability)
mediators [He 2012].
The key bioﬁlm component providing this increased protection is the
EPS matrix. Its stickiness holds the bioﬁlm together under external
loading. The reticulated web of EPS slows down mass transfer consider-
ably inside the bioﬁlm. EPS are highly hydrated polymers, also allowing
a very good hygroscopic retention of water [Flemming 2010], a feature
often crucial in nature. When water availability is changing, bioﬁlms are
able to delay dessication substantially whereas planktonic populations
will not be able to avoid water evaporation. Bioﬁlms thus contribute to
bacterial resilience [Jeﬀerson 2004].
1.4.2 Colonization of surfaces
Besides protection, the second reason for the success of the bioﬁlm
life form is its ability to colonize. The word "colonization" can be
interpreted in two diﬀerent ways.
The ﬁrst is the capacity to stay at a certain place in order to secure
an implantation. Bioﬁlms do that quite well, notably thanks to speciﬁc
adhesins, cell surface proteins, that fasten the community to the surface
on which they thrives. For example, Streptococcus pyogenes possesses
two surface proteins, encoded by the prtF and emm genes, binding
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to ﬁbronectin and ﬁbrinogen, respectively [Patti 1994b]. In the same
vein, SspA and SspB of Streptococcus gordonii, two binding proteins of
saliva agglutinins, facilitates the anchorage of cells on the teeth surface
[Burne 1998]. Also, the ﬂagella, pili and ﬁmbriae have been shown to
contibute to bacterial adherence to surfaces for Salmonella enterica,
Pseudomonas aeruginosa and V. cholerae [Lejeune 2003].
The second interpretation of colonization relates to the ability to
migrate and occupy new ecological niches. As mentioned above, a well
established surface dwelling community continuously releases planktonic
cells, sent as emissaries to look for greener grass elsewhere. Some of these
bacterial cells will encounter surfaces on which they can grow and develop
a new bioﬁlm which will, in turn, release cells as it comes to maturity.
This strategy can be quite eﬃcient in environments such as rivers, oceans,
industrial plants [Abee 2011] where mass transport around the bioﬁlm
is abundant.
1.4.3 Bioﬁlms : a cooperative hub for bacteria
A third advantage for bacteria to live in bioﬁlms is the community.
This is where bacteria ressemble multicellular organisms the most: they
cooperate, divide the metabolic burden and even perform horizontal
gene transfer more eﬃciently [Molin 2003]. These activities are
particularly relevant in mixed species bioﬁlms. Indeed, as the pool of
available genes is larger, the community is capable to perform tasks
that mono species cannot. The group of Pr. Springael at KULeuven
showed that degradation of the pesticide linuron by a consortium of
three soil bacteria, each able to perform one step of the three-step
degradation pathway, was only eﬀective when the three species were
entangled in the macrocolonies of a bioﬁlm. Oppositely, bioﬁlms
developped with citrate as a carbon source, mainly composed of
mono species macrocolonies, were not able to signiﬁcantly degrade the
pesticide [Breugelmans 2010] [Horemans 2013]. Another example is
the anammox reaction in bacterial granules for wastewater treatment.
Anammox requires a speciﬁc set of conditions for several functional
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groups of bacteria to transform NH+4 and NO
−
2 into N2. These condi-
tions are only met in granules (dense aggregates of bacteria) but not
in activated sludge, the most used technology to date [VanDongen 2001].
The hypothesis that bioﬁlm is the default mode of growth of the over-
whelming majority of bacteria in nature tends to be widely accepted.
Though the shift in paradigm from "pure culture" to "bioﬁlm as default
growth mode" took time to operate, partly due to a lack of appropriate
technology to grow bioﬁlms in the laboratories. However, progress has
now been made and bioﬁlms are routinely grown in vitro in the labora-
tory with reliable methods [Goeres 2005] [Hu 2008] [Brenner 2012].
1.5 Impact of bioﬁlm on humans
The span of bioﬁlms impact on human in general is broad and can
be either beneﬁcial or detrimental. An overview of the signiﬁcance of
bioﬁlms is proposed in the following paragraphs.
1.5.1 Beneﬁcial bioﬁlms
Even before humans made their own use of bioﬁlms, they revealed
themselves useful in nature. Indeed, an American Society for Microbi-
ology (ASM) report called "Global environmental changes: Microbial
contributions and Microbial solutions" states that bioﬁlms are key
players in the biogeochemical cycles happening in soils, rivers and
oceans acting as major driving forces in the recycling of organic matter
[King 2014]. Bioﬁlms also largely contribute to the nutrient uptake
of plants through symbiotic relationships with plants [Bogino 2013].
Besides this involvement in natural processes, humans have put bioﬁlms
to work in more than one fashion. Bioﬁlms are used for the conversion
of biomass into gases (mostly methane and hydrogen) subsequently
burnt to produce heat and energy [Parawira 2008]. In the form of
activated sludge or granules, bioﬁlms are the core the our wastewa-
ter treatment technology [Nicolella 2000]. Bioﬁlms have also been
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grown in bioreactors to produce high value added compounds such
as enzymes [Sarkar 2011] or to perform deﬁned chemical reactions,
acting as catalysts [Halan 2012]. Other promising technologies are
being currently developed with bioﬁlms : microbial fuel cells designed
to produce electricity by degradation of organic matter (i.e. lac-
tate, acetate) [Liu 2004] or bioreactors to remove micropollutants (i.e.
pesticides and heavy metals) from treated waste water [Horemans 2013].
1.5.2 Detrimental bioﬁlms
The detrimental eﬀets of bioﬁlms on humans are numerous, the most
notable are presented here. First, the involvement of bioﬁlms in var-
ious pathologies makes them of high clinical importance. In fact,
they are the causative agents of, among others, nosocomial infections
associated with implanted devices [Costerton 1999] [Huebner 1999]
[Donlan 2001] [Hoiby 2011], otitis [Bakaletz 2007], tooth decay, gingivi-
tis [Jenkinson 2005], complications in wounds [Wolcott 2008]. Hence,
bacteria in bioﬁlms tend to tolerate antibiotic concentration up to 50
times greater than the minimal inhibitory concentrations of planktonic
bacteria (MIC) [García-Castillo 2007]. Second, in industrial settings,
bioﬁlms contaminate food production lines [Kumar 1998], heat exchang-
ers, water pipes [Mattila-Sandholm 1992] and actively corrode metal al-
loys and concrete [Zuo 2007]. These problems are often tackled with dif-
ﬁculty and at high costs. Finally, biofouling, including bacterial bioﬁlms,
algae and macrofouling by marine organisms, on ship hulls provokes in-
creased corrosion and increased fuel consumption, due to higher shear
forces. As an example, the annual supplementary cost in fuel for a mid-
size destroyer of the US Marine is 50 million dollars, imputable to drag
force caused by bioﬁlms [Schultz 2011].
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1.6 Bioﬁlms in the laboratory
1.6.1 Model species
Four species have been used as models to investigate bioﬁlm forma-
tion : P. aeruginosa, E. coli, B. subtilis and Staphylococcus aureus
[López 2010].
P. aeruginosa is ubiquituous, Gram-negative, versatile
pathogen often involved in complication in cystic ﬁbrosis patients
[Moreau-Marquis 2008]. This species forms dense bioﬁlms with abun-
dant EPS production, a feature that can be recognized as a virulence
factor [Mann 2012]. In industrial settings, contamination due to
Pseudomonas spp. is rather frequent causing, for example, major
losses in the food industry and also reduces the yield of heat exchanger
[Costerton 1987]. The problems associated with P. aeruginosa led
the scientiﬁc community to use it as a reference species for bioﬁlm
formation. Klausen et al. grew bioﬁlms of P. aeruginosa and noticed
the appearance of mushroom like structure upon changing carbon source
[Klausen 2003]. Others found that twitching mobility by ﬂagella was
important for bioﬁlm morphology [Heydorn 2002].
E. coli is an enterobacterium also well-known as an entero- and
uropathogen. In E. coli, the role played by surface appendages such as
ﬁmbriae, pili and ﬂagella in bioﬁlm formation was extensively studied
[Pratt 1998] [Wright 2007]. It was also shown that E. coli produced
curli proteins that were in fact amyloid ﬁbers, drivers of the bioﬁlm
stability and architecture [Chapman 2002] [Blanco 2012].
B. subtilis is a soil bacterium that readily forms bioﬁlm at air-liquid
interfaces. It dwells on plant roots and relies on bioﬁlm formation
to increase its colonization of the rhizoshere [López 2010]. Essential
features of bioﬁlms have been highlighted in B. subtilis thanks to mutant
generation [Vlamakis 2013]. Famous examples are, among others, the
composition of the EPS matrix (poly-γ-glutamate and amyloid ﬁbers)
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and the cellular components that trigger and regulate bioﬁlm develop-
ment and dispersal such as, the Spo0A pathway involved in sporulation
[Fujita 2005] and SlrR-SinR switch that govern cell chaining [Chai 2010].
Finally S. aureus and more recently Staphylococcus epidermidis have
become reference species to study bioﬁlm formation since their ability to
form bioﬁlm was recognized as a major virulence factors in nosocomial
infections [Otto 2012]. Staphylococci have evolved to bind a variety of
host proteins, cells and tissues as well as biomaterials, and accumulate
on these surfaces as dense bioﬁlms [Otto 2009]. These are mainly com-
posed of polysaccharides that confer protection against aggressions from
the immune system (anti-microbial peptides, neutrophils and antibodies)
[Vuong 2004a] [Kristian 2008].
1.6.2 In vitro Culture techniques
Concerning bioﬁlm cultivation in the laboratory, two main categories are
currently available: static or ﬂow displacement systems.
Static conditions
The most frequently used microtiter plates (MTP) technique has been
extensively implemented for almost 30 years according to a protocol
developed by Christensen et al. in 1985. Bioﬁlms in MTP are often
grown directly on the polystyrene well surface, but coupons have also
been used in 6, 12 or 24 wells MTP. Alternatively, the so-called Calgary
device allows to grow bioﬁlms on pegs (plastic protrusions, see Fig.
1.2 B.) dipped into the wells on the MTP. The pegs can be removed
from the plate containing the spent medium and dipped into another
plate, which makes it convenient to assess Minimal Bioﬁlm Eradication
Concentration (MBEC) [Ceri 1999]. Finally, static bioﬁlms can also
be developped on the surface of agar or at the liquid-air interface in a
bottle of growth medium. Fig. 1.2 illustrates the diﬀerent techniques
used to grow bioﬁlms in static conditions.
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Figure 1.2: Static bioﬁlm growth in laboratories. A - Conventional bioﬁlm
growth in MTP, followed by coloration with crystal violet to reveal bioﬁlm
formation. Bioﬁlm develops on the bottom and walls of the wells. B - Calgary
device, composed of two parts : the standard MTP containing the growth
medium and the upper plate with the pegs dipped into the wells. Bioﬁlms
grow on the pegs of the upper plate which can be transferred from one plate
to another, for example to challenge bioﬁlms with antibiotics. C - To the left
hand side, a B. subtilis bioﬁlm on on nutrient agar surface, to the right hand
side, a bioﬁlm of the same species at the air-liquid interface in a medium bottle
(Source : [Vlamakis 2013]).
In MTP systems, a ﬁxed quantity of medium is added to the well
containing a bacterial inoculum. There is no replacement of the medium
during the experiment unless the experimentator does so. Uncontrolled
shear stress can be applied by shaking the MTP. The key for the success
of this method is its high throughput rate and low reagent consumption
[Coenye 2010].
Flow displacement systems
In contrast to the closed systems, a variety of "open" systems have been
developed. They are continuously fed with fresh medium and can be
classiﬁed in two main categories: the Continuous Flow Stirred Tank
Reactor (CFSTR) and the Plug Flow Reactors (PFR) [Heersink 2003].
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Schematic representation and characteristics of MTP, CFSTR and PFR
are shown in Fig.1.3.
Figure 1.3: The 3 main modes of in vitro bioﬁlm growth. A - Bacth mode: a
closed system with ot without mixing. No liquid goes in or out the reactor. The
substrate availability decreases as the bioﬁlm grows and starvation inevitably
occurs at a certain point. The most common example is MTP. B - Continu-
ous ﬂow stirred tank reactor (CFSTR), mixing happens in all directions and
substrate availability is monitored and kept constant, the reactor acheives a
steady-state. C - Reactors fed by plug ﬂow imply that spent medium is pushed
out of the chamber by injection of the fresh medium according to the direction
of the ﬂow. Mixing only occurs radially, the substrate is thus consumed by the
bioﬁlm as it ﬂows along the length of the PFR chamber. The residence time
of the medium in the chamber is governed by ﬂow rate. As a consequence, the
substrate/product diagram is drawn in function of the axial distance and not
the time as for CSTFR and MTP. Source: [Coenye 2010]
CFSTR systems work in steady-state: the ﬂow rate of fresh medium
in the tank is the same as the outﬂow of waste products. The hydraulic
retention time (HRT [s] = Volume of the tank [m3] / Flow rate [m3/s])
is chosen to be shorter than the doubling time of the cultivated species.
In that way, planktonic bacteria are regularly washed away, only the
sessile cells remain. CFSTR are operated with one or several coupons
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of a chosen material upon which bioﬁlms may grow. A mixing arm
stirs the reactor in order to ensure a good homogeneity in the solution
[Coenye 2010]. The major drawback of the method is the bench
space and equipment needed to run the system. A good example of
such devices is the Center for Disease Control (CDC) bioﬁlm reactor
[Goeres 2005] shown in Fig. 1.4 a. This reactor was found to be an
appropriate tool to grow Streptococcus pneumoniae [Donlan 2004] and
P. aeruginosa [Coenye 2010] bioﬁlms.
In PFR systems, a ﬂux of fresh medium is fed in the reactor from the
input and the incoming medium pushes the spent medium towards the
output [Heersink 2003]. The concentration of nutrient tends to diminish
over the length of the PFR whereas the waste products concentration
builds up. PFRs are usually much smaller in size than CFSTR and
can easily be paralleled. The mixing in such devices is only occuring
radially and waste products are totally removed from the reactor. As a
consequence, PFRs do not reach a steady state. Two examples of PFRs
are : the modiﬁed Robbins Device (MRD) [McCoy 1981], ﬂow cells such
as STOVALL (also called microﬂuidic devices if the channel dimensions
are below the millimeter). In some cases, the surface available for
bioﬁlm growth cannot be recovered after the experiment Both devices
are depicted in Fig. 1.4 b and c.
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Figure 1.4: A - The CDC bioﬁlm reactor, belonging to the class of CFSTR,
two vessels are run in parallel, fed with a stock of fresh medium. B - Modiﬁed
Robbins Device (MRD), a PFR, composed of a main channel in which coupons
can be inserted orthogonally, ﬂow runs tangentially to the coupon. Up to 6
coupons can be run at the same time. C - A PFR ﬂow cell device (STOVALL),
the chamber accepts a plastic slide for bioﬁlm growth. Source : Adapted from
[Coenye 2010] for A and B, from Stovall Life Science, Inc. for C.
The growth method chosen to cultivate in vitro bioﬁlms inﬂuences
the characteristics of sessile bacterial communities. It is important to
keep in mind that there is no panacea yet, each method presents its pros
and cons. One must therefore carefully choose the device according to
the questions being addressed [Coenye 2010].
1.6.3 In vivo bioﬁlm development
Although growing bioﬁlms in vivo is more relevant, it is also more time
consuming. A variety of organisms have already been used for in vivo
bioﬁlm studies: non-mammalian such as the nematode Caenorhabditis
elegans, the fruitﬂy Drosophila melanogaster, and the zebraﬁsh Danio
rerio and mammalian such as murine models and rabbits [Lebeaux 2013].
Non mammalian models oﬀer interesting perspectives in terms of
throughput, ethical considerations, cost and experimental possibilities.
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C. elegans, for instance, has a generation time of 4 to 7 days and presents
analogies to mammals in its immune response. It has been found to
be well suited for the study of gut colonization [Marsh 2012]. This
model has been employed for the study of bioﬁlm formation by species
of Shigella, Mycobacterium and Listeria [Lebeaux 2013]. However, it is
more distantly related to mammalian pathology.
Murine models, on the other hand, are particularly relevant for
clinical research but suﬀer from low throughput rates, ethics and
labour-intensive logistics [Coenye 2010] [Lebeaux 2013]. They have
notably proved valuable to understand the development of bioﬁlm-
related pathologies on implantable medical devices such as vascular
catheters [Rupp 2001] [Kokai-Kun 2009]. In particular, a recent work
has highlighted the importance of bioﬁlm formation as a way for
bacteria to avoid macrophage phagocytosis and to signiﬁcantly reduce
inﬂammation, i.e. exposition to the immune system [Thurlow 2011].
1.6.4 Bioﬁlm analysis and characterization
Quantiﬁcation of bioﬁlms can be performed by several techniques. First,
the number of Colony Forming Units (CFU) is usually determined by
standard plate count method after recovering the bioﬁlm biomass. This
technique has some limitations, notably due to the presence of Viable
but Non Culturable cells (VNC) [Paulson 2009]. Biomass quantiﬁ-
cation can also be performed by staining with non-speciﬁc dyes (e.g.
crystal violet or safranin) and measuring absorbance. Morphological
analysis of bioﬁlm in situ is best performed with confocal microscopy
(i.e. ﬂuorescence). The z resolution of this microscope oﬀers precious
information on the three-dimensional structure of the bioﬁlm [Neu 2010].
More recently, combined electron microscopy with ﬂuorescent hy-
bridization and confocal microscopy have been successfully implemented
to visualise bioﬁlms with much details [Schaudinn 2009]. In order
to extract quantitative morphological parameters from microscopy
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images, sophisticated algorithms for image treatment have also been
developed, e.g. COMSTAT [Heydorn 2000]. These algorithms are
able to compute, among others, bioﬁlm roughness, substrate coverage
and total biomass volume based on stacks of confocal microscopy images.
The mechanical properties of bioﬁlms can be approached by rhe-
ology [Stoodley 1999]. Because EPS display visco-elastic properties,
rheometry allows to draw stress-strain curves, indicating how a bioﬁlm
yields under a deﬁne mechanical load. This parameter is of importance
to apprehend the resilience of bioﬁlms in environments with high shear
stresses (e.g. in industrial pipes, on river rocks or on ship hulls).
Molecular biology techniques can also prove useful to analyse
bioﬁlms. For example, quantitative PCR coupled with propidium
monoazide has been used to determine the levels of live versus dead
cells in bioﬁlm samples [Alvarez 2013] or to assess the level of expression
of speciﬁc genes in bioﬁlms [França 2012].
In addition, sensors can be employed to quantify the amount of
bioﬁlm forming on a surface or to follow speciﬁc parameters such as
the concentration in oxygen or the pH [Wang 2013]. These sensors can
be optical [Kwak 2014], electrical [Paredes 2013] or even mechanical
such as microcantilevers to measure cohesion in bioﬁlms [Aggarwal 2010].
Spectroscopy has recently gained much popularity in the analysis of
bioﬁlms due to its non-invasiveness. In particular, Raman spectroscopy
has been employed to assess the distribution of bacterial species within a
bioﬁlm without the need for labelling [Pätzold 2006] and Fourrier Trans-
form Infra-Red spectroscopy (FTIR) allows to follow the apparition of
chemical bonds, for example by the production of biopolymers (such as
EPS), with a spatial resolution of a few micrometers [Holman 2009].
Magnetic Resonance Imaging (MRI) has been used to get access to
bioﬁlm composition and to map mass transfer from and to a bioﬁlm,
mainly due to the diﬀerence in relaxation time of excited nuclei in the
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bioﬁlm compared to the bulk phase [Neu 2010].
Observation of bioﬁlms in vivo, for example in murine models, has
been implemented using bioluminescent bacteria. Brieﬂy, a highly sensi-
tive CCD camera is ﬁxed in a dark room where the anesthesized animals
are placed. The camera collects photons emitted by bioluminescent
bacteria present in the animal. Generated images display the zones
colonized by the bioﬁlm inside the infected mouse. This technique is
non invasive and is particularly useful to follow and localize infections
sites on live individuals through time [Kadurugamuwa 2008].
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This work was dedicated to studying S. epidermidis. In this Chapter,
the key characteristics of this species are presented. Particular emphasis
will be put on the pathogenesis of S. epidermidis and notably the role
of bioﬁlm formation.
2.1 General characteristics and classiﬁcation
Staphylococci were ﬁrst observed in the late nineteenth century, iso-
lated from pus. Due to the lack of discriminant criteria other than
Gram-positive, non-motile, non-sporulant, spheres of 0.5 µm to 1.5
µm, their classiﬁcation has been changed numerous times. In 1975, a
simple but eﬃcient classiﬁcation scheme based on metabolic features,
notably the capacity to produce a coagulase and the utilization of
various carbons sources, was proposed [Kloos 1975]. Though it is only
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in 1990 that Staphylococci were classiﬁed in a family (i.e. Staphylo-
coccaceae) of their own, therefore separated from the Micrococaceae
family to which they belonged. The main reasons for that was their fac-
ultative anaerobic metabolism and a higher G+C content [LeLoir 2010].
To date, ca. 50 species belonging to the genus have been described.
The ability to produce a coagulase is widely used to classify the species
in two groups. The "coagulase-positive" group comprise 7 species
including the famous pathogen S. aureus whereas the "coagulase-
negative" group is composed of more than 40 species among which S.
epidermidis [LeLoir 2010].
The genomes of Staphylococci usually comprise between 2.5 and 3
Mb (million base pairs), corresponding to ca. 2,500 coding sequences
and have a G-C content of about 33 % [Zhang 2003] [Baba 2008]. The
occurrence of plasmids, often of small size (below 10 kb), and transposons
is quite high [Gill 2005]. The impact of the latter on the genetic evolution
of Staphylococci will be discussed in Section 2.3.
2.2 Ecology and habitat
S. epidermidis and S. aureus are both colonizers of the skin and mucosa
of mammals. S. epidermidis is the most frequently encountered species
on human skin whereas S. aureus is present in smaller numbers and,
according to a recent study, only in about 10 to 25 % of the human
population [den Heijer 2013]. Several mechanisms confer to S. epider-
midis an ecological advantage to reside on the skin. Firstly, it secretes a
cell surface protein Aap (accumulation associated protein) that is able
to bind to corneocytes, fastening cells on the skin [Macintosh 2009].
Secondly, the capsule produced by most of the strains, made of poly-γ-
glutamic acid (PGA), has an osmoprotective role against the relatively
high salinity of the skin. PGA also inhibits the action of antimicrobial
peptides secreted by the host [Kocianova 2005]. S. epidermidis is
also able to sense these antimicrobial peptides and activate speciﬁc
resistance mechanisms [Li 2007]. Finally, the species possesses several
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Na+ and H+ exchangers to face saline bursts [Hiramatsu 1998].
For healthy individuals, the presence of S. epidermidis on the skin
is beneﬁcial as it limits the colonization of other species, like S. aureus
or other pathogenic Gram-positive bacteria [Lina 2003] [Cogen 2010].
However, immunocompromised people are unfortunately subject to in-
fections by opportunistic pathogens, a class in which S. epidermidis has
now acquired a solid reputation [Otto 2009]. The pathogenicity of S.
epidermidis and S. aureus will be discussed in Section 2.4.
2.3 Genetic variability
Molecular techniques such as Pulsed Field Gel Electrophoresis (PFGE),
Multi Locus Sequence Typing (MLST), DNA-DNA hybridizatin and
Whole Genome Sequencing (WGS) coupled with in silico analysis
have highlighted the diversity amongst S. epidermidis [Lina 1992]
[Jamaluddin 2008] [Schoenfelder 2010] and S. aureus genomes
[Fitzgerald 2001] [Lindsay 2004] [Maiden 2006] [LeLoir 2010]. Several
mechanism account for the reported intra-species diversity.
The ﬁrst type of mechanism supporting the constant evolution of
Staphylococci is horizontal gene transfer (HGT). Three main types of
HGT exist : transformation, conjugation and transduction.
Transformation consists in the uptake, by so-called competent
bacterial cells, of DNA from the environment. It has long been a
question whether S. aureus is naturally competent [LeLoir 2010], but a
recent study demonstrates chromosomal DNA (i.e. methicillin resistance
genes) uptake in S. aureus [Morikawa 2012]. However, it also showed
that this phenomenon probably occurs at a low frequency as only a
minor fraction displayed natural competence, upon the expression of a
cryptic sigma B factor, SigH.
On the contrary, conjugation amongst Staphylococci is rather
frequent. Conjugative plasmids self-transfer from one strain to another
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thanks to a speciﬁc transfer machinery. Conjugation facilitates the
mobility of DNA inside the species, the genus and even further, depend-
ing on the host range of plasmids. Mobile plasmids frequently carry
pathogenicity islands and antibiotic resistance genes [Grohmann 2003]
[McCarthy 2012]. It is worthy to note that conjugation has been found
to be highly dependent on the conditions inside bioﬁlms [Hausner 1999]
[Ehlers 1999] [Madsen 2012]. It was also recently shown for plasmid
transfer amongst Staphylococci in bioﬁlms [Savage 2013].
The last type of HGT is transduction, it happens upon phage
infection as the viral particle contains, in its genome, bits of genomic
DNA from another host. These carried fragments can be integrated
into the genome of the infected cells. PAthogenicity Islands (PAI) are
amongst the sequences usually transferred through this pathway. Some
of which are former prophages having lost their ability to complete a
lytic cycle [Novick 2003]. Transduction is thought to be the major
mode of HGT in Staphylococci [LeLoir 2010].
Secondly, events of mutation, deletion, insertion of single base pairs
participate to the genetic plasticity of S. epidermidis and S. aureus
genomes. Such events normally happen at low frequency (∼10−9 per
base pair), though in some isolates mutations were shown to occur at
a higher frequency, from 10 to 1000-fold [Hall 2006]. Spontaneous
mutation or recombination is a strong driving force of bacterial evo-
lution in adverse conditions, it has been shown that resistance to
several antiobiotics originates from it. For example, point mutations
in Penicillin Binding Protein 2 (PBP2) conferred resistance to methi-
cillin in S. aureus isolates [Hackbarth 1995] [Ba 2014]. Mutations
in gyrase A and B (gyrA and gyrB) genes suppressed susceptibility
to quinolones [Ito 1994]. Finally, resistance to daptomycin can be
mediated by mutations in several genes with various functions, from
protease to nucleotide synthesis (walK, agrA, clpP and prs) [Song 2013].
Thirdly, an important part of genomic variability can be attributed
to Insertion Sequences (IS). These elements, composed of two Inverted
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Repeats (IR) sequences, and a transposase/recombinase are "jumping"
across the genome [Mahillon 1998]. Transposition can inactivate some
genes or disturb their expression. Therefore, IS are potent agents
of genetic remodeling. Several IS have been spotted in genomes of
Staphylococci, some of which, i.e. IS256 and IS257, are involved in
the regulation of bioﬁlm formation and antibiotic resistance by S.
epidermidis [Kozitskaya 2004] [Gill 2005] [Schoenfelder 2010].
Finally, recombination of small chromosomal fragments, often
brought by HGT, or even replacement of large portions of chromo-
somes (up to 500 kb) which are taken up by bacterial cells in a yet
unclear fashion, have been reported in Staphylococci [Robinson 2004]
[Everitt 2014]. This type of genetic rearrangements create a diversity in
staphylococcal genomes. Though happening at low frequencies, it could
be one of the driving forces of bacterial evolution in environments with
high selective pressure.
2.4 Pathogenicity - S. epidermidis the bad and
S. aureus the ugly ? or vice-versa
S. epidermidis and S. aureus share some common features but they also
diﬀer as it comes to pathogenicity.
2.4.1 Statistics
S. aureus is recognized as a major threat to public health. It
causes acute bloodstream infections, purulent wounds, abcesses, fu-
runcles, osteomyelitis and implanted device infections [Archer 1998]
[Gordon 2008]. The most dangerous infections are caused by Methicillin-
Resistant S. aureus (MRSA) and Vancomycin Intermediate S. aureus
(VISA) since they are insensitive to several clinically used antibiotics.
According to CDC, in 2014, the overall incidence of MRSA infections
in the US was estimated to a rate (community and hospital acquired
confounded) of 0.03 %, i.e. one person out of 3,000 on the global
population in the US. Two categories of people were pointed out as
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being clearly more at risk (up to 100 fold): dialysis patients and +65
people [Dantes 2013]. Mortality of MRSA and VISA infections was
estimated at 27 % on 700 patients with bacteriemia between 2002 and
2007 [Pastagia 2012]. Comparable mortality rate of 21.5 % was found
in another study considering deaths associated with all types of MRSA
infections, not only bloodstream [Datta 2008].
S. aureus is also responsible for food intoxications due to the
production of several toxins in food products [Argudín 2010]. Such
episodes are very rarely lethal and represent a minority of reported food
associated diseases [Mead 1999] [LeLoir 2003].
S. epidermidis has long been considered as a benign skin colonizer
before its ability to develop implanted device-related infections was ap-
prehended [McCann 2008] [Otto 2009]. The number of device-related
infections caused by coagulase nagative Staphylococci is estimated at
250,000 cases each year in the US, or about 1.5 % of the 150 million
devices implanted each year in this country [Raad 2007]. Because of
its ubiquity on human skin and mucosa [Grice 2011], S. epidermidis
is the most frequent causative agent of these infections [Otto 2012].
Among the consequences, patients stay longer in the hospital (7 days
on average) and the treatment represents heavy ﬁnancial burden for the
healthcare system [O'Grady 2002] [Raad 2007]. Hence, the associated
mortality rate of S. epidermidis infections ranges from 1 to 25 %
depending on situations [Otto 2012].
Being less virulent than S. aureus, S. epidermidis particularly aﬀects
immunodepressed people and neonates [Vuong 2002].
2.4.1.1 Stahylococcal virulence factors
S. aureus is a highly virulent pathogen, carrying an impressive arsenal
of toxins : Panton-Valentine leukocidin, Toxic-shock syndrome toxin,
pore-forming α-toxin, enterotoxins that possess superantigenic prop-
erties, haemolytic toxins [Bergdoll 1981] [Johnson 1991] [Lina 1999]
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[Gill 2005]. The list presented here is not exhaustive but demonstrate
the extent of S. aureus resources. Therefore, the infections it causes
are usually rapidly deteriorating patients state, under the assault of
several cytotoxic toxins. The number of antibiotic resistance genes S.
aureus isolates display associated to the quick evolution of the disease,
make S. aureus infections diﬃcult to handle for clinicians [Klevens 2007].
On the other hand, S. epidermidis has virtually no virulence factors
sensu stricto, except phenol soluble modulins (PSM), toxins with a weak
cytolytic activity. It proceeds in a diﬀerent manner to invade the host.
Indeed, the strategy developed by S. epidermidis is based on its ability
to grow in the form of bioﬁlms, the main cause of persistent infections.
2.4.2 The role of bioﬁlms in staphylococcal pathogenesis
A common scenario for bioﬁlm-related infection is as follows. After the
inital contamination of the implanted device, a long period of latent
infection is taking place during which S. epidermidis develops slowly
and fastens its anchorage in the body. Once a mature bioﬁlm is formed,
inﬂammation symptoms occur, causing discomfort to the patients
[del Pozo 2007]. This is the consequence of dispersal, the fourth phase
of bioﬁlm development, that provokes a release of planktonic cells in
surrounding tissues and blood [Boles 2011]. On top of the redoubtable
ability of S. epidermidis to resist antimicrobial therapies, bacteria
in bioﬁlms proﬁt from an increased tolerance to these antibacterial
compound [Fux 2005a] [Hoiby 2011]. Ultimately, due to the failure
of antibiotics to eradicate S. epidermidis bioﬁlms, the removal of
the infected device appears as a necessary step to eliminate them
[Shapiro 2011]. In some cases though, the pathogen dispersed in blood
by the bioﬁlm formed at a primary site of infection, i.e. medical device,
has colonized host tissues somewhere in the body. These aﬀected tissues
are called secondary sites of infection and complicate the treatment
even further [Kiedrowski 2011].
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While bioﬁlms are the cornerstone of S. epidermidis pathogenicity, it
is a less preponderant factor in S. aureus infective strategy. It is rather
a way for S. aureus to increase its persistence in the host [Fux 2005a].
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In the ﬁrst chapter, the four steps of bioﬁlm development have been
described in a manner that remained general for most bacterial genera.
Evolution has led each bacterial species to acquire a variety of speciﬁc
factors to initiate, develop and regulate its life in bioﬁlms. This section
presents the formation of bioﬁlms by S. epidermidis in details.
32
Chapter 3. Bioﬁlm formation by S. epidermidis - The
speciﬁcs
3.1 First step - Adhesion to surfaces
Adhesion to surfaces is the ﬁrst step to the formation of bioﬁlms.
The extent of colonization by the bioﬁlm crucially depends on the
establishment of adhesive bonds between bacterial cells and the
surface. In fact, adhesion remains critical throughout the life of
the bioﬁlm, to ensure that the community is not loosening its grip
on its substratum. S. epidermidis is able to bind to surfaces in two ways.
The ﬁrst is non-speciﬁc adhesion, happening through physical
interactions. Alternatively, speciﬁc S. epidermidis adhesion to host
proteins can occur thanks to receptor-ligand interactions, mediated by
speciﬁc binding cell surface proteins. Speciﬁc adhesion is an important
mechanism in the process of colonization of the host by S. epidermidis.
3.1.1 Non-speciﬁc adhesion of S. epidermidis
3.1.1.1 Theory of bacterial adhesion
S. epidermidis can adhere non-speciﬁcally on a substratum. Adhesion
occurs through the interplay of the ELectrostatic (EL), Lifshitz Van-
derWaals forces (LW), Acid-Base (AB) and OSmotic (OS) interactions
proposed by Van Oss as an extension of the Derjaguin-Landau-Verwey-
Overbeek (DLVO) theory, in 1989. Thanks to this theory, Gibbs
free energy can be calculated to assess the thermodynamic feasability
of the event. Bacteria would adhere if ∆Gtot is negative [Van Oss 1989].
Various factors aﬀect the calculation of the free energy, including pH,
ionic strength, temperature or the presence of biopolymers in suspension
[Hermansson 1999]. One other critical factor on which the free energy
components AB, LW, OS and EL all depend on is the cell-substratum
distance. As a result, ∆Gtot, computed as a sum of the EL, LW, AB and
OS interactions, is usually plotted as a function of the cell-substratum
distance, assuming all other forecited parameters are kept constant. In
Fig. 3.1, an example of plot showing the free energy as a function of
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distance of a negatively charged bacterium approaching a negatively
charged substratum is represented. In this Fig., the electrostatic (EL)
and acid-base (AB) repulsions are balanced by attractive VanderWaals
interactions.
Figure 3.1: Schematic representation of free energy components as a negatively
charged bacterium comes in contact with a negatively charged substratum, ac-
cording DLVO theory. EL, LW and AB interactions all decay with the distance.
Although it may not be properly represented on the graphs, AB and EL decay
exponentially and LW decays proportionally to 1/d2. BO is the born repul-
sion caused by the fact that atoms and molecules cannot approach one another
at a distance smaller than 0.14 nm. The resulting free energy is plotted in
red. i - The secondary minimum at which the total energy of interaction is
favorable to attraction, LW are overcoming the EL and AB repulsions. ii - A
local maximum, or energy barrier between the two minima. The total energy
of interaction is positive, adhesion is not thermodynamically favored. iii - At
a short distance, a primary minimum exist. Adapted from [Van Oss 1989].
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The presence of one or several minima and maxima in ∆Gtot indicate
a distance at which bacterial cells will respectively be retained to or
repelled from the surface with a force proportional to the depth of the
minimum/maximum. A bacterium caught in a secondary minimum
adheres in a reversible fashion. External forces such as shear stress, if
suﬃcient to outbalance the one that anchors the cell on the substratum,
can induce detachment. In an intermediate state, a bacterium can still
be weakly attached to the substrate while being carried away by the
ﬂow, this is called mobile adhesion [Boks 2009]. Reversible adhesion
can, on the one hand, turn into irreversible when bacteria "jump" the
energy barrier (see Fig. 3.1 B) to get, closer to the substrate, to the
primary minimum. At this point, the cell is anchored on the substrate
in a favorable situation with regard to free energy. This step is called
bond strengthening [Boks 2008a].
There are important assumptions in this theory coming from the
science of colloids. First, a bacterium should present a smooth cell
surface and ideally show no deformation under loading. Second, the
surface chemistry of the colloid, i.e. the bacterial cell, is not supposed to
evolve over time. Finally, the substratum should be ﬂat or with a mini-
mal surface roughness [Van Oss 1989]. It should be noticed that these
conditions are hardly ever met in real situations [Hermansson 1999].
Since roughness can induce tangential forces not apprehended by the
extended DLVO theory [Hermansson 1999], adaptations were proposed
to take surface roughness into account via a numerically calculated
surface element integration that allow better prediction of energy
proﬁles locally [Hoek 2006].
A recent work reports the calculation of a predictive free energy
∆Gtot as a function of the distance with measured contact angles of
bacteria with water, formamide, α- bromonaphthalene and methylene
iodide as well as with the zeta potential. In the absence of external forces
such as hydrodynamic shear stress, their model was able to predict the
adhesion of S. epidermidis cells to glass and hydrophobic glass at large
distance but not close to the substratum [Boks 2008b]. The authors
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recognize that precautions should be taken while interpreting DLVO
curves because it does not take into account the surface appendages
harbored by bacteria and the relative softness of the bacterial cell. Any
protrusion that diﬀers from the perfectly smooth substratum or cell
surface could cause bridging eﬀects and facilitate the transition towards
irreversible adhesion [Bos 1999] [Hermansson 1999].
Another study, focussing on the measurement of bond strength-
ening by Atomic force microscopy (AFM) on both hydrophobic and
hydrophilic glass surfaces with S. epidermidis has come to conclusions
that were not in accordance with the theory. Interestingly, the authors
observed a larger increase in bond strength over time on hydrophilic glass
compared to hydrophobic coated glass whereas the theory predicted a
larger minimum in free energy for the hydrophobic substratum. This
phenomenon was attributed to the conformational changes operated
by proteins of the cell surface to increase their interaction with the
substrate [Boks 2008a]. In this case, the adaptability of S. epidermidis
could not be integrated in the model calculations [Bos 1994].
The extended DLVO theory has its limits but can be carefully em-
ployed to explain non-speciﬁc adhesion of bacterial cells to surfaces.
3.1.1.2 Impact of surface properties on S. epidermidis adhe-
sion
Physico-chemical properties of substrata have a signiﬁcant inﬂuence on
the adhesion of S. epidermidis. On hydrophobic materials, a general
tendency is that S. epidermidis adheres in high numbers. However,
when the surface has previously been coated with host proteins,
adhesion largely decreases (up to 2 log). This was demonstrated in
vitro on PolyTetraFluoroEthylene (PTFE) coated with Fibronectin (Fn)
[Abusalim 2013], on Elasthane coated with bovine serum [Patel 2006],
and on four types of surfaces including silicone and PolyEthyleneTereph-
talate (PET) coated with bovine serum albumin (BSA) or with Fn
[Linnes 2012]. On hydrophilic materials, the eﬀect of adsorbed proteins
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on S. epidermidis adhesion to surfaces is similar as for hydrophobic ones
but to a lesser extent [MacKintosh 2006] [Linnes 2012].
These tendencies can be explained by the repelling properties
of a proteic ﬁlm on surface towards bacteria. At physiological pH,
most serum proteins are negatively charged, as is the surface of S.
epidermidis cells. In view of the DLVO theory, a signiﬁcant increase in
EL interactions occurs when bacteria come close to the protein layer
coating the surface. Hence, AB interactions between the biopolymers of
the cell surface and adsorbed proteins are also repulsive [Nune 2012].
To overcome such barriers hampering colonization of coated surfaces,
bioﬁlm formation and survival in the host, S. epidermidis expresses a
panoply of cell surface receptors to speciﬁcally bind to host proteins.
The next section presents the diﬀerent classes of these factors called
adhesins.
3.1.2 Speciﬁc adhesion of S. epidermidis to substrates
S. epidermidis adhesins are macromolecules that speciﬁcally recognize
host proteins in a receptor-ligand fashion [Patti 1994a] [Klemm 2000].
Two main groups are distinguished: the Microbial Surface Components
Recognizing Extracellular Matrix Molecules (MSCRAMMs) which are
covalently bound to the cell surface and the Secretable Expanded Reper-
toire of Adhesive Molecules (SERAMs) that are excreted in the environ-
ment, without covalent binding to the cell surface [Heilmann 2011].
3.1.2.1 MSCRAMMs
S. epidermidis genomes comprise up to 12 genes encoding MSCRAMMs.
These proteins are characterized by a LPXTG motif that allows a sor-
tase, i.e. a transpeptidase, to anchor them covalently to an amine group
of the peptidoglycan [Schneewind 1993].
Amongst the MSCRAMMs of S. epidermidis, there is a family
of protein containing several serine-aspartate repeats (Sdr). Two of
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its members are well characterized : SdrG that binds Fibrinogen
(Fg) with high aﬃnity according to a "dock, lock and latch" model
[Hartford 2001] [Ponnuraj 2003], and SdrF, a protein that recognizes
collagen [Arrecubieta 2007]. Another family of surface proteins, with-
out repeats, called S. epidermidis surface proteins (Ses), has been dis-
covered in 2005 and shown to be expressed in the course of an infec-
tion as revealed by the presence of anti-Ses antibodies in patients blood
[Bowden 2005]. Their role in S. epidermidis adhesion however, remains
unclear [Fey 2010].
3.1.2.2 SERAMs
Contrary to the MSCRAMMs, SERAMs are bound to cell surface by yet
unknown mechanisms. Several proteins fall into this category. Notably,
the Extracellular matrix-binding protein (Embp), a giant extracellular
protein enables binding to Fn [Williams 2002], GehD, a lipase with an
aﬃnity for collagen [Bowden 2002] and Ebp an analog to S. aureus
protein EbpS that binds to elastin [Park 1996]. Also, autolysins (Aae
and Atle), on top of their essential role in cell wall remodelling, were
shown to bind Fn, Fg and Vitronectin (Vn) [Hirschhausen 2010].
3.1.3 The transition from reversible to irreversible adhe-
sion
The role of adhesins in the process of S. epidermidis attachement to
substrata is to favor the transition from reversible to irreversible adhesion
(see Section 3.1.1.1). By adding up speciﬁc interactions to a situation of
reversible adhesion, a loosely bound bacterium is able to fasten itself on
its substratum by bridging the energy gap shown in Fig. 3.1. It is clear
that adhesins confer to the bacteria an ecological advantage to colonize
certain types of surfaces. They secure the adhesion of bacterial cells in
order to allow the initiation of the second phase of bioﬁlm formation :
the accumulation and the development of microcolonies (see Fig. 1.1).
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3.2 Second step - Accumulation
In this phase of the bioﬁlm development, the surface bound cells divide
and grow into microcolonies. These are multi-layered structures span-
ning in three dimensions. According to the DLVO theory, negatively
charged staphylococcal cells agglutination does not occur spontaneously
since repulsive EL interactions keep cells apart. Besides, AB interac-
tions between two cell surfaces loaded with biopolymers should also
be somewhat repulsive [Van Oss 1989]. In brief, the ∆Gtot of cell-cell
aggregation should normally be greater than zero, and cell-cell clumping
should not happen. This can be observed in pure cultures in which
planktonic bacteria seldom aggregate.
S epidermidis compensate this cell-cell repulsion through the produc-
tion of several biopolymers that make cell-cell aggregation eﬀective. In
particular, two surface anchored proteins have the ability to bring cells
together and the polymers of the EPS matrix act as a glue that engulfs
the growing microcolonies.
3.2.1 Surface proteins mediating cell-cell aggregation
These two surface proteins are the 140 kDa accumulation associated
protein (Aap) [Hussain 1997] and the 237 kDa bioﬁlm-associated-
like protein (Bhp), an homolog of Bap ﬁrst described for S. aureus
[Cucarella 2001].
Aap is a protein that requires proteolytic activation to form poly-
meric ﬁbrils [Rohde 2005]. These ﬁbrils self-assemble by dimerization
of the so-called G5 domains in the presence of Zn2+ to yield a ﬂexible,
spring-like link [Conrady 2012]. Interestingly, it was found that only
a subpopulation of S. epidermidis harbored ﬁbrils while the rest did
not. The mechanisms leading to this specialization are yet unknown
[Otto 2012]. In strains deﬁcient for PNAG production, Aap is a key
factor in bioﬁlm formation. The bioﬁlms formed by this type of strains
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are commonly referred to as proteinaceous bioﬁlms.
Bhp is a large surface protein composed of several tandem repeats.
The gene from which it is encoded can be located on pathonecity is-
lands [Tormo 2005a]. Its precise role is not yet fully elucidated. Bhp
is thought not to be necessary but rather helpful in the formation of
bioﬁlms [Lasa 2006].
3.2.2 The role of matrix polymers
The polymeric matrix of EPS is, for strains that are able to pro-
duce it, of crucial importance in the development of mature bioﬁlms
[Flemming 2010]. As it was mentioned in Section 7.2, the EPS are com-
posed, in variable proportions of polysaccharides, proteins, DNA, and
in minor quantities, lipids and minerals. In the case of S. epidermidis,
poly-N-acetylglucosamine (PNAG) also known as polysaccharide inter-
cellular adhesin (PIA) is the major compound of the matrix [Otto 2009].
The genetic determinants encoding the synthesis of PNAG are lo-
cated on the ica locus, composed of four genes icaA-D and a regulator,
icaR. IcaA and IcaD are two subunits of an N-acetylglucosamine-
transferase that assembles NAG monomers together by forming β1-6
bonds. IcaC is responsible for the elongation and the excretion of
the polymer chain. Finally, IcaB, located at the cell surface, is a N-
acetylase that cleaves some acetyl residues from elongated PNAG chains,
composed of 130 monomers on average [Heilmann 1996] [Gerke 1998]
[Otto 2012]. Fig 3.2 summarizes the production and excretion of PNAG.
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Figure 3.2: Assembly and excretion of PNAG. IcaA and IcaD polymerize the
NAG monomers (purple balls). The chains in elongation are exported outside
the cell by IcaC. IcaB ﬁnishes the process by deacetylating a portion of the
polymerized monomers (blue balls). Source : [Otto 2009].
Partial deacetylation confers to PNAG a positive charge. This
feature is critical to diminish the repulsion of the negatively charged
cells and ensure cell-cell aggregation in microcolonies. Although not
required for the formation of a bioﬁlm as such, evidences suggest
that proteinaceous bioﬁlms developped by strains deﬁcient in the ica
locus are less resistant to mechanical stresses than their homologs
producing PNAG [Rohde 2007]. Besides this role of intercellular
adhesin, PNAG also has the ability to protect S. epidermidis from the
action of antimicrobial peptides, immunoglobulins (Ig) and neutrophils
[Vuong 2004a]. Eventually, its implication in virulence is presumed but
a lack of evidence prevented authors of previous works to conclude on
the subject [Otto 2012]. In the early moments of a bioﬁlm development,
PNAG thus plays an important role that goes beyond its properties of
sticking cells together.
Another type of cell surface polymers play important role in bioﬁlm
development. Teichoic acids (TA), prominent cell surface polymers
composed of phosphate, glycerol and polyols, were found to favor
cell-cell interactions. Indeed, mutants in tagO, a gene responsible for the
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biosynthesis of wall teichoic acids (WTA), showed an impaired adhesion
and accumulation on hydrophobic polystyrene (PS), partly due to a
decrease in icaABCD expression and PNAG synthesis [Holland 2011].
Finally, over time, the proportion of EPS other than PNAG increases,
especially eDNA. Released upon autolysis (by autolysins AtlE) of cells
within the bioﬁlm [Qin 2007], eDNA plays a role in the stabilization
of the bioﬁlm (bacterial adhesion and aggregation) through favorable
acid-base interactions [Das 2010].
3.3 Third step - Maturation towards a 3-D ar-
chitecture
The growth of microcolonies, supported by PNAG and other matrix
components, leads them to increase their thickness and to merge with
adjacent microcolonies if they are close enough. At this point, due to
the heterogeneity of the conditions inside the bioﬁlm, bacteria undergo
a dramatic switch in their physiological states [Rani 2007]. Either
in response to environmental conditions, by stochastic gene activa-
tion/inactivation, distinct subpopulations appear [Stewart 2008]. Some
lose the ability to produce PNAG in a reversible fashion [Ziebuhr 1999],
others excrete small tensioactive peptides called phenol soluble modulins
(PSMs) that locally decrease the cohesion of the bioﬁlm [Wang 2011].
The result of this specialization of the subpopulations is the build
up of a multi-layered 3-D architecture. In general, it is composed of
mushroom (or tower) shaped macrocolonies in and around which water
ﬁlled channels permit the circulation of the medium [Costerton 1995].
Owing to this intraspecies diversity [Schoenfelder 2010], various pheno-
types can be observed in the bioﬁlms formed by S. epidermidis strains
[Schaudinn 2014]. Fig. 3.3 illustrates the transition from the adhering
bacteria to the mature bioﬁlm.
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Figure 3.3: Development of surface bound S. epidermidis cells into a mature
bioﬁlm. From left to right, adhesion on host matrix proteins, accumulation in
microcolonies, and maturation in a speciﬁc 3-D architecture with towers and
channels. Color gradient in the towers indicates the heterogeity of conditions
inside the mature bioﬁlm. Source : adapted from [Otto 2009].
In the maturation phase, the bioﬁlm also reinforces mechanisms of
protection towards the aggressions of its environment. First, the in-
creased proportion of EPS ensures a mechanical stability against me-
chanical disruptive forces while delaying the penetration of host im-
mune defenses as Ig and Anti-Microbial Peptides (AMPs) inside the
bioﬁlm [Vuong 2004b]. Secondly, exoenzymes such as proteases and li-
pases are produced by the cells in the bioﬁlms to actively degrade AMPs
[Lai 2007], and transform some toxic host compounds, such as speciﬁc
fatty acids, into harmless degradation products [Chamberlain 1997].
3.4 Fourth step - Dispersal
The last step to complete the life cycle of a bioﬁlm is dispersal. As
it was underlined in Chapter 1, the release of individual cells or larger
sections of the bioﬁlm is a strategy to support the colonization of new
spots. Although little is known about the dispersal mechanisms, PSMs
and proteases have been shown to be involved in a similar fashion as in
the maturation phase [Boles 2008] [Wang 2011]. Quorum Sensing (QS),
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espcially the agr system, was also pointed out as an important regulator
of detachment, through the regulation of PSM and proteases expression
[Vuong 2004b]. The speciﬁc regulatory aspects of bioﬁlms are addressed
in the next section.
3.5 Regulation of staphylococcal bioﬁlm forma-
tion
The development of a mature bioﬁlm requires a ﬁne temporal control
of the expression of factors mediating adhesion, accumulation, matura-
tion and dispersal. Besides, in order to maintain its ﬁtness in changing
conditions, a bioﬁlm should be able to respond to a series of environmen-
tal stimuli. In this section, regulatory mechanisms, i.e. transcriptional
regulation, QS and phase variation, are developed. The response to en-
vironmental stimuli is presented as well.
3.5.1 Transcriptional regulation of PNAG
The expression of PNAG, a central element in bioﬁlm regulation,
is associated with the ica locus. The transcriptional regulator IcaR
represses the transcription of the other genes of the ica locus, i.e.
icaABCD [Conlon 2002] [Gotz 2002]. The transcriptional activity
of the icaR promoter is controlled by σB which is itself inﬂuenced by
RsbV, RsbW and RsbU, i.e. regulators of sigma factor B, accord-
ing to a chain of phosphorylation (see Fig. 3.4) [Knobloch 2004].
Besides σB down-regulation of icaR trancription, SarX is able to
hamper the binding of IcaR on icaABCD promoter. Levels of SarX
are inﬂuenced by the transcriptional activator Rbf that up-regulates
sarX. Rbf thus has a positive eﬀect on bioﬁlm formation [Cue 2013].
On the contrary, up-regulation of icaR transcription can occur via
the regulatory protein Spx, leading to decreased icaABCD transcrip-
tion. Normally, ClpP protease degrade Spx and counterbalance the
repressive eﬀect of Spx on PNAG production [Pamp 2006] [Wang 2010].
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Three pathways for direct icaABCD regulation, i.e. IcaR indepen-
dent, have been described. The ﬁrst is dependent on staphylococcal
accessory regulators sarA and sarZ. The promoter of sarA is activated
by high levels of σB and high levels of SarA enhance expression of
icaABCD promoter [Wang 2008]. Contrary to SarA, SarZ has a
repressive eﬀect on icaABCD transcription. Finally, the transcription
of icaABCD is upregulated by the purine repression operon (purR)
[Tormo 2005b].
Environmental cues have also been shown to impact bioﬁlm for-
mation by S. epidermidis in vitro. For example, ethanol favors the
expression of icaABCD by repressing icaR transcription [Conlon 2002],
glucose activates the synthetic pathways of PNAG [Dobinsky 2003] and
NaCl favors icaABCD expression via RsbU and σB [Knobloch 2004]. It
has also been shown that the activity of the tricarboxylic cycle (TCA)
has a large inﬂuence over the production of PNAG . Indeed, a lower
activity of TCA cycle induce a larger amount of PNAG produced,
probably as a response to a metabolic stress. Similarly, in conditions of
high TCA cycle activity, PNAG synthesis was found to be diminished
[Vuong 2005] [Sadykov 2010]. The understanding of the exact mode of
action of such regulations is still incomplete.
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Figure 3.4: Summary of transcriptional regulation of the icaABCD operon.
The large circle deﬁnes the cell membrane. Rectangles represent genes and ovals
proteins. Arrows indicate a positive regulation whereas straight lines blocked
by a perpendicular line indicate down-regulation. Promoters are indicated by
little arrows upstream of genes. For details, see main text. Source : inspired
from [Mack 2007].
3.5.2 QS regulation
QS is the cell-cell communication mechanism used by bacteria to adapt
their behaviour in response to population density [Waters 2005]. In S.
epidermidis, two systems are reported to date : Agr and LuxS. Their
modes of action and impacts on bioﬁlm formation are presented here.
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3.5.2.1 Agr system
Agr QS is encoded by an operon composed of agrABCD and RNAIII.
It is a relatively common system among Gram-positive bacteria
[Cegelski 2008]. Its principle of action relies upon the secretion of an
Auto-Inducing Peptide (AIP). AIPs are presynthesized by AgrD, pro-
cessed and externalized by AgrB in the form of semi-cyclic molecules:
a cycle is formed by a thioester bond between a conserved cysteine and
another amino acid while a tail of 2 to 5 amino acid long is attached
to this cycle [Lyon 2004]. Fig. 3.5 shows the diﬀerent families of AIPs
discovered in S. aureus. Extracellular AIP binds to AgrC, an histidine
kinase sensor that will in turn phosphorylate AgrA, the transcription
regulator for the agr operon [Yarwood 2003]. When the concentration
in extracellular AIP reaches a threshold, suﬃcient levels of activated
AgrA are produced and the system enters in a positive feed-back loop.
Fig. 3.6 illustrates the principle of agr QS.
Figure 3.5: Four families of AIP found in S. aureus. The aminoacids are rep-
resent according to the standard one-letter code. Outlined letters represent the
amino acids of the AIP tail. The thioester bond is closing the cycle between the
cysteine (C) and the C-terminal amino acid. Residues crucial to the recognition
of AIP by AgrC are indicated by an asterisk. Source : [Lyon 2004].
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Figure 3.6: Mechanism of Agr QS in Gram-positive bacteria. The agr locus
composed of agrA-D genes encode respectively : a transcriptional regulator of
the operon (agrA), a membrane protein to export AIPs (agrB), an histidine ki-
nase receptor (agrC ), an enzyme that catalyses the production of AIPs (agrD).
RNAIII expression is under the control of phosphorylated AgrA, that in turn
depends on extracellular levels of AIP. RNAIII has pleiotropic eﬀects on gene
regulation, notably a repressive control over adhesive factors in Staphylococci.
The sequence of action is as follows: 1. AIP is recognized by AgrC, 2. and 3.
AgrC phosporylates AgrA and 4. AgrA acts as a transcriptional regulator of
the operon. Source : [Cegelski 2008].
The eﬀector molecule of Agr QS is RNAIII. This molecule regulates
the transcription rates of various target genes. Amongst these, RNAIII
exert repressive control over MSCRAMMs synthesis, therefore inhibiting
adhesion of S. epidermidis to host proteins. RNAIII also down-regulates
the production of AtlE, an enzymes known to be essential to the
release of eDNA [Qin 2007] (see Fig. 3.4). On the contrary, agr QS
boosts the expression of virulence factors and triggers dispersal by S.
epidermidis, notably via an increase in PSM, protease and lipase excre-
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tion as conﬁrmed by proteomic analysis [Vuong 2000] [Batzilla 2006]
[Kretschmer 2012]. It seems that agr governs the transition from the
colonizing to pathogenic behaviour of S. epidermidis in bioﬁlms.
Besides these direct regulatory eﬀects on bioﬁlms, Agr QS has a
pleiotropic eﬀect on bacterial growth, indirectly aﬀecting bioﬁlm devel-
opment [Mack 2007].
3.5.2.2 LuxS system
LuxS QS works through the excretion of the Auto-Inducing molecule 2
(AI2), an homoserine lactone, that is in turn internalized. The exact
mechanism of AI2 intracellular signalling are not yet fully understood
[Li 2008].
In S. epidermidis, ∆luxS mutant was found to increase the ex-
pression of the icaABCD up to four-fold, resulting in the formation of
thicker bioﬁlms in vitro [Xu 2006]. LuxS QS thus down regulates the
production of PNAG, the main component of S. epidermidis bioﬁlms.
A more recent study has shown that LuxS aﬀected ica expression in
an IcaR dependent manner in S. aureus [Yu 2012]. In addition to this
eﬀect on icaABCD, LuxS inﬂuences virulence and dispersal in a way
that remains to be elucidated.
As for Agr, LuxS has pleiotropic eﬀects on the growth of Staphylo-
cocci, not limited to the formation of bioﬁlms.
3.5.3 Phase variation
Phase variation is a mechanism by which bacteria regulate the expres-
sion of their genes in a "on/oﬀ" fashion [Seifert 1996] [Fux 2005b].
Pathogenic bacteria such as Salmonella enterica, Neisseria gonorrhae or
some streptococcal species (S. mutans, S. pneumoniae) use this mecha-
nism to silence the expression of antigenic molecules [Ziebuhr 1999].
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In S. epidermidis, one of the major driving force of phase variation
are insertion sequences (IS) or transposons. These mobile genetic
elements, described in Section 2.3, can insert themselves in speciﬁc
genes and inactive them. IS256 has been found to cause reversible inac-
tivation of the ica locus, as well as rsbU and sarA genes [Ziebuhr 1999]
[Kozitskaya 2004] [Conlon 2004]. Fig. 3.7 illustrates how IS256
participates to the genetic plasticity of S. epidermidis genomes. Be-
sides IS, phase variation can also be mediated by point mutations,
DNA rearrangements, altered methylation or frame-shift mutations
[Ziebuhr 1999] [Otto 2012]. Of note, the insertion of the transposon
Tn917 in loci involved in regulation of icaABCD expression, or in
icaABCD itself, has also been reported. This is a major mechanism
to modulate bioﬁlm regulation in S. epidermidis [Knobloch 2001]
[Dobinsky 2002].
Figure 3.7: IS256 and its eﬀects of genome ﬂexibility of S. epidermidis.
Two modes of action are shown : transposition and recombination. Source
: [Schoenfelder 2010].
Phase variation is one of the mechanisms that generate a notable phe-
notypic diversity amongst subpopulations of S. epidermidis in bioﬁlms.
It is a feature essential to the development of the speciﬁc 3-D architecture
of mature bioﬁlms and to the coordination of the bacterial population
metabolic activity [Conlon 2004] [McCann 2008].
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3.5.4 pH homeostasis
During the development of a bioﬁlm, the maintenance of stable pH
throughout the bioﬁlm is of importance. Generation of acidic metabolic
waste, in particular in the anaerobic zones of a bioﬁlm, tends to cause an
acid stress [Stewart 2008]. To counterbalance this eﬀect, a recent study
demonstrates that S. epidermidis is able to produce ammonia by degra-
dation of arginine thanks to a deiminase coded by the arc genes. Strains
lacking the Arginine Catabolic Mobile Element (ACME), i.e. carrying
the arc genes, formed signiﬁcantly less viable bioﬁlms due to a growth
dependent pH drop [Lindgren 2014].
3.6 Persistence and persister cells
To survive in challenging environments, bioﬁlms of S. epidermidis have
put persistence at the core of their survival strategy. One of the main
reasons for this increased persistence is the occurrence of dormant cells
called persisters [Lewis 2005] [Schoenfelder 2010].
The existence of persister cells was highlighted in dose-response
studies of antibiotics on bacterial populations [Bigger 1944]. They
stochastically appear in planktonic cultures as well as in bioﬁlms in
various proportions depending on, among other things, growth stage,
DNA damage and oxidative stress [Wu 2012]. Experiments have
proven that the persister phenotype was reversible [Brooun 2000]
[Keren 2004a]. It was also proposed that antibiotic tolerance exhibited
by persisters was due to the combination of slow growth and expression
of speciﬁc genes. These genes encode Multi-Drug Tolerance (MDT)
proteins that interfere with the lethal action of bactericidal antibiotics
after they bound their target [Keren 2004b]. MDT confers tolerance to
multiple antibiotics since it inactivates a target often common to several
bactericidal molecules.
In E. coli, toxin/anti-toxin (TA) systems were identiﬁed as respon-
sible for the tolerance to multiple antibiotics [Lewis 2005]. A TA
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system is composed of a toxin, and its antitoxin, usually less stable.
When in excess, the toxin inhibits a cellular target (see Fig. 3.8 B (ii)).
Examples of cellular target of TA systems are: DNA gyrase, mRNA,
ribosome, ATP synthase. TA systems can be encoded on both plasmids
and chromosomes. On plasmids, their primary function is to ensure
partitioning of the plasmids in the daughter cells during host replication
[Naito 1995] [Hayes 2003] [Cooper 2010]. Thanks to HGT, TA systems
colonize an ever increasing number of bacterial species, notably via
conjugation [Van Melderen 2009].
The occurence of persister cells induced by TA systems can be
attributed to a stochastic variation in toxin and antitoxin concen-
tration in the cytosol [Cohen 2013]. Indeed, in persister cells, the
concentration of the toxin compared to the antitoxin in their cytosol
is higher (Fig. 3.8 C) [Gerdes 2012]. As a consequence, the toxin
inactivates its cellular target, leading to slow growth. TA systems can
induce tolerance to antibiotics if they compete for the inactivation of
the same cellular target (see Fig. 3.8 B (iv)). In this case, persisters
are protected from the action of cidal antibiotics, that cannot corrupt
the cell function already inactivated by the TA toxin [Lewis 2010].
For example, aminoglycosides interrupt the translation of mRNA
into proteins and generate misfolded peptides. These create pores
in the cell membranes, leading to cell death. TA systems that inac-
tivate the ribosomes prevent the action of aminoglycosides [Lewis 2005].
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Figure 3.8: TA systems as a mechanism for persister cell formation. A. The
TA locus, with the antitoxin gene (A) and the toxin gene (T). The antitoxin
(hexagone) has three fates: be a transcriptional regulator the TA locus expres-
sion, bind the toxin to form an inactive complex or be degraded. The toxin can
be either complexed by the antitoxin or left free. B. (i) The cellular target, i.e.
ribosome, mRNA, DNA gyrase..., is working normally when there is no toxin
bound to it. (ii) The toxin left free by a lack of antitoxin, binds the cellular
target (blue oval) and induces persistence. (iii) The antibiotics bind a cellular
target without previous modiﬁcation by the toxin, the cell dies. (iv) The toxin
is already bound to the cellular target, the antibiotic cannot corrupt its target,
the cell is a persister. C. A schematic representation of the stochastic variabil-
ity in the ratio of toxin and antitoxin concentration in a bacterial population.
Persisters are characterized by higher values of this ratio, i.e. more toxin than
antitoxin available, leading to the protection of speciﬁc cellular target from the
corruptive action of antibiotics. Source : modiﬁed from [Lewis 2005].
In S. epidermidis, several Fst-like TA systems were identiﬁed
[Kwong 2010]. Fst-like system belongs to a family of RNA-regulated
toxins causing severe membrane stresses due to dramatic changes in
the expression of transporters [Greenﬁeld 2002]. The exact mechanism
of action of Fst-like system is still largely unknown [Brinkman 2013].
Also, in S. aureus, the presence of RNA cleaving TA systems of the
mazEF family has been spotted [Fu 2007]. The implications of TA
systems in the presence of high levels of persisters in staphylococcal
populations could not yet be demonstrated [Shapiro 2011]. Though,
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based on evidences in E. coli, one can reasonably suppose that TA
systems could induce the persister phenotype in Staphylococci.
Another type of mechanism related to MDT in S. aureus, is the
generation of Small Colony Variants (SCV). SCV are so called because of
the relatively small size of the colonies grown on non selective medium.
They present phenotypic and pathogenic traits that diﬀer from the
parental strain [von Eiﬀ 2008]. A majority of SCV carry mutations
in menD and hemB genes, leaving them auxotrophic for menadione,
hemin and thymidine biosynthesis [Bates 2003]. S. epidermidis is
also able to produce SCVs, as conﬁrmed by isolation from prostethic
joint infections [Maduka-Ezeh 2012]. Even though the antibiotic
tolerance of SCV is usually higher than that of the parental strain, the
mechanisms for drug tolerance by SCV are yet unknown [Lechner 2012].
There is still a controversy about the proportion of persisters in
bioﬁlms, especially whether this proportion is higher in bioﬁlms than in
planktonic cultures [Roberts 2005] [Lewis 2005]. Not withstanding the
quantity of persisters, the competitive advantage of persisters in bioﬁlms
lies in a supplementary protection provided by the EPS matrix. Indeed,
as shown in Fig 3.9, where persisters of planktonic population that sur-
vived antibiotic treatment are mopped up by macrophages in vivo, those
in bioﬁlms avoid phagocytosis. When the bactericidal agent has faded
away, the persisters in the bioﬁlm can grow again. As a consequence,
persister cells markedly improve the resilience of bioﬁlms in the presence
of antibacterial compounds, causing complications in the treatment of
bioﬁlm associated chronic infections [Otto 2008] [McCann 2008].
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Figure 3.9: Role of persisters in bioﬁlm resilience. The eﬀect of bacterici-
dal molecules on bioﬁlms (bottom) and planktonic cells in liquid medium (gray
circle at the top) are compared. Persisters (in black) are protected from phago-
cytosis by the EPS matrix of the bioﬁlm where planktonic cells are vulnerable.
Note : the layers (from greenish to blue) indicate the heterogeneity of condi-
tions in the bioﬁlm.
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The prevalence of implanted device-related nosocomial infections in-
creases every year. Nowadays, bioﬁlms are involved in 65% of these infec-
tions [de la Fuente-Núñez 2013]. In most cases, the failure of antibiotics
to cope with the infection leaves no choice but to proceed to the surgical
removal of infected devices. This therapeutic dead-end has drawn the
attention from the scientiﬁc community over the last two decades. In
the quest for novel therapeutics strategies, two main directions are be-
ing pursued: the ﬁrst is preventive by avoiding bioﬁlm formation from
the start, the second is curative by eradicating mature bioﬁlms. Both
approaches are complementary as to this day, there is no silver bullet to
prevent or treat bioﬁlm associated chronic infections. In this chapter,
when relevant, the focus will be put on methods to prevent infections by
Staphylococci.
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4.1 Preventive strategies
So far, preventive approaches to tackle the bioﬁlm issue have essentially
focussed on two means. The ﬁrst is to modify the physicochemical prop-
erties of the implantable materials in order to decrease adhesion and/or
kill bacteria upon contact. The second is to make use of host natural
defences, with appropriate vaccines, to target an infection in its early
moments.
4.1.1 Modiﬁed surfaces
Modiﬁed biomaterials aim to reduce bacterial adhesion and/or kill bac-
teria as they come in contact with their surface. Of note, all the surface
treatment applied to implantable materials should meet the requirements
of biocompatibility, i.e. support host cell growth, and not be toxic to the
host [Kohn 2004].
4.1.1.1 Anti-adhesive surfaces
The goal in designing anti-adhesive surface is to reduce the amount
of attractive interactions between the surface itself and bacteria. The
paragraphs here below present several examples of works that aimed to
achieve bacteria-repellent coatings.
The simplest approach is to increase surface hydrophilicity. Some
studies have used physical treatment such as plasma [Everaert 1998],
others have used heparin to passivate the surface towards bacterial
adhesion [Appelgren 1996]. The clinical success of this approach
was, however, quite moderate, most probably due to the variety of
mechanism that bacteria employ to achieve adhesion [Habash 1999].
Hence, polymer coating, if not covalently bound, can be displaced
either by human biopolymers or excreted bacterial polymers. The
properties of the modiﬁed surface can therefore be signiﬁcantly altered
[Rodrigues 2011]. Interestingly, in some cases, although adhesion
decreased, bioﬁlm formation in vivo was shown to be increased on
modiﬁed biomaterial compared to be untreated control [Everaert 1998]
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[MacKintosh 2006].
The main issue in the ﬁrst approach was the adsorption of biopoly-
mers, some of which facilitate bacterial adhesion. To prevent adsorption
of biopolymers, another type of surfaces was proposed. They are coated
with highly hydrated polymers such as PolyEthyleneGlycol (PEG)
[Kingshott 2003], hydrophilic polyurethanes [Pavithra 2008] or polymer
brushes, usually made of poloxamers (block copolymers) [Kaper 2003].
The eﬀectiveness of such coatings may vary greatly according to the
bacterial species involved [Hetrick 2006]. It was also noticed that
this type of surface modiﬁcations only delay initial bacterial adhesion.
Indeed, they tend to be gradually inactivated by a conditioning ﬁlm of
host proteins or dead bacteria over time [Bryers 2008].
In conclusion, these approaches to simply prevent bacterial adhesion
with coatings proved to be eﬀective in vitro, but they did not have the
expected success in clinical trials [Habash 1999]. However, recent ad-
vances in coating technologies and surface modiﬁcations have helped to
develop more reliable biomaterials, notably with respect to tissue inte-
gration [Richards 2012]. For example, a more recent trend relying on
the control of surface topography at micro- and nano-scale in order to
repel bacteria has been paid much attention to. The presence of surface
features, their height, width and spacing were shown to be critical to
prevent adhesion of bacteria and bioﬁlm development [Graham 2014].
Notably, surfaces mimicking the topography of echinoderms and shark
skin showed a pronounced inhibition of adhesion and bioﬁlm formation
by P. aeruginosa, E. coli and S. aureus [Epstein 2013].
4.1.1.2 Anti-microbial coatings
Since bacterial adhesion on implants in vivo could not be completely
avoided, much eﬀorts have been put in the design of biomaterials
releasing or immobilizing anti-bacterial compounds. Several classes of
anti-bacterial agents have been used to dope the surface of implants,
including, among others : silver ions, antibiotics, anti-microbial pep-
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tides, quaternary ammonia, lactic acid and phages [Donlan 2009]
[Rodrigues 2011]. Almost all the studies implementing this approach
have also included a surface modiﬁcation described in the previous
section, in order to keep the anti-adhesive property.
Three possibilities have been explored to dope biomaterials with
anti-bacterial agents. All three are presented in Fig. 4.1.
First, in most cases, these anti-bacterial molecules are released from
the bulk of the biomaterial by simple diﬀusion towards the environment.
It has been, for example, implemented for : PolyMethylMethAcry-
late (PMMA) bone cement supplemented with antibiotic-ﬁlled beads
[Webb 2007] and vascular grafts with an hydrogel coating soaked with
ampicillin, gentamicin or cefazolin [Pritchard 2013], in which the
hydrogel is essential to delay the release of antibiotics from minutes
to days [Blanchemain 2005]. Nanoparticles have also been employed
to increase surface/volume ratio and retention time of silver ions or to
encapsulate antibiotics in implantable materials [Rai 2009] [Huh 2011].
The major drawback of the methods is that the passivation by a
conditioning ﬁlm of proteins inside the host tends to slow the diﬀusion
process [Rodrigues 2011].
Second, biomaterials featuring a controlled release by progressive
biodegradation of the implant polymer have been developed. This
is notably the case with Poly Lactic Acid (PLA) coatings that are
degraded by the host. Antibiotics concealed in the bulk of PLA are
set free upon PLA dissolution. Such a strategy was proposed to coat
Kirschner-wires, metallic pins used in bone surgery [Gollwitzer 2003].
A last possibility consists in the direct grafting of anti-bacterial
compounds on the biomaterial. Grafted anti-bacterial agents perform
as well as their non-grafted counterparts if the linker molecule that
binds them to the substrate allows a suﬃcient mobility [Statz 2008].
Numerous studies have highlighted the in vitro eﬃcacy of the technique.
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For example, anti-bacterial properties coupled with enhanced tissue inte-
gration were observed with AMPs and arginine-glycine-aspartate (RGD)
peptides covalently bound to Pluronic F127 (a commercially available
poloxamer) grafted on biomaterials [Muszanska 2014]. Immobilization
of ampetoids (synthetic polypeptides mimicking the eﬀect of AMP but
with increased resistance to proteases [Chongsiriwatana 2008]) on TiO2
surface has proven eﬃcient in preventing bioﬁlm development while
preserving good tissue integration properties [Statz 2008].
A special mention should be made to biosurfactants as they display
both anti-adhesive and anti-microbial properties [Muthusamy 2008].
They can be glycolipids, peptides, phospholipids, fatty acids, lipopro-
teins and are synthesized by various bacterial species including: B. sub-
tilis, Lactobacillus spp., Acinetobacter calcoaceticus, P. aeruginosa and
E. coli. [Rodrigues 2011]. Their potential use in commercial implantable
devices has been demonstrated for several applications. For example,
urethral catheters pre-coated with surfactin, a biosurfactant produced
by B. subtilis, were found to reduce bioﬁlm formation of S. enterica
and E. coli as model uropathogens [Mireles 2001]. In another study,
a surfactant of Lactobacillus paracasei showed anti-adhesive and anti-
microbial activity against S. aureus and S. epidermidis among others
[Gudiña 2010]. Although the potential for biomedical applications of
biosurfactants has been largely demonstrated, three factors explain the
absence of commercial products on the market: the methods to bind
them to surfaces are not yet optimal, cost of large scale production are
still too high and toxicity towards mammalian cells requires further in-
vestigation [Rodrigues 2011].
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Figure 4.1: The three types of anti-bacterial agents releasing biomaterials.
Time scales are: T1 corresponds to the initial state of the biomaterial, before
implantation, T2 is shortly after biomaterial implantation and T3 is hours to
days after implant insertion in the body. A. Implant material is soaked in
anti-bacterial agent, upon implantation, they are progressively released in the
environment. When bulk concentration decreases an a conditioning ﬁlm forms,
diﬀusion is less pronounced. B. Implant is made of biodegradable biomaterial,
i.e. PLA, ﬁlled with anti-bacterial agents. PLA is slowly degraded inside the
host, releasing the trapped anti-bacterial molecules. C. Polymer brushes coat
the biomaterial, some of them carry anti-bacterial agents at their non surface-
bound end. Bacteria are repelled by polymer brushes and kill by contact with
anti-bacterial molecules. These surfaces are still compatible with host tissue
integration.
4.1.2 Immunotherapy
Make use of the strength of the immune system by means of im-
munotherapy to combat infections at an early stage is appealing.
Although plenty of work has been done to identify potential epitopes
expressed at the surface of bacteria in the course of infections, there
is currently no immunotherapy approved to combat Staphylococcal
infections [Kiedrowski 2011]. Yet, several therapies are still in clinical
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and preclinical trials, some others have failed to pass the tests or proved
to be ineﬃcient [Jansen 2013].
Amongst the products admitted in clinical trials, two kinds are to
be distinguished. First, the vaccines that trigger the production of
antibody directed at a certain target, known as active immunization.
Second, the therapies that stimulate the humoral response and bring
a dose of non-host produced IgGs, also called passive immunization
[Ohlsen 2010]. Both methods, though meant to be used for distinct
classes of patients, target the same following compounds expressed at
the staphylococcal surface in vivo: the PNAG, the capsular polymer
Poly Glutamic Acid (PGA), MSCRAMMs, LipoTeichoic Acids (LTA),
the iron surface determinant and toxins [Burlak 2007] [Ohlsen 2010].
Notably, an attempt to conceive a whole cell vaccine is at the phase I of
clinical trials [Jansen 2013].
The major issues in creating eﬀective vaccines to prevent staphy-
lococcal infections are the following. Firstly, not all antibodies have
the same capacity to induce the phagocytosis of bacterial cells by neu-
trophils (opsonosis). An accurate method exists to assess this feature
in vitro (i.e. OpsonoPhagocytosic Assay (OPA), an assay to measure
the rate of bacterial killing), but it is currently under used, probably
due to its complexity [Nanra 2013]. Secondly, the expression of viru-
lence factors by Staphylococci is highly dependent on the environment
they colonize, hence the intraspecies variability in virulence can be great.
Therefore, single antigens are often unable to provide eﬀective host pro-
tection against invading bacteria [Ohlsen 2010]. Finally, the patients
may react to vaccines in various ways, that clearly aﬀect the quality of
the protection. Typically, age, ﬁtness and lifestyle of individuals may
have a great impact. In addition, people more at risk for S. epidermidis
infections usually are immunodeﬁcient therefore limiting the options for
active immunization. All these factors should be taken into account in
the design of novel vaccine formulations [Jansen 2013].
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4.2 Curative strategies
Despite the tremendous research eﬀorts being made to develop preventive
strategies, many hurdles are to be crossed before they reach the market
and could be used on patients. As most probably none of them will turn
out to be 100 % eﬀective, there is a need for curative strategies that are
able to tackle bioﬁlm infections. This section reviews the currently used
therapeutic strategies and the prospective leads.
4.2.1 Antibiotics
Staphylococci in bioﬁlms are highly resistant and/or tolerant to various
antibiotics. Owing to the presence of persisters, the relatively slow
metabolism, the surface bound state [Muszanska 2012] and the frequent
occurence of resistance genes, MBEC of an antibiotic molecule can
be up to 100 times higher than the Minimal Inhibitory Concentration
(MIC) established for planktonic cells. That was shown for several
clinically relevant antibiotics including among others: rifampicin,
tigecyclin, vancomycin and ciproﬂoxacin [Molina-Manso 2012]. In
addition to the high rates of survival, sub-inhibitory concentrations
of certain antiobiotics induce a cascade of genetic response that, in
part, increases the production of PNAG [Rachid 2000] and therefore
favors the transcription of aap and atlE [Reiter 2014]. These considera-
tions have led to reconsider the paradigm of the single antibiotic therapy.
Although some antibiotics, such as daptomycin, seem to re-
main active against mature bioﬁlms of Staphylococci [García 2010a]
[Bauer 2013], the tendency is now to combine antibiotics with ei-
ther other antibiotics, or adjuvants that sensitize bacteria in bioﬁlms
[Cushnie 2014] [Brooks 2014] [Beloin 2014]. These approaches aim to
take advantage of synergistic eﬀects of two compounds to increase bac-
tericidal activity in bioﬁlms [Gill 2015]. Also, coupling two or more an-
tibiotics should limit the appearance of resistant mutants. Recent works
have shown that combinatorial anti-bioﬁlm treatment are promising. For
example, the use of peptide 1018 in combination with ciproﬂoxacin has
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proved eﬃcient to enhance killing of P. aeruginosa in bioﬁlms and de-
crease dispersal [Reﬀuveille 2014]. Other approaches, though not partic-
ularly focused on bioﬁlm resistance, could prove useful to increase the
sensitivity of bioﬁlm bacteria towards antibiotics. These are notably the
use of membrane permeabilizers or eux pump inhibitors [Gill 2015].
4.2.2 Antimicrobial peptides
AMPs are 15 to 30 amino acids long peptides synthesized by numer-
ous organisms, including crustaceans, insects, plants, bacteria, fungi
and amphibians [Jorge 2012], to protect themselves from invasion
of bacterial pathogens [Rossi 2008]. Their amphipathic properties
allow them to selectively permeabilize bacterial membranes, inducing
leakage, depolarization and death [Shai 2002] [Beckloﬀ 2007]. Known
resistance to AMPs is relatively rare, which makes them good candi-
dates to be used as anti-infective therapeutic agents [Hancock 2006]
[Sang 2008]. Recently, synthetic versions of AMPs called ampetoids,
either mimetic or non mimetic, have been shown to be more resistant to
proteolysis and as eﬃcient at lysing bacterial cells as the natural ones
[Chongsiriwatana 2008]. The still largely untapped potential for novel
natural AMPs discovery and synthesis of eﬀective peptoids is about to
be explored thanks to bioinformatic tools [Jorge 2012].
An abundant literature covering the prophylactic use of AMPs
as a pre-treatment to prevent bioﬁlm formation is available. Yet,
reports of the use of AMPs or ampetoids to control mature bioﬁlms
are relatively recent. This eﬀect was observed on S. epidermidis,
S. aureus and P. aeruginosa bioﬁlms with both natural AMPs
[Shi 2009] [Molhoek 2011] [Kharidia 2011] and synthetic ampetoids
[Flemming 2009] [Kapoor 2011] [Liu 2013]. Two general mechanisms
of action have been proposed. In the ﬁrst place, AMPs and ampetoids
disrupt the stability of the EPS matrix, therefore fragilizing the bioﬁlm
[Kapoor 2011]. Secondly, they are able to interfere with the expression
of bioﬁlm formation related genes by binding DNA [Beckloﬀ 2007]
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[Dean 2011].
Bioﬁlms may however display tolerance and resistance to AMP
and synthetic peptoids. As far as tolerance is concerned, the EPS
matrix plays a key role. Indeed, it is able to signiﬁcantly slow down
the diﬀusion of such molecules inside the community, notably thanks
to the addition of charged moeities to EPS [Folkesson 2008]. Active
mechanisms such as AMP sensing and eux pumps also participate to
the protection of the bacterial cell against AMPs [Li 2007] [Otto 2009].
Finally, resistance may occur due to mutations in intracellular targets
of AMPs [Herbert 2007].
Although the preliminary results of AMPs as anti-bioﬁlm agents are
promising, several diﬃculties lie in the path to their commercialization as
approved therapies [Jorge 2012]. First, their production is expensive and
fastidious. Then, post AMP treatment eﬀects are still largely unknown,
both regarding the response of host (e.g. immunity) and of the bioﬁlm.
Indeed, the response of the bioﬁlm to AMP is not yet well understood
[Jorge 2012].
4.2.3 Quorum sensing or quorum quenching
The inﬂuence of QS on the development of bioﬁlms was developed in
Section 3.5.2. Quorum Sensing Inhibitors (QSI), or Quorum Quenching
(QQ), interfere with QS mechanism [Hoiby 2011] at various stages
of the process: production of the AI molecules, sequestrations of
AIs or binding to the QS receptors without triggering the expected
response. Just as AMPs, QSI are synthesized by a wide variety of
organisms [Kalia 2013]. The possible application of QSI to combat
P. aeruginosa and S. aureus bioﬁlms in chronic infections has been
proposed [Bjarnsholt 2005] [Kiran 2008] [Njoroge 2009]. In general,
inhibition of QS induce a physiological shift towards less virulence and
impaired bioﬁlm formation [Kalia 2013].
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In Staphylococci, successful eradication of bioﬁlms were performed
by activating Agr QS in vitro [Lauderdale 2010] [Wang 2011]. Proof
of concept for combinatorial therapies in which QSI act as potentia-
tors of antibiotics have also been successfully performed. This was the
case for three QQ molecules (biaryl hydroxyketones) that promoted the
healing of wound infected with MRSA in bioﬁlms on animal models.
These molecules could also signiﬁcantly sensitize MRSA to nafcillin and
cephalothin [Kuo 2015]. However, in vivo, this strategy might have thus
some undesireable consequences: the release of planktonic cells in vivo
and the expression of virulence factors (for both S. aureus and S. epi-
dermidis) [Yarwood 2003] [Boles 2008].
4.2.4 Nanoantibiotics
Advances in nanotechnologies have made possible to fabricate NanoPar-
ticles (NPs) with potent antimicrobial properties [Huh 2011]. Several
types of NPs have been designed and can act according to diﬀerent
mechanisms including, among others, the local production of Reactive
Oxygen Species (ROS), protein damage, DNA mutagenesis or membrane
leakage [Hajipour 2012].
Treating bioﬁlms with NPs can be made easier by modifying their
surfaces in order to increase the on-site delivery of antibiotics. For
example, vancomycin loaded cationic liposomes displaying high aﬃnity
for S. epidermidis bioﬁlms, mainly through non-speciﬁc electrostatic
interactions and hydrogen bonding, could deliver high doses of van-
comycin to the infection site [Sanderson 1996]. Also, immunoliposomes,
coated with molecules targeting bioﬁlm components, proved eﬃcient
at selective delivery of chlorhexidine to Streptococcus oralis bioﬁlms
[Forier 2014]. Finally, nano-encapsulated antibiotics displayed increased
activity against bioﬁlms of P. aeruginosa in chronic infections in lungs
compared to classical inhaling therapies [Hadinoto 2014]. The diﬀerence
comes from the better penetration of antibiotic loaded NPs inside the
mucus and the bioﬁlm EPS [Forier 2013]. In addition, since NPs are
not recognized as foreign bodies, they are not rapidly cleared, resulting
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in an improved retention of antibiotics in close vicinity of the bioﬁlm
[Weers 2009].
Though very eﬀective and promising for the treatment of bioﬁlms
formed by multi-drug resistant bacteria, the toxicity of antimicrobial
NPs in humans should be carefully considered. Potential adverse side
eﬀects can largely outweigh the beneﬁts of using such a technology to
therapeutic ends [El-Ansary 2013]. In particular, some NPs can success-
fully cross the blood-brain barrier, a very rare and dangerous property
with regard to neurotoxicity [Hu 2010].
4.2.5 Enzymes
The production of exoenzymes is one of the key mechanisms by which
bacteria favor dispersal of planktonic cells from bioﬁlms [Lister 2014].
The same strategy can be employed by using enzymes as anti-bioﬁlm
agents, enabling for the dissolution of the matrix of EPS [Beloin 2014].
Amongst these enzymes, DNases, polysaccharidases and proteases
are good candidates to degrade bioﬁlms. For example, pulmozyme R©, a
commercial product, contains recombinant human DNAse I (rhDNAse)
as a main active principle and is able to reduce mucus viscosity due
to P. aeruginosa bioﬁlms in cystic ﬁbrosis patients [Frederiksen 2006].
The same type of rhDNAse is also able to inhibit bioﬁlm formation
by S. aureus [Kaplan 2012]. Dispersin B, a PNAG degrading enzyme
isolated from Actinobacillus actinomycetemcomitans, could signiﬁcantly
degrade the matrix of staphylococcal bioﬁlms, of which PNAG is a
major compound [Kaplan 2004] [Boles 2011]. Also, dispersin B in
combination with other antimicrobial compounds showed synergistic
eﬀect on the killing of S. aureus compared to the bactericidal molecule
alone [Darouiche 2009]. Finally, proteases have been reported to remove
bioﬁlms, although, their activity was clearly dependent on the composi-
tion of the bioﬁlm [Chaignon 2007]. Interestingly however, a recent work
have highlighted that Esp, a serine protease secreted by S. epidermidis
could inhibit and degrade mature S. aureus bioﬁlms [Iwase 2010]. It
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might be one of the strategies developed by S. epidermidis to hamper
the colonization of ecological niches by S. aureus.
Another class of enzymes, lysins, also known as PeptidoGlycan
(PG) hydrolases, is of interest in the struggle to combat bacterial
bioﬁlms. Lysins comprise bacterial lysins (exolysins, autolysins,
lysozymes) and endolysins from phages. Four mechanistic classes of
PG bond cleavage are distinguished: glycosidases, endopeptidases,
speciﬁc amidohydrolases, and lytic transglycosylases [Nelson 2012].
Gram-negative lysins show a globular structure and a molecular weight
of around 20 kDa [Briers 2007] whereas Gram-positive lysins typically
display a modular architecture with one to three domains and a higher
moleculer weight [Díaz 1990]. Functional domains of lysins can include
a Cell-wall Binding Domain (CBD) recognizing various motifs at the
cell surface, and one or more of the enzymatic activities mentioned above.
For Staphylococci, generic PG composition and hydrolase activities
of characterized lysins are schematically represented in Fig. 4.2.
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Figure 4.2: Structure of staphylococcal lysins and their PG cleavage sites. A.
Typical modular structure of stapylococcal PG hydrolases. The scale indicates
the length of the protein, in amino acids. The three domains are represented
as an example are: a CHAP (standing for Cystein Histidine dependent amin-
phydrolase/peptidase), an amidase and a CBD, usually from the SH3-5 family.
It is notably the structure of LysK, and several other phage lysins. B. Cleav-
age sites of PG hydrolases i nthe staphylococcal cell wall. NAM stands for
N-acetyl-muramic acid, and NAG for N-acetyl glucosamine. i. A N-acetyl glu-
cosaminidase cleaves at the reducing end of NAG. ii. Cleavage between NAM
and NAG at the reducing end of NAM. This activity is a N-acetly muramidase
typical of lysozymes. Of note, lytic transglycosidases cleave the same bond but
follow a diﬀerent mechanistic way [Nelson 2012]. iii. An -N-acetylmuramoyl-
L-alanine amidase cuts the bond between the glycan and peptide chains. iv
to vii. Peptide bonds are cleaved by endopeptidase with deﬁned speciﬁcities.
Source : inspired from [Nelson 2012]
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PG hydrolases have the property to lyse bacterial cells from the
outside, as it was highlighted in 1940 by Delbruck [Delbrück 1940].
Indeed, when added exogeneously to the medium, lysins degrade PG
of Gram-positive cells which lyse due to the large diﬀerence in osmotic
pressure (up to 50 atm.) of their cytosol compared to the environment
[Seltmann 2002] [Fischetti 2006]. For Gram-negative bacteria, lysis
from outside is complicated by the presence of the outer membrane,
which protects the PG from the lysins action. Lysis would occur when
lysins act in synergy with surfactants or chelators to disrupt the outer
membrane integrity [Vaara 1992] [Briers 2011].
The use of lysins as anti-microbials is appealing since they gen-
erally display a near-species speciﬁcity, rarely broader. Indeed, the
ﬁne chemical structure of PG presents variations from one bacterial
species to another, aﬀecting the susceptibility of the concerned species.
Notably, the number and type of amino acids in the side chain can
vary, the peptide bridge can connect peptide chains together at
various sites and the composition of glycan chains is variable from
one species to another [Schleifer 1972] [Vollmer 2008]. As a result,
speciﬁc species can be targeted by using a lysin as bactericidal agent
[Nakimbugwe 2006], avoiding the disadvantages of the usual broad
range antibiotics [Nelson 2012].
Concerning the resistance of bacteria to lysis by PG hydrolases,
phage endolysins should be distinguished from other lysins. Indeed,
several mechanisms of resistance have been identiﬁed for bacterial
lysins and lysozymes. For lysostaphin, a bacterial exolysin produced by
Staphylococcus simulans, three resistance mechanisms have been discov-
ered. The ﬁrst involves the lif gene or immunity factor from S. simulans
that protects the host from the lytic action of its lysin [DeHart 1995]
[Thumm 1997]. Then mutations in femA, a factor essential to methi-
cillin resistance in S. aureus, were shown to imply modiﬁcations in
the muropeptides leading to increased resistance towards lysostaphin
[Sugai 1997] [Climo 2001]. Finally, lyrA, a lysostaphin resistance
gene, was pointed out to mediated lysostaphin resistance, even though
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puriﬁed PG from resistant strains was still sensitive to lysostaphin.
This suggests that lyrA acts by aﬀecting the cell envelope without
modifying the PG chemical structure [Gründling 2006]. Similarly
to lysostaphin, resistance to lysozymes has been reported to happen
through modiﬁcations in the glycan backbone of PG [Davis 2011]. On
the contrary, there is so far no report of mutants resistant to phage
endolysins [Nelson 2012]. Two studies have tried to submit bacterial
populations to sublethal doses of endolysins but did not observe any
change in susceptibility afterwards [Fischetti 2005]. It is hypothesized
that the bacteria-phage co-evolution has driven the endolysins to target
strongly conserved PG bonds [Nelson 2012].
During the last decade, a few studies have shown that both bacterial
and phage lysins were able to eradicate staphylococcal bioﬁlms. For
example, phage endolysins Φ11 and LysK, composed of a CBD, an
endopeptidase and an amidase, dissolved S. aureus bioﬁlms in vitro in
static models [O'Flaherty 2005] [Sass 2007]. Lysostaphin proved to be
as eﬀective on S. epidermidis and S. aureus bioﬁlms in vitro and on
catheters in infected mice in vivo [Walencka 2005] [Kokai-Kun 2009].
More recently, similar results were obtained with a chimeric lysin
[Yang 2014]. These examples demonstrate the potential of lysins to play
a role in the control of bioﬁlms, mainly thanks to their ability to rapidly
lyse slow growing cells [Donlan 2008].
The potency of lysostaphin and phage endolysins to combat staphy-
lococcal infections has also been shown in vivo. For example, 50 µg of
LysGH15, a lysin isolated from a staphylococcal phage named GH15,
was able to protect mice from bacteremia following the intraperitoneal
injection of a lethal dose of MRSA [Gu 2011]. Lysostaphin has been
tested in in vivo models to cure burn wounds, ocular infections, nasal
colonization [Nelson 2012]. Additionally, studies focusing on the treat-
ment of aortic valve endocarditis in rabbits have obtained promising
results [Climo 1998] [Patron 1999].
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However, the clinical use of lysins, either topically or intravascularly,
requires a more advanced knowledge of the potential adverse eﬀects
such as allergies and anaphylactic shock and more long term eﬀects on
the kidneys and liver [Climo 1998]. Antibodies inactivating the lysins
can also be generated by the host. To test this hypothesis, studies
were conducted in vitro to assess the activity of lysins in presence of
IgGs. For Cpl-1, a pneumococcal endolysin, the acitivity of the enzyme
was slowed but still present, indicating that inactivation by IgGs was
not complete [Fischetti 2005]. The same enzyme was used in vivo for
the treatment of mice with bacteremia [Loeer 2003] or meningitis
[Grandgirard 2008] and the animals showed no signs of adverse eﬀects
while bacterial titers were signiﬁcantly reduced [Nelson 2012]. The
same was noticed for lysostaphin in the treatment of bacteriemia by
intravenous injection [Schaﬀner 1967] [Climo 1998].
Altogether, these results indicate that an enzymatic treatment of re-
calcitrant staphylococcal infections should be possible in a not so far
future. It is especially interesting since PG hydrolases have displayed
synergies with other lysins and with some other anti-microbial agents.
For example, lysostaphin and LysK (phage K lysin) lyse MRSA more eﬃ-
ciently in combination [Becker 2008], β-lactams display improved killing
of MRSA when lysostaphin is present [Kiri 2002], and ﬁnally LysH5 a
staphylococcal phage lysin acts in synergy with nisin to eradicate S.
aureus in milk [García 2010b].

Chapter 5
Objectives
Chronic foreign body infections associated with the development of
bioﬁlms represent a real threat to public health and a major burden for
health care systems. S. epidermidis, formerly considered as a harmless
commensal, now widely recognized as opportunistic pathogen is the
main aetiological agent of these infections. The core of its infective
strategy lies in the formation of a mature, persistent bioﬁlm. Therefore,
understanding how the environment is challenging S. epidermidis in its
bioﬁlm formation process, from adhesion to dispersal, is key to improve
clinical maganagement of such infections.
This study aims to get more insights on the impact of the environ-
ment on the bioﬁlm formation process of S. epidermidis as well as to
challenge mature bioﬁlms with lytic and EPS-degrading enzymes.
The emphasis will be ﬁrst set on understanding the complex
dynamics of S. epidermidis bioﬁlm formation. The particular roles of
SdrG (Fg binding cell surface protein) in S. epidermidis adhesion to
surfaces will be investigated. The dependence of bacterial aggregation
on the ionic strength will also be addressed.
In line with the increasing public health concern about bioﬁlm re-
lated infections, two strategies will be explored to prevent and challenge
bioﬁlms. First, an innovative method for the detection of surface bound
bacteria by means of electrical sensing will be evaluated. Secondly, in
the quest for novel therapeutic strategies to combat mature bioﬁlms, S.
epidermidis bioﬁlms will be challenged in vitro with cocktails of lytic
and matrix degrading enzymes.

Part II
Results

Chapter 6
Scientiﬁc strategy
To achieve the goals of this study stated in the Objectives, several state-
of-the-art techniques have been used. This Chapter presents an overview
of these methods, notably AFM and impedance spectroscopy.
6.1 Atomic Force Microscopy (AFM) on living
cells
AFM is a high spatial resolution technique that gives access to informa-
tion such as: the topography or the elasticity of a sample. The working
principle is shown in Fig. 6.1. Brieﬂy, a tip (of about 20 nm wide)
connected to a cantilever scans the surface of a sample. The deﬂection
of the cantilever in z is measured through the reﬂection of a Lazer
beam that is sensed by a photodiode. The piezoscanner on which the
sample is mounted controls the x,y,z positions. Finally, a computer
handles the feed-back loop between the deﬂection of the cantilever and
the movement of the piezoscanner.
Scanning samples can be performed either in contact mode, in which
the tip encounters the sample, that is the case for rheology assessment,
or in tapping mode, in which there is very limited contact between
tip and sample, mostly used for topographical or imaging studies
[Alessandrini 2005].
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Figure 6.1: Schematic working principle of AFM. The deﬂection of the
cantilever upon approach of the sample surface is sensed by the photodi-
ode (the lazer direction is changing). A feedback loop is operated between
the piezoscanner that holds the sample and the photodiode signal. Source :
http://pharm.virginia.edu/facilities/atomic-force-microscope-afm/
AFM has been applied to various ﬁelds such as food technology
(study of polymer rheology, or interfacial phenomena) [Liu 2011] or
materials science [Magonov 1997] but also importantly in biophysics
[Alessandrini 2005]. The application of AFM to the imaging of
live cells has yielded interesting ﬁndings on the organization of cell
membranes and the structure of cell walls [Dufrene 1999] [Dufrêne 2008].
In this study, two applications of the AFM were used : the Sin-
gle Molecule Force Spectroscopy (SMFS), also known as chemical force
microscopy and the Single Cell Force Spectroscopy (SCFS). These tech-
niques allow to measure the forces involved in the interactions of two or
a few molecules. The magnitude of the forces usually range from dozens
of picoNewton (pN) for weak forces to a couple of nanoNewton (nN) for
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strong bonds. The next sections are dedicated to the presentation of
SMFS and SCFS in further details.
6.1.1 Single Molecule Force Spectroscopy (SMFS)
In the SMFS setup, the AFM tip is chemically modiﬁed to harbor a
deﬁned chemistry or a single molecule. Sample scanning, in this case the
surface of a bacterium, is usually performed in contact mode. The tip
is brought in contact with the live bacterium and upon its retraction,
the force that retains the tip to the cell surface is recorded. Fig. 6.2
displays an example of SMFS with a Fibrinogen modiﬁed tip, as used in
this work (Chapter 8).
Figure 6.2: Example of SMFS in which a Fibrinogen modiﬁed AFM tip scans
the surface of a live bacterium trapped in a membrane. Credit: P. Herman
2014.
This technique can be performed in wet conditions, which allow to
collect information on chemical interaction of a living cell with a deﬁned
molecule in liquid. However, mastering the chemistry of AFM might
reveal challenging. In this work, SMFS was appropriate to obtain a car-
tography of the presence of SdrG, a cell surface adhesin of S. epidermidis,
on living bacteria.
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6.1.2 Single Cell Force Spectroscopy (SCFS)
In this particular application of the AFM, a single cell is attached on a
tip-less cantilever (Fig. 6.3). A colloidal bead is preferred to the tip in
order to facilitate the binding of the bacterial cell. Attachment of the
bacterium is performed with polydopamine, known as a biological glue, in
order to make sure the cell remains bound to the colloid while scanning.
Like SMFS, SCFS can be performed in liquid, a tremendous advantage
to study bacterium-substrate interactions in relevant natural conditions.
In this work (Chapter 8), SCFS was used to assess the binding of single
cells to various silicone substrates, some of which were coated by proteins,
notably Fibrinogen.
Figure 6.3: Representation of SCFS work ﬂow. A single bacterial cell shown
in green is attached to a colloid that bridges the gap to the AFM cantilever.
The cantilever brings the bacterial cell in contact with the surfaces represented
by gray disks then retracts the cell and the adhesion force is recorded. The
procedure is repeated more than 100 times for each surface. Credit: P. Herman
2014.
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6.2 Impedance spectroscopy to detect bacteria
In this work (Chapter 9), a method to selectively detect whole cell
bacteria has been developed. It is based on impedance spectroscopy.
The next paragraphs brieﬂy describe the other biosensing methods
available to date and why our choice was oriented towards impedimetric
sensing of bacteria.
A wide variety of biosensors tailored for bacterial detection exist.
The type of sensing can be: optical (using bioluminescence, ﬂuorescence
or colorimetry), acoustical, mechanical (e.g. aﬃnity-based deﬂection
of coated cantilevers), magnetic or electrical (potentiometry or charge
sensing) [Lazcka 2007] [Su 2011] [Hasan 2014]. Amongst all these
methods, impedimetric sensing as chosen for three main reasons. First
and most importantly, impedimetric sensing presents the opportunity
for advanced miniaturization and integration. Indeed, microelectrodes
used in impedance spectroscopy can be made by using classical micro-
fabrication techniques, also used in the production of microprocessors
for computers [Varshney 2009]. Second, impedimetric sensors perform
well in the detection of whole cell bacteria, especially when coupled
to microﬂuidics, removing the need for extensive sample preparation
[Yang 2008]. Finally, contrary to other sensing methods that use labels
to increase the signal, impedance spectroscopy allows a direct, label free
detection of bacteria [Tsouti 2011].
Amongst impedimetric biosensing techniques, two main classes can
be distinguished. Some detect transient eﬀect such as saline bursts orig-
inating from cell lysis (change in medium resistivity), whereas others
detect a stable eﬀect originating from the dielectric properties of bac-
terial cells. In this second category, the detection principle is based on
the shift in impedance occurring at deﬁned range of frequencies (of the
electrical signal) when a bacterium happens to be in the interelectrode
space. This shift is the bacterial impedance, Zb (see Fig. 6.4 for the
electrical circuit of label-free impedance spectroscopy). Zb arises from
the diﬀerence in permittivity of the bacterial cytosol compared to the
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external medium and from the presence of a complex double layer of
membrane and cell wall around the bacterial cell. That deﬁnes Zb, the
impedance of the bacterial cell. The measurement of Zb is optimal at
high frequencies (i.e. around 1 MHz or higher), where the signal of Zb
is much more pronounced compared to possible contamination such as
dust or aggregates of polymers.
Figure 6.4: Schematic representation of the electrical circuit of microelec-
trodes, patterned on a SiO2 wafer, for the sensing of whole cell bacteria. The
red-ﬁlled circle is a bacterium, DL means Double-Layer, C accounts for Capac-
itance, R for resistance. Credit: N. Couniot 2014.
In this work, the method used is called capacitive sensing. Interdig-
itated electrodes have been employed because their design was shown
to be adequate for bacterial detection [Tsouti 2011]. The measurements
of impedance are performed in picoFarads (pF), relating to a change in
the capacity or resistivity of the medium in between the interdigitated
electrodes. The presence of bacterial cells in the interelectrode space in-
creases the capacitance of the circuit (by addition of the Zb contribution)
and an increase in impedance (pF).
Chapter 7
Diversity in S. epidermidis
Aim
In this Chapter, the characterization of a collection of S. epidermidis
strains originating from the environment, the hospital and directly from
patients suﬀering from an infection is presented. The goal was to high-
light the genetic diversity related to the bioﬁlm forming ability of S.
epidermidis. A total of 16 genes or genetic determinants known to be
involved in bioﬁlm formation by S. epidermidis according to [Otto 2009]
were selected. Their presence or absence in the strains of the collection
was tested by PCR. Clustering methods were then used to analyse the
dataset and to highlight the main trends in the results.
Material and methods
Strain collection
A total of 134 S. epidermidis strains were collected. Fifty were isolated
from the environment, thirty six from clinical settings (i.e. various spots
in hospital rooms : sinks, bed frame, tablets) and 46 are clinical iso-
lates, originating from infected patient samples. Strains from patients
admitted in Saint-Luc hospital (Woluwe, Belgium) were isolated from
blood cultures (26 strains) and the 20 strains from Mont-Godinne univer-
sity hospital (Godinne, Belgium) were collected by swabbing of infected
wounds, catheters or samples drawn from patients. The two remaining
were ATCC reference strains : ATCC 12228 and ATCC 35984. The
strains were identiﬁed as S. epidermidis by 16S DNA sequencing or by
MALDI-TOF IVD identiﬁcation (Bruker).
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Detection of bioﬁlm related genes
The presence or absence of 16 genes or loci in the strains of the collection
was assessed by PCR. Dilutions of DNA previously extracted using classi-
cal phenol-chloroform protocols was used as template. Table 7.1 displays
the primer pairs used in this study. PCR were performed according to
the protocols described in the referenced works. Table 7.2 summarizes
the cycle that was used to perform the PCR with the primers designed
in this study.
Clustering analysis
The data collected from the PCR were then used to build a matrix of 1
and 0, corresonding to presence and absence of the genes. A dendrogram
was constructed with a hierarchical clustering method using the Ward
method to compute distance between clusters in JMP (SAS).
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Table B.1 (continued): Primers used to detect the presence of bioﬁlm
related genes in the collection of S. epidermidis strains.
Gene Primers (5' - 3') Source
sdrF F -CAATGGTTCTTCAACAGCACAGG This study
R -CTCTAAACCTGTGAATTCATATT
capA F -GTGATACGAGAGACAAAGATAGC This study
R -CAATCTCATTGACTACGACG
agrI F -GCTGCAACCAAGAAACAACC [Li 2004]
R -CGTGTATTCATAATATGCTTCGATT
agrII F -TATGCAAGCCAAGCACTTG [Li 2004]
R -GTGCGAAAGCCGATAACAAT
agrIII F -CCTTGGCTAGTACTACACCTTC [Li 2004]
R -GTGCTTGGCTTGCATAAACA
Table 7.2: PCR cycles used for primer pairs designed in this study.
Cycles Temperature (oC) Duration Step
1 x 95 5 min Denaturation
30 x
94 30 sec Denaturation
55 30 sec Hybridization
72 1 min Elongation
1 x 72 7 min Final elongation
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Results and discussion
The result of the clustering is shown in Fig. 7.1. A decomposition in 7
clusters was justiﬁed by a breaking point in the distance graph shown
at the bottom of Fig. 7.1. Clusters I, II and III are composed only of
environmental isolates strains and are rather remote to the rest of the
strains. Cluster IV regroups mainly isolates from surfaces in hospital
rooms and also contains few environmental strains. In cluster V, a
majority of environmental strains can be found along with 7 clinical
isolates. Strikingly, clusters VI and VII solely contain strains originating
from hospitals or directly from patients.
Of note, the mecA (methicillin resistance) gene strongly discrim-
inates clinical strains from environmental isolates. Close to 90 % of
strains isolated from patients samples carried mecA, while less than 10
% of environmental strains did. About 30 % of the strains originating
from surfaces in hospital rooms carried at least a copy of the mecA
gene. These data, in line with previous reports [Schoenfelder 2010]
[den Heijer 2013], show that exposure to patients within healthcare
facilities increases the likelihood for a bacterium to collect the mecA
gene, either by conjugation with other bacteria, by transformation or
by transduction with phages carrying the methicillin resistance gene.
The distribution of the strains in the clusters supports the hypoth-
esis of the eﬀect of a strong selective pressure in healthcare facilities.
To a lesser extent, the strains isolated from infected patients appear to
cluster apart from the majority of the strains collected from inert sur-
faces in hospitals, indicating that dwelling in patients body accentuates
the need for bacteria to keep, maintain or acquire bioﬁlm-related genes
[Schoenfelder 2010].
88 Chapter 7. Diversity in S. epidermidis
Figure 7.1: Dendrogram constructed from the PCR data of presence or absence
of bioﬁlm related genes in S. epidermidis strains. The colors indicate the origin
of the strains: green is environmental, blue is reference (ATCC), orange is
hospital surfaces and ﬁnally red is from patients. Numbers in capital indicate
the number of the 7 clusters. Number in arabic show the branching events.
The plot at the bottom of the ﬁgure represents the distance overcome at each
cluster join. Clustering begins from the right and goes to left. A breaking point
is clearly visible after 7 cluster joins, meaning that further clustering would not
be relevant.
Chapter 8
Adhesion of S. epidermidis
to surfaces
Contents
8.1 Role played by SdrG in S. epidermidis attach-
ment to Fibrinogen coated surfaces . . . . . . . . 90
8.2 Cell surface abundance of SdrG modulates the
aﬃnity of S. epidermidis for Fibrinogen-coated
surfaces . . . . . . . . . . . . . . . . . . . . . . . . 109
In this Chapter, two comprehensive studies of the process of S. epi-
dermidis adhesion to Fg-coated surfaces are presented. The focus was set
on SdrG, a cell surface adhesin, mainly responsible for the recognition
and the attachment of S. epidermidis to the plasma protein Fg.
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8.1 Role played by SdrG in S. epidermidis at-
tachment to Fibrinogen coated surfaces
In this section, the force with which S. epidermidis strains bind ﬁbrino-
gen (Fg) coated surfaces was assessed using an AFM approach called
Single Cell Force Spectroscopy. To this end, two isogenic strains, HB and
HB ∆SdrG have been used in order to verify that the observed forces
could indeed be attributed to the SdrG-Fg interaction. It was shown
that the so-called signature of the AFM retraction curves is typical of
a multiple domain protein unfolding with, at last, a strong rupture force.
This work brings biophysical insights into the ligand-receptor binding
of Fg and SdrG. Although the stabilisation of the ligand through a "dock,
lock and latch" mechanism was discovered in 2003, a quantiﬁcation of
the force uniting SdrG and Fg was lacking. The fact that the extent of
this force is unusually large supports the hypothesis that SdrG is a key
asset for S. epidermidis to anchors on surfaces in its human host.
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Abstract
Cell surface proteins of bacteria play essential roles in mediating the
attachment of pathogens to host tissues and, therefore, represent key
targets for anti-adhesion therapy. In the opportunistic pathogen S. epi-
dermidis, the adhesion protein SdrG mediates attachment of bacteria to
the blood plasma protein ﬁbrinogen (Fg) through a binding mechanism
that is not yet fully understood. We report the direct measurement of
the forces driving the adhesion of S. epidermidis to Fg-coated substrates
using single cell force spectroscopy. We found that the S. epidermidis-
Fg adhesion force is of around 150 pN magnitude and that the adhesion
strength and adhesion probability strongly increase with the interaction
time, suggesting that the adhesion process involves time-dependent con-
formational changes. Control experiments with mutant bacteria lacking
SdrG and substrates coated with the Fg β6-20 peptide, instead of the
full Fg protein, demonstrate that these force signatures originate from
the rupture of speciﬁc bonds between SdrG and its peptide ligand. Col-
lectively, our results are consistent with a dynamic, multi-step ligand-
binding mechanism called : dock, lock, and latch.
Introduction
S. epidermidis is a bacterial commensal of humans that colonizes the
skin. It is a common cause of infections associated with indwelling med-
ical devices [1] [2] [3]. Survival in the infected host is promoted by
the ability of bacteria to attach to the surface of indwelling devices that
have been conditioned with host plasma proteins, such as ﬁbrinogen
(Fg) and ﬁbronectin. S. epidermidis expresses on its surface a protein of
the microbial surface component recognizing adhesive matrix molecule
(MSCRAMM) family called SdrG [4] [5], which binds to the β-chain of
Fg by the "dock, lock, and latch" mechanism [6] [7]. The N-terminal
ligand-binding A region is linked to the bacterial cell by a ﬂexible stalk
comprising a variable number of repeats of the dipeptide Ser-Asp. At
the C-terminus, a sorting signal promotes covalent attachment of the
SdrG protein to cell-wall peptidoglycan. SdrG binds to a short, un-
folded peptide near the N-terminus of the Fg β-chain (residues 6-20)
[7]. The peptide docks into a trench located between the separately
folded subdomains N2 and N3 of region A. Once docked and stabilized
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by hydrophobic interactions and hydrogen bonds, a C-terminal exten-
sion of subdomain N3 undergoes a conformational change and folds over
the inserted Fg peptide to lock it in place and ﬁnally complements a
β-sheet in subdomain N2, forming the latch. Despite a detailed molec-
ular understanding of ligand binding by SdrG and other staphylococcal
MSCRAMMs gained from in vitro experiments with puriﬁed proteins, lit-
tle is known about the forces that govern attachment to and detachment
from ligand-coated surfaces. While classical microbiological assays probe
large ensembles of cells, single-cell microbiology uses advanced technolo-
gies to analyze single-cell heterogeneity and to reveal rare events and
properties that were otherwise not accessible [8] [9] [10]. Among these
new tools, atomic force microscopy (AFM) makes it possible to measure
cell surface interactions at the single-molecule and single-cell levels [10]
[11] [12] [13] [14] [15] [16]. Several protocols have been developed to at-
tach bacterial cells onto AFM cantilevers to measure bacterial adhesion
forces, including the use of chemical ﬁxation [17], electrostatic interac-
tions [18], and polydopamine adhesives [19]. Here, we combine the use
of colloidal probes and polydopamine as a new AFM-based single-cell
force spectroscopy (SCFS) approach, enabling us to quantify the speciﬁc
forces driving the adhesion of S. epidermidis to Fg-coated substrates.
The results show that the interaction between S. epidermidis and Fg
involves essentially speciﬁc bonds between SdrG and its β6-20 peptide
ligand and that the interaction force strengthens with time, consistent
with the "dock, lock, and latch" mechanism.
Materials and Methods
Bacterial cultures
We used S. epidermidis ATCC 12228 cells grown at 37 oC and 150 rpm in
Tryptic Soy Broth (TSB), unless otherwise stated. Control experiments
were performed with S. epidermidis HB strain, in which SdrG expression
was impaired by gene disruption after pG+Host9'fbe plasmid integration
in the fbe (SdrG) gene (SdrG(-)) [4]. This strain was cultivated in TSB
broth supplemented with 10 µg mL−1 erythromycin (Sigma, E5389).
The cells were harvested in the stationary phase (16-18 h) by centrifu-
gation for 10 min at 7500 x g and washed 3 times in phosphate-buﬀered
saline (PBS) buﬀer. For cell probe preparation, 50 µL of a suspension
of ca. 1 x 106 cells was transferred into a glass Petri dish.
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Bacterial Cell Probes
Using a Nanoscope VIII Multimode atomic force microscope (Bruker
Corporation, Santa Barbara, CA), triangular shaped tipless cantilevers
(NP-O10, Microlevers, Veeco Metrology Group) were slowly immersed
in a very thin layer of ultraviolet (UV)-curable glue (NOA 63, Norland
Edmund Optics) spread on a glass slide and slowly brought into con-
tact with a silica microsphere (6.1 µm diameter, Bangs Laboratories).
After 3 min of contact, the colloidal probe was cured for 10 min under
a UV lamp. The cantilever was then immersed for 1 h in a 10 mM
Tris buﬀer + 150 mM NaCl solution (pH 8.5) containing 4 mg mL−1
dopamine hydrochloride (99%, Sigma). The probe was then washed and
dried under N2. Proper attachment and positioning of bacteria on the
colloidal probe were achieved using a BioScope Catalyst (Bruker Corpo-
ration, Santa Barbara, CA) equipped with a Zeiss Axio Observer Z1 and
a Hamamatsu camera C10600. To check the viability of the bacteria, a
LIVE/DEAD BacLight Bacterial Viability Kit (Invitrogen, Kit L7012)
was used. Prior to attachment, 2 µL of a 1:1 Syto 9 (green-ﬂuorescent
nucleic acid stain)/propidium iodide (red-ﬂuorescent nuclear and chro-
mosome counterstain) mixture at 1.5 mM was added to a drop of 50 µL
of bacteria suspension and mixed thoroughly. The suspension was de-
posited in the glass bottom Petri dish, where the protein model surfaces
were previously attached, and the bacteria were left to incubate with the
dyes for 15 min in the dark. Sedimented bacteria and Fg substrates were
immersed by the addition of 4 mL of PBS buﬀer in the Petri dish. The
colloidal probe was then mounted into the atomic force microscope and
brought into contact with an isolated bacterium. After conﬁrmation of
proper attachment of the cell by ﬂuorescence imaging, the cell probe was
positioned over the Fg substrates without dewetting.
[
]Fg and β6-20 Peptide Substrates To prepare Fg-coated substrates, clean
glass coverslips coated with a thin layer of gold were immersed overnight
in an ethanol solution containing 1 mM 10% 16-mercaptododecahexanoic
acid/90% 1-mercapto-1-undecanol (Sigma), rinsed with ethanol, and dried
with N2. Substrates were then immersed for 30 min into a solution con-
taining 10 mg mL−1 Nhydroxysuccinimide (NHS) and 25 mg mL−1 1-
ethyl-3-(3- dimethylaminopropyl)-carbodiimide (EDC) (Sigma), rinsed 5
times with Ultrapure water (ELGA LabWater), incubated with 0.2 mg
mL−1 of Fg for 1 h, rinsed further with PBS buﬀer, and then immedi-
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ately used.
In a control experiment, β6-20 peptide substrates were prepared using
the same protocol, except that Fg was replaced by the β6-20 peptide
NEEGFFSARGHRPLD (Eurogentec).
Force Measurements
AFM measurements were performed at room temperature (20 oC) in
PBS buﬀer at pH 7.4 using a BioScope Catalyst AFM (Bruker AXS
Corporation, Santa Barbara, CA). Using the inverted optical microscope,
the bacterial probe was engaged onto the substrates. Multiple force
curves were recorded on three diﬀerent spots using a maximum applied
force of 250 pN, a contact time of 50 ms or 1 s, and constant approach
and retraction speeds of 1000 nm s−1. For each condition, at least three
bacteria from independent cultures were probed. Optical imaging was
used during the measurements to ensure that the cells remained properly
positioned on the cantilever.
Results
SCFS Setup
To probe the SdrG-Fg interaction on a single-cell basis, we combined the
use of colloidal probe cantilevers and a bioinspired polydopamine wet ad-
hesive (Fig. 1a) [20]. The polydopamine-coated colloidal probes enabled
us to attach single bacterial cells on AFM cantilevers without altering
their viability (Fig. 1b). Using these cellular probes, we measured the
forces between single S. epidermidis cells and Fg surfaces. Topographic
imaging showed that the morphology of Fg-coated substrata was homoge-
neous and stable upon repeated scanning, indicating strong attachment
of the macromolecules (Fig. 1c). Imaging a small area at a large force
removed the Fg layer and enabled us to assess its thickness, approx. 4
nm (Fig. 1c; see square in the center of the image).
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Figure 1: Single-bacterial cell force spectroscopy. (a) Living cells from the
pathogen S. epidermidis are picked up with a polydopamine-coated colloidal
probe, and the forces between individual bacteria and Fg-coated substrates are
measured. The enlarged view (bottom) emphasizes speciﬁc bonds between the
cell adhesion protein SdrG (green) and Fg (red). Two IgG-like subdomains
of the SdrG molecule bind to a peptide sequence of 14 amino acids found in
the N-terminal β chain of Fg (violet), through a putative dynamic multi-step
ligand binding mechanism. (b) Use of an integrated AFM-inverted optical
microscope shows that single S. epidermidis bacteria attached to the cantilever
probes are properly located and alive (green color). (c) AFM height image
(z scale = 10 nm; a vertical cross-section taken in the center of the image is
shown beneath the image) recorded with a silicon nitride tip documenting the
presence of a smooth, homogeneous layer of Fg molecules covalently attached
to carboxylterminated surfaces. To determine the layer thickness (approx. 4
nm), a small square area was ﬁrst scanned at large forces (>10 nN), followed
by recording a larger image of the same area under smaller forces.
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Measuring the Adhesion Forces between S. epidermidis
and Fg
Multiple force-distance curves were recorded between single bacterial
cells and Fg substrates. Fig. 2 shows the adhesion force and rupture
length histograms, together with representative force curves, obtained
at short contact time (50 ms) for three diﬀerent cells from independent
cultures. About 35% of the curves showed well-deﬁned force peaks of
145 ± 27 pN magnitude and 25-250 nm rupture length (cells 1 and 2).
The general features of the curves did not substantially change when
recording consecutive force curves (up to several hundreds) on diﬀerent
spots, indicating that force measurements did not alter the interacting
surfaces. While cells from independent cultures generally yielded adhe-
sion properties that were in the same range (cells 1 and 2), some cells
featured lower adhesion frequency (cell 3), an eﬀect that we attribute to
heterogeneity of the bacterial population.
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Figure 2: Measuring the adhesion forces between S. epidermidis and Fg. Adhe-
sion force (red) and rupture length (blue) histograms, as well as representative
retraction force curves (insets), obtained by recording multiple force curves in
buﬀer at short contact time (50 ms) between single S. epidermidis cells and Fg
substrates. Numbers listed in the top left corners of the graphs represent the
percentages of zero adhesion forces. Results from three cells from independent
cultures are shown (n > 400 force-distance curves for each cell).
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In the light of several independent controls (see Fig. 3 and text be-
low), we suggest that the measured force signatures reﬂect the rupture of
single (or few) SdrG-Fg complexes. The approx. 150 pN binding force is
larger than the value obtained at fairly comparable loading rates (around
60 000 pN s−1) for other cell adhesion molecules, such as cadherins [21]
and other bacterial adhesins [22] [23] including staphylococcal adhesins
[24] which suggests that multiple receptor-ligand complexes are probed
in parallel or that the SdrG-Fg bond is particularly strong. Adhesion
force peaks could not be ﬁtted with the worm-likechain(WLC) model,
which usually describes the unfolding of protein secondary structures
[25] [26]. This, together with the fact that multiple peaks were rarely
observed, could mean that the adjacent subdomains containing IgG-like
folds of SdrG are too stable to be unraveled one by one.
Notably, we found that increasing the contact time to 1 s (3) substan-
tially changed the characteristics of the force proﬁles. First, a dramatic
increase in adhesion frequency was noted (from 35 to 97%), suggesting
that the probability to form SdrG-Fg bonds increases with the interac-
tion time as observed for other receptor-ligand bonds [21] [22]. Second,
the mean adhesion force generally increased from 145 to 250-1500 pN
(cells 1 and 3). Some cells (cell 2) however did not show such a large
increase in adhesion, suggesting again that the cell population was het-
erogeneous. Nevertheless, the observed time dependency may reﬂect
the time necessary for conformational changes within the SdrG and Fg
molecules to achieve optimal ﬁtting. Speciﬁcally, the increased adhesion
force is consistent with the "dock, lock, and latch" mechanism, which is
thought to stabilize the SdrG-Fg bond. This model involves docking of
the ligand in a pocket formed between two SdrG subdomains followed
by the movement of a C-terminal extension of one subdomain to cover
the ligand and to insert and complement a β-sheet in a neighboring sub-
domain [6]. Hence, our results suggest that the increased adhesion may
originate from an increased number of SdrG-Fg bonds, as observed with
animal cells [27] and/or from enhanced stability of the bonds.
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Figure 3: Adhesion forces depend upon contact time. Adhesion force (red)
and rupture length (blue) histograms, as well as representative retraction force
curves (insets), obtained by recording multiple force curves in buﬀer at pro-
longed contact time (1 s) between single S. epidermidis cells and Fg substrates.
Results from three cells from independent cultures are shown (n > 400 force-
distance curves for each cell). Cells 1-3 are the same as those probed at short
contact time (Fig. 2).
Interaction Forces Originate from the Speciﬁc Adhesion
between SdrG and Its Fg β6-20 Peptide Ligand.
To determine the speciﬁcity of the measured adhesion forces and rule out
the possibility of artifacts associated with the cell probe preparation, sev-
eral control experiments were performed using a 1 s contact time (Fig.
4). First, use of polydopamine-coated probes instead of bacterial probes
led to a major reduction of adhesion frequency (down to 60%; Fig. 4a),
indicating that the adhesive events measured above were associated with
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the S. epidermidis surface and not the polydopamine adhesive. Second,
treatment of the cells with free Fg molecules led to a lower adhesion fre-
quency (from 90 to 76%), suggesting that blocking of the SdrG molecules
inhibits speciﬁc SdrG-Fg bonds. However, the observed inhibition was
moderate, which could mean that Fg molecules on the cell surface may
bind Fg on the substrate or that other cell surface molecules mediate
adhesion (Fig. 4b). Third, use of a mutant S. epidermidis impaired
in SdrG production (SdrG(-)) abolished most adhesion events (adhesion
frequency of only 10%), providing a direct demonstration that the mea-
sured adhesion forces are indeed associated with speciﬁc SdrG-Fg bonds
(Fig. 4c). Fourth, instead of the full Fg molecule, we tested a short
synthetic peptide (β6-20) corresponding to the SdrG binding site in Fg.6
Force curves recorded between WT S. epidermidis and a substrate cov-
ered with β6-20 peptides featured force signatures that were similar to
those obtained with the full proteins, thus conﬁrming the speciﬁc nature
of the probed interactions (Fig. 4d).
Accordingly, these observations demonstrate that the S. epidermidis-
Fg interaction forces measured here originate from the speciﬁc adhesion
between SdrG and its Fg β6-20 peptide ligand.
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Figure 4: S. epidermidis-Fg adhesion forces involve speciﬁc bonds between
SdrG and its peptide ligand. (a-d) Adhesion force and rupture length his-
tograms, together with representative force curves, obtained by recording force
curves at prolonged contact time (1 s) (a) between polydopamine-coated probes
and Fg substrates, (b) between WT S. epidermidis cells and Fg substrates in
the presence of free Fg (0.1 mg mL−1) after 1 h of incubation, (c) between
S. epidermidis mutant cells impaired in SdrG expression and Fg substrates,
and (d) between WT S. epidermidis cells and substrates covered with the Fg
β6-20 peptide. For each condition, similar data were obtained in duplicate
experiments.
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Conclusion
Knowledge of the fundamental forces driving the adhesion of Staphylo-
cocci to host cells and matrix components is critical to our understanding
of the molecular bases of staphylococcal infections. In recent years, AFM
techniques have provided quantitative information on the fundamental
forces driving the adhesion of bacterial pathogens, including Staphylo-
cocci. In particular, the use of force spectroscopy with cell probe can-
tilevers has enabled researchers to measure the adhesion forces of Pseu-
domonas aeruginosa pili [15], to probe the interaction forces of Candida
parapsilosis and P. aeruginosa to surfaces [12], to investigate the eﬀect
of cranberry on Escherichia coli adhesion [14], to study the inﬂuence
of substrate properties on the adhesion of S. epidermidis [11], and to
quantify the adhesion forces between S. epidermidis [13] or S. aureus
[16] [28] and ﬁbronectin. These results however are generally diﬃcult to
interpret at the molecular level for several reasons: cells were attached
on the cantilever using protocols that lead to cell surface denaturation
or cell death; multiple cells were attached and probed together; and cell
positioning and cell-substrate contact area were poorly controlled.
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8.2 Cell surface abundance of SdrG modulates
the aﬃnity of S. epidermidis for Fibrinogen-
coated surfaces
In this section, the role of the abundance of the SdrG adhesin on the
cell surface of S. epidermidis was investigated. Previous works have
described the mechanism by which SdrG is able to bind to Fg, alongside
with the force involved in this binding event. These results established
a correlation between the density of SdrG exhibited on the cell envelop
and the ability of single cells as well as whole bacterial populations to
adhere to Fg-coated substrates.
The results presented in this section establish that not only the
presence but also the abundance of SdrG on the bacterial cell surface
matter as it comes to adherence on a Fg coated substrate. This work
highlights the need for future studies on the pathway of fbe expression
to understand the factors inﬂuencing the density of active SdrG on the
cell envelop.
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Abstract
S. epidermidis is a world leading pathogen in health-care facilities, mainly
causing medical device-associated infections. These nosocomial diseases
often result in complications such as bacteremia, ﬁbrosis or peritonitis.
The virulence of S. epidermidis relies on its ability to colonize surfaces
and develop thereupon in the form of bioﬁlms. Bacterial adherence on
biomaterials, usually covered with plasma proteins after implantation,
is a critical step leading to bioﬁlm infections. The cell surface protein
SdrG mediates adhesion of S. epidermidis to Fibrinogen (Fg) through
a speciﬁc "dock, lock and latch" mechanism, which results in greatly
stabilized protein-ligand complexes. Here, we combine single-molecule,
single-cell and whole population assays to investigate the extent to which
the surface density of SdrG determines the ability of S. epidermidis clin-
ical strains HB, ATCC 35984 and ATCC 12228 to bind to Fg-coated
surfaces. Strains that showed enhanced adhesion on Fg-coated Poly-
DiMethylSiloxane (PDMS) were characterized by increased amounts of
SdrG proteins on the cell surface, as observed by single-molecule analysis.
Consistent with previous reports showing increased expression of SdrG
following in vivo exposure, this work provides direct evidence that abun-
dance of SdrG on the cell surface of S. epidermidis strains dramatically
improves their ability to bind to Fg-coated implanted medical devices.
Introduction
The opportunistic pathogen S. epidermidis is the main etiological agent
of infections associated with implanted medical devices, especially vas-
cular and urinary catheters [1]. In the US, infections involving S. epider-
midis are estimated to reach 200.000 cases per year [2]. Most often, these
diseases occur in a chronic form owing to the development of a bioﬁlm
on the implanted material [3] [4]. The treatment of chronic infections is
complicated by the intrinsic resistance of bacteria or tolerance of bioﬁlms
to antibiotics, resulting in a signiﬁcant burden for public health systems
[5] [6].
Bacterial contamination of implanted devices in patients can hap-
pen during surgery or while the device is being used to inject drugs
to or withdraw biological ﬂuids from patients [7]. Adhesion of bacteria
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on the surface of biomaterials will determine their ability to start an
infection. In the human body, surfaces of medical devices tend to be
readily coated by host factors upon contact with biological ﬂuids. On
its cell surface, S. epidermidis possesses a group of receptors, referred
to as MSCRAMMs (Microbial Surface Components Recognizing Adhe-
sive Matrix Molecules), that speciﬁcally bind to human proteins such
as Fg, Fibronectin (Fn) and Collagen (Cn) [8] [9] [10]. One of these
MSCRAMMs is SdrG, a protein belonging to the Serine Aspartate Re-
peat family (Sdr), anchored to the cell wall by a LPXTG motif. SdrG
mediates binding to Fg with a high aﬃnity [11]. A sequence of 14 amino
acids at the N-terminus of Fg is speciﬁcally recognized by SdrG accord-
ing to a speciﬁc "dock, lock and latch" mechanism [12]. In this model,
the target peptidic sequence is ﬁrst trapped in between the two main
domains of SdrG (N2 and N3), then, an arm of SdrG covers the peptidic
sequence of Fg to secure the interaction. Recently, SdrG was found to
bind to Fg with a force of 2 nN, which is remarkably strong [13]. It
was also shown that contact time between the two protein inﬂuences the
rate of eﬃcient SdrG-Fg binding and consequently the fate of bacterial
adhesion on Fg-coated surfaces [14].
While the molecular mechanism controlling the SdrG-Fg interaction
is well established, little is known about the impact of SdrG surface
density on the ability of various S. epidermidis strains to adhere on Fg-
coated surfaces. By combining whole population, single-cell and single-
molecule atomic force microscopy (AFM) [15] [16] approaches, we show
that S. epidermidis strains that display a higher density of SdrG on their
cell surface show enhanced adhesion to Fg-coated substrates. In light of
these data, a model is proposed in which the density of cell surface sites
displaying high Fg aﬃnity (i.e. active SdrG molecules) correlates with
the proportion of bacteria from a population that eﬀectively bind to
Fg-coated substrates.
Materials and Methods
Bacterial strains and cultures
Four S. epidermidis strains were used in this study: HB [17], HB SdrG(-)
a mutant in which the sdrG gene is deleted, kindly provided by Prof. T.
Foster [11], ATCC 12228 and ATCC 35984. Bacteria from -80°C frozen
stocks were grown on Tryptic Soy Agar (TSA, Bio-Rad) for at least 16 h
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at 37 oC. Single colonies were then used to inoculate Tryptic Soy Broth
(TSB) and cultures were carried out under agitation at 120 RPM, 37 oC
for 16 h.
Preparation of bacterial suspensions
Bacterial suspensions were prepared according to the following proce-
dure. Stationary phase cultures were centrifuged, the supernatant was
removed and the pellet was re-suspended in PBS at pH 7.4 (Tablets,
Sigma). Centrifugation were performed either once or three times, at
either 1,000 g or 6,000 g for 15 min.
Whole population adhesion assays in 96-well plates
The adhesion assays in static conditions were carried out in 96-well plates
coated with PolyDiMethylSiloxane (PDMS). The coating of the wells was
performed by adding, at the bottom of the wells, 10 µL of 1:2 (v:v) solu-
tion of PDMS (Sylgard 184, Dow Corning) in hexane (VWR), previously
ﬁltered on 0.22 µm. 96-well plates were then left to dry at 55 oC for at
least 1 h.
To coat the PDMS wells for whole population adhesion assays, they
were ﬁrst ﬁlled either with PBS or a 0.22 µm ﬁltered solution of Human
Fg (Sigma) 0.5 mg/ml in PBS or Bovine Serum Adult (BS, Sigma) di-
luted 1:10 in PBS, also previously ﬁltered on 0.22 µm and left to incubate
at 37 oC for 1 h. Afterwards, 150 µL were withdrawn, and 150 µL of
PBS were added as a rinse. This rinsing step was repeated ﬁve times.
50 µL of liquid were left in the wells at each step to avoid un-wetting.
In the last rinsing step, 100 µL of liquid was withdrawn and 100 µL of
bacterial suspension was added. The content of each well was homog-
enized by pipetting up and down twice. Incubation was performed for
1 h at 37 oC. The same rinsing procedure was applied to the plates to
remove unbound bacteria. Each strain was tested at least in four wells
for each PDMS surface type (bare, Fg or BS coated) and repeated three
times with independent cultures.
To quantify bacterial adhesion at the bottom of the wells, two bright
ﬁeld micrographs were taken in each well using a 40x long working dis-
tance objective (numerical aperture 0.6, Fluotar, Leica) mounted on an
inverted microscope (Leica, DMI 6000) equipped with a sensitive B/W
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cooled CCD camera (Leica, DFX 365). Surface bound bacteria were
counted in ImageJ thanks to the particle analyzer function, after an
appropriate thresholding was performed. Results (number of bacteria
per image (covering 75.600 µm2)) were converted into bacterial surface
densities expressed as the number of bacterial cells/mm2.
Single molecule force spectroscopy
Single-molecule force spectroscopy (SMFS) measurements were performed
at room temperature (20 oC) in PBS buﬀer using a Nanoscope VIII
Multimode AFM (Bruker corporation, Santa Barbara, CA) and oxide
sharpened micro-fabricated Si3N4 cantilevers with a nominal spring con-
stant of ∼ 0.01 N m−1 (MSCT, Microlevers, Bruker Corporation). The
spring constants of the cantilevers were measured using the thermal noise
method (Picoforce, Bruker). Bacterial cells were immobilized by mechan-
ical trapping into porous polycarbonate membranes (Millipore, Billerica,
MA) with a pore size similar to the cell size [18] [19]. After ﬁltering a cell
suspension, the ﬁlter was gently rinsed with PBS, carefully cut (1 cm x
1 cm), attached to a steel sample puck using a small piece of double face
adhesive tape, and the mounted sample was transferred into the AFM
liquid cell while avoiding de-wetting.
Fg-functionalized tips were obtained using PEG-benzaldehyde link-
ers [20]. Prior to functionalization, cantilevers were washed with chloro-
form and ethanol, placed in an UV-ozone-cleaner for 30 min, immersed
overnight into an ethanolamine solution (3.3 g ethanolamine into 6 ml
of DMSO), then washed 3 times with DMSO and twice with ethanol,
and dried with N2. The ethanolamine-coated cantilevers were immersed
for two hours in a solution prepared by mixing 1 mg Acetal-PEG-NHS
dissolved in 0.5 ml of chloroform with 10 µl triethylamine, then washed
with chloroform and dried with N2. Cantilevers were further immersed
for 5 min in a 1 % citric acid solution, washed in Ultrapure water (ELGA
LabWater), and covered with a 200 µl droplet of PBS solution contain-
ing human Fg (2 µM) to which 2 µl of a 1 M NaCNBH3 solution were
added. After 50 min, cantilevers were incubated with 5 µl of a 1 M
ethanolamine solution in order to passivate unreacted aldehyde groups,
and then washed three times with PBS and lastly with PBS supple-
mented with 0.01 % NaN3 for storage. Bovine Serum Albumin (BSA)
tips for control experiments were obtained according to the same proto-
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Bare tips were ﬁrst used to localize and to image individual cells and
then replaced by Fg-tips. Adhesion maps were obtained by recording
32 x 32 force-distance curves on areas of 500 x 500 nm, calculating the
adhesion force for each force curve and displaying the adhesive events as
grey pixels. Unless speciﬁed otherwise, all force curves were recorded at
100 ms contact time, with a maximum applied force of 250 pN and using
a constant approach and retraction speed of 1,000 nm s−1.
Single-cell force spectroscopy
PDMS-coated surfaces
Round glass cover slips were spin coated with PDMS. Brieﬂy, a 1:5 solu-
tion of PDMS (Sylgard 184) in hexane (VWR) was prepared and 0.2 ml
of this solution was dropped onto the cover slips before they were spun
at 3,000 rpm for 1 min in the spin-coater (Technologies, model: WS-
400B-6NPP/Lite). Surfaces were then cured at 95 oC for 1 h to allow
to PDMS to polymerize. PDMS coated cover slips were stored at room
temperature in sealed Petri dishes until use.
Fibrinogen and bovine serum-coated substrates
To prepare Fg-coated substrates, as well as bovine serum substrates,
for single-cell probe experiments, glass cover slips coated with a thin
layer of gold were immersed overnight in an ethanol solution contain-
ing 1 mM of 10 % 16-mercapto-dodecahexanoic acid, 90 % 1-mercapto-
1-undecanol (Sigma), rinsed with ethanol, and dried with N2. Sub-
strates were then immersed for 30 min into a solution containing 10
mg ml-1 N-hydroxysuccinimide (NHS) and 25 mg ml-1 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) (Sigma), and rinsed ﬁve times
with Ultrapure water (ELGA LabWater). For Fg-coated surfaces, sub-
strates were incubated with 0.5 mg ml−1 of Human Fg (Sigma) for 1 h,
rinsed with PBS buﬀer, and immediately used without de-wetting. For
BS surfaces, substrates were incubated with bovine serum diluted 1:10 in
PBS, rinsed with PBS buﬀer, and immediately used without de-wetting.
Single-cell force spectroscopy measurements
Bacterial cell probes were obtained as previously described [21] [22].
Brieﬂy, colloidal probes were obtained by attaching single silica micro-
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sphere (6.1 µm diameter, Bangs laboratories) with a thin layer of UV-
curable glue (NOA 63, Norland Edmund Optics) on triangular-shaped
tipless cantilevers (NP-O10, Microlevers, Veeco Metrology Group) and
using a Nanoscope VIII Multimode AFM (Bruker corporation, Santa
Barbara, CA). The cantilever was then immersed for 1 h in a 10 mM Tris
Buﬀer, 150 mM NaCl solution (pH 8.5) containing 4 mg ml−1 dopamine
hydrochloride (99 %, Sigma). The probe was then rinsed in 10 mM Tris
Buﬀer, 150 mM NaCl solution (pH 8.5) and used directly for cell probe
preparation. The nominal spring constant of the colloidal probe can-
tilever was ∼ 0.06 N m−1, as determined by the thermal noise method
(Picoforce, Bruker).
For cell probe preparation, 50 µl of a suspension of ca. 1 Ö 106
CFU were transferred into a glass Petri dish in which the diﬀerent sub-
strates were attached. The cells were stained in the dark during 15 min
using a Baclight viability kit (Invitrogen, kit L7012) following the man-
ufacturer instructions to check the viability and positioning of the cell.
After staining, 4 ml of PBS were added to immerse bacteria and the
surfaces. The colloidal probe was brought into contact with an isolated
bacterium. Single bacteria were attached on the centre of the colloidal
probes using a Bioscope Catalyst AFM (Bruker Corporation, Santa Bar-
bara, CA) equipped with a Zeiss Axio Observer Z1 and a Hamamatsu
camera C10600. When proper attachment of the cell was conﬁrmed by
ﬂuorescence imaging, the cell probe was positioned over the appropriate
substrate without de-wetting. Single-cell interaction forces with surfaces
were measured at room temperature (20 oC) by recording multiple forces
curves on three diﬀerent spots, using a maximum applied force of 250
pN, 1 s contact time, and constant approach and retraction speeds of
1,000 nm s−1. For each condition, at least three bacterial cells from in-
dependent cultures were probed, 150 times for BS surfaces, and at least
350 times with PDMS and Fg-coated substrates.
Statistical analysis
Results of whole population assays were treated with JMP© (SAS) to
calculate the means, standard deviations and conﬁdence intervals at 95
% of bacterial surface densities on coated or bare PDMS surfaces.
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Results
Fg binding activity of SdrG is sensitive to repeated fric-
tional forces
The impact of centrifugation on the preparation of bacterial suspensions
was assessed by means of whole population adhesion assays to Fg-coated
PDMS. In brief, the bacterial suspensions were removed after 1 h of incu-
bation in contact with the surface and the wells were thoroughly rinsed
with PBS. Adherent bacterial cells were numbered on microscopic pic-
tures to determine the surface density in terms of cells per mm2. Fig.
1A presents the results for suspensions obtained by centrifuging the liq-
uid cultures three times either at 1,000g or 6,000g for 10 min. Almost
twice as many bacteria from the suspension centrifuged three times at
1,000g remained bound to the Fg-coated PDMS surface compared to
the suspension centrifuged at 6,000g. These results strongly suggest a
loss in SdrG activity in response to a higher centrifugation speed. The
adherence to Fg-coated surfaces of bacterial cells that were centrifuged
either once or three times at 6,000g was tested (Fig. 1B). Strikingly,
increasing the number of centrifugation steps decreases the ability of a
population of S. epidermidis to attach to surface bound Fg. Repeated
exposures of the cell surface to mechanical stresses partially inactivate
SdrG and may lead to underestimate its role in bacterial adhesion. In
the following experiments, the preparation of bacterial suspensions was
performed with only one centrifugation step to preserve the activity of
SdrG on the bacterial cell surface.
Whole population adhesion assay of four S. epidermidis
strains on bare and coated PDMS substrates
Fig. 2 presents the results of whole population adhesion assays of four S.
epidermidis isolates: ATCC 12228, ATCC 35984, HB and HB SdrG(-),
an isogenic mutant in which fbe has been knocked out, to PDMS sur-
faces, either bare or coated with BS or Fg in modiﬁed multi-well plates
(Fig. 2A).
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Figure 1: Inﬂuence of centrifugation on the adhesion of S. epidermidis strain
HB to Fg-coated PDMS. Whole population adhesion assays performed with
bacterial suspension of the HB strain centrifuged three times at 1,000 and
6,000g (A) and either once or three times at 6,000g (B). Plots represent the
number of bacterial cells per mm2 on the surface of the well. Error bars are
conﬁdence intervals at 95 %.
On bare PDMS, all strains tested in this study strongly adhered to
cover the entire surface of the wells entirely as shown in Fig. 2B. This
situation is achieved when around 150.000 cells can be found per square
mm. On PDMS coated with BS, bacterial adhesion was generally weak
(at least to orders of magnitude less than on bare PDMS). Bacterial sur-
face densities of all tested strains could not be statistically discriminated
and remained just above or close to the limit of detection of our method,
i.e. 500 bacteria/mm2.
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Figure 2: Whole population adhesion assays on bare and coated PDMS sur-
faces in 96-well plates. (A) Plot of the density of surface bound bacterial cells
is expressed as the log10 of the number of bacterial cells per mm2 on the surface
of the well. Adhesion of S. epidermidis strains ATCC 12228, ATCC35984, HB
and HB SdrG(-) to PDMS either bare or coated with Fg or BS is represented.
Error bars are conﬁdence intervals at 95 %. (B-E) Micrographs of the surface
of a well of Fg-coated PDMS at the end of the adhesion assay performed with
suspensions of ATCC 35984, ATCC 12228, HB and HB SdrG(-) respectively.
The scale bar indicates 25 µm.
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On Fg-coated PDMS, SdrG(-) behaved as for the reference BS-coated
PDMS, with about 1,000 surface-bound bacteria/mm2 (see Fig. 2 E).
This means that the mutant strain SdrG(-) interacts with the layer of
adsorbed Fg in the same way as with a layer of other proteins, as expected
given the absence of SdrG on its cell surface. For the other strains, WT
HB strain (see Fig. 2 D) adhered signiﬁcantly better than ATCC 12228
by 0.6 log (see Fig. 2 C), and the latter displayed a signiﬁcantly higher
aﬃnity for Fg-coated surfaces than ATCC 35984, also marked by a 0.6
log diﬀerence in the bacterial surface density (see Fig. 2 B). The adhesion
of ATCC 35984 on Fg could just be discriminated from its adhesion to
the control BS-coated surface.
Single-cell adhesion forces
The binding forces between single S. epidermidis cells and PDMS, Fg-
coated and BS-coated surfaces were then measured using SCFS [21] [22].
As illustrated in Fig. 3A, single-bacterial cells were picked up with
colloidal probe cantilevers coated with polydopamine. Force-distance
curves were then recorded between the cellular probes and the diﬀerent
substrates. Fig. 3B shows the adhesion force histograms, as well as
representative force curves, obtained between three diﬀerent cells (black,
red and green histograms) of ATCC 12228, ATCC 35984, HB and HB
SdrG(-) strains and bare, BS-coated and Fg-coated PDMS surfaces.
On bare PDMS, all strains displayed 100 % of adhesive events, indi-
cating strong binding to hydrophobic surfaces. The binding forces varied
amongst the strains, from ∼ 250 pN to 1,500 pN. These forces most prob-
ably result from hydrophobic interactions between the cell surfaces and
PDMS. The surface hydrophobicity of S. epidermidis has been reported
to be strain-dependent [23] and be essentially mediated by surface pro-
teins such as AtlE and Aae [8]. By contrast, on BS-coated surfaces,
ATCC 35984, HB and SdrG(-) cells showed hardly any binding, while
ATCC 12228 featured adhesion forces of 50-100 pN in 20 % of the curves.
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Figure 3: Single-cell force spectroscopy (SCFS) of the interaction between S.
epidermidis strains and PDMS, Fg-, and BS-coated substrates. (A) Schematic
representation of the SCFS protocol. The bacterial probe is composed of a
bacterial cell, attached to a colloidal bead immobilized onto a tipless AFM
cantilever. The same bacterial probe is brought into contact with PDMS,
Fg, and BS-coated surfaces. (B) Adhesion force histograms, together with
representative force curves (x axis represents the distance (in nm) while the
y axis is the force (in pN), for the four S. epidermidis strains ATCC 12228,
ATCC 35984, HB and HB SdrG(-) interacting with the three types of surfaces.
The three colors (black, red and green) represent the results obtained with
three independent bacterial cells.
On Fg-coated surfaces, the diﬀerences between the strains were more
pronounced. While there was hardly any adhesion with ATCC 35984,
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one out of the three ATCC 12228 cells showed strong interactions towards
the Fg-coated surface. This intra-strain variation reﬂects heterogeneity
of the cell population. The force value (∼ 2.1 nN), as well as the force
signatures, were similar to those previously observed and associated with
the Fg-SdrG "dock, lock and latch" binding mechanism [13]. The ad-
hesive ATCC 12228 cell presented a relatively low adhesion frequency
of 30 % compared to what we found previously [13]. For strain HB,
the adhesion frequency, the recorded force value and the force signatures
were comparable to what was previously observed [13]. S. epidermidis
HB however showed greater adhesion reﬂecting the possibility of probing
multiple SdrG-Fg interactions in parallel. HB SdrG(-), in which the fbe
gene has been disrupted, was then used to conﬁrm the speciﬁcity of the
SdrG-Fg interactions. As expected, HB SdrG(-) cells showed little to no
adhesion.
Finally, BS-coated surfaces were tested to further control the speci-
ﬁcity of binding on PDMS and Fg-coated substrates. ATCC 35984, HB
and HB SdrG(-) cells showed hardly any adhesion reﬂecting the spe-
ciﬁc nature of the adhesion forces. ATCC 12228 however showed little
adhesion characterized by weak adhesion forces (< 250 pN) with a low
adhesion frequency (18 to 26 %).
In general, the trends observed in SCFS results are in line with those
of whole population adhesion assays. Adhesion to Fg-coated surfaces
occurring through the speciﬁc SdrG-Fg recognition is well documented
in the SCFS data of the HB strain and still present but less marked in
the strain ATCC 12228, whereas ATCC 35984 and SdrG(-) showed no
sign of aﬃnity for Fg. Hydrophobic PDMS is very reactive towards S.
epidermidis cell surfaces and the protein layer covering the BS-coated
PDMS almost totally inhibits the cell-surface interactions resulting in
very low adhesiveness.
Mapping single SdrG proteins on the S. epidermidis cell
surface
AFM-based single molecule force spectroscopy (SMFS) [24] [25] was used
to map the distribution of single SdrG molecules on living bacteria. The
cell surface of the ATCC 12228, ATCC 35984, HB and HB SdrG(-)
strains was probed with a Fg-modiﬁed tip in order to detect the pres-
ence of SdrG (Fig. 4). Spatially-resolved SMFS of live cells immobilized
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on porous membranes (Fig. 4A) allowed us to directly measure the
localization and binding strength of single adhesins. Adhesive events
were attributed to the speciﬁc detection of single SdrG molecules for
two reasons: ﬁrst, the procedure that we used was already validated in
previous work [13], second, use of irrelevant tips, i.e. tips functionalized
with BSA, hardly gave any adhesion forces on the four strains (Fig. 5,
available in Supplementary information). The maps resulting from these
experiments are shown in Fig. 4B; they display the spatial distribution
of single SdrG molecules of a 0.25 µm2 area on the cell surface which
represents about 1/10 of the total bacterial cell surface.
The highest density (between 19 and 29 %) of SdrG molecules was
found on the HB strain. The strain ATCC 12228, ranked second as one
of the tested cells, displayed 12 % of adhesive events, while the cell sur-
faces of the two others were almost non-adhesive. This behavior could
reﬂect the natural heterogeneity of the bacterial population. Indeed,
stochastic gene expression can generate diversity amongst the cells of a
population [26] [27]. For the mutant strain SdrG(-), two cells displayed
10 % of adhesive events but these interactions are likely to be non-speciﬁc
since no typical SdrG-Fg force signatures were observed (Fig. 4C). Fi-
nally, ATCC 35984 was essentially non-adhesive (99 % of non-adhesive
events). This indicates that ATCC 35984 has the same reactivity to-
wards Fg as the mutant strain in which the fbe gene coding for SdrG has
been deleted. As this strain carries a copy of fbe, its lack of adhesion to
Fg could be explained by a strain dependent genetic regulation, possibly
cross-inﬂuenced by other regulatory/signaling pathways. The possibility
to have a signiﬁcant crowding by other cell surface polymers that would
reduce the opportunity for SdrG to appropriately bind to Fg cannot be
excluded.
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Figure 4: Imaging single SdrG proteins on the S. epidermidis cell surfaces
using single-molecule force spectroscopy (SMFS) with Fg-modiﬁed AFM tips.
(A) The surface of a bacterial cell trapped in a porous membrane is probed with
a Fg-modiﬁed tip. Deﬂection image shows the emerging part of the trapped cell.
(B) Adhesion forces maps (500 nm x 500 nm) recorded on the diﬀerent strains
using Fg-tips. Every bright pixel documents the detection of a single SdrG
protein. Percentages indicated on top of the maps correspond to the detection
frequency for every map. The data were obtained from three independent cells
for each strain. (C) Adhesion force histograms (x -axis represents the magnitude
of the binding forces while y-axis represents the percentage of events) together
with representative force curves. For HB and ATCC 12228 strain, the large
forces (∼ 2 nN) are attributed to the binding of SdrG to Fg. The three colors
(black, red and green) represent the results obtained with the three independent
bacterial cells of each strain.
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These SMFS results provide direct indication as to the abundance
of SdrG on the cell surface of S. epidermidis strains. These strains can
be classiﬁed in the following order: HB > ATCC 12228 > ATCC35984
' SdrG(-). This corresponds to the conclusions drawn from the whole
population adhesion assays and the SCFS data on Fg-coated surfaces.
Discussion
Adhesion of bacteria on implanted biomaterials determines their fate in
the host. Bacterial anchorage on surfaces paves the way to the develop-
ment of bioﬁlms and determines the ability to cause chronic infections
[7]. In S. epidermidis, SdrG mediates strong and speciﬁc binding to Fg,
a molecule most often present in the conditioning ﬁlm of proteins that
forms upon implantation of devices [28]. In this paper, we present pieces
of evidence that underline the importance of the cell surface abundance
of SdrG in the ability of single cells and whole populations to eﬃciently
adhere to surface bound Fg.
First, it was observed that the Fg binding activity of SdrG on the
cell surface is inﬂuenced by strong frictional forces. Adhesion assays per-
formed with bacterial suspensions from the same culture prepared using
distinct centrifugation parameters resulted in decrease bacterial surface
density on Fg-coated PDMS for the suspension submitted to repeated
centrifugation steps or to a higher centrifugation speed. Centrifugation
has recently been reported to cause damages at the bacterial cell surface,
notably causing a decrease in S. aureus adhesion to glass substrates [29].
It is likely that the quaternary structure of SdrG is altered by excessive
frictional forces occurring between two cells surfaces, therefore impair-
ing its ability to speciﬁcally recognize Fg. As a consequence, reducing
manipulations that involve frictional forces as much as possible is highly
recommended when studying the Fg-binding function of SdrG.
Using complementary population- and single-cell-based approaches,
the adhesion of S. epidermidis to Fg-coated surfaces was found to be
strongly strain dependent. Indeed, SCFS showed that the aﬃnity of
HB strain for surface bound Fg was high, ATCC 12228 aﬃnity was less
marked whereas ATCC 35984 and SdrG(-) did not display any speciﬁc
recognition of Fg. In line with these conclusions, the adhesion of whole
population assays resulted in high surface bacterial density of the HB
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strain, moderate adhesion of ATCC 12228 and the two other strains dis-
played the same level of adhesion as on the control BS-coated PDMS,
indicating the absence of speciﬁc SdrG-Fg recognition.
Based on these results, it was postulated that the diﬀerences between
strains could originate from variations in the abundance of SdrG on the
cell surface. To get more insights on the distribution of active SdrG
molecules on the S. epidermidis surface, SMFS with a Fg-modiﬁed AFM
tip was used to probe the surface of the strains. The proportion of sites
that speciﬁcally recognized Fg were numerous for HB strain, with about
20 % of the surface of three independent HB cells that interacted with Fg
according to the "dock, lock and latch" mechanism. For ATCC 12228, 12
% of the surface of one ATCC 12228 cell did recognize Fg, but no SdrG
could be detected on the other two cells tested. On the last two strains
ATCC 35984 and HB SdrG(-), the SdrG adhesin was not detected on
the cell surface. Our interpretation is that the abundance of SdrG on
the cell surface determines the ability of single cells and whole bacterial
population to remain bound on a surface conditioned with Fg.
The results of bacterial adhesion on bare and BS-coated PDMS lead
us to argue on the ecological role of SdrG in S. epidermidis. Indeed,
since the attractive hydrophobic surfaces become repelling as they are
conditioned with serum proteins [30] [31], SdrG provides bacteria with
the ability to counterbalance the eﬀect of the adhesion-inhibiting layer
of proteins and mediate adhesion to the surface.
The expression of fbe, at both mRNA and protein levels, has already
been shown to be rather low in in vitro culture and to signiﬁcantly in-
crease following exposure to in vivo environments, i.e. in a murine model
[32]. In S. aureus, the expression of many virulence factors, including
the ﬁbrinogen binding protein, is signiﬁcantly higher in human blood as
conﬁrmed by transcriptome analysis [33]. In the same vein, the expres-
sion of MSCRAMMs in S. aureus has recently been reported to strongly
increase in the presence of human plasma in vitro [34].
Even though the regulatory pathway involved in fbe expression has
not yet been elucidated, it is clear that S. epidermidis has developed a
strategy to crowd its surface with SdrG when the bacteria are inside their
host. Taken together with the results of this work, this suggests that S.
epidermidis responds to environmental changes in order to improve its
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adhesiveness to surfaces partially coated by Fg, such as indwelling med-
ical devices and host tissues. It is generally admitted that increased
adhesion to biomaterials is a key step for S. epidermidis to establish in
the host in the form of a bioﬁlm, therefore causing chronic infections.
In future work, it would be interesting to further investigate the im-
pact of SdrG clustering on cell adhesion, including further investigation
of the cell-to-cell variability. For instance, one could collect cells that
adhere more strongly to ﬁbrinogen and assess the surface density and
clustering of SdrG to see whether those two factors are important for
the adhesion phenotype.
In conclusion, this paper establishes a link between the abundance
of SdrG on the cell surface of S. epidermidis and the adherence of this
species to the surface of materials coated with Fg, i.e. vascular catheters
and prostheses. Future works identifying the molecular regulation path-
ways that control fbe expression and surface density of SdrG and, hence,
the adherence to Fg-coated surfaces would help to understand the critical
factors that govern the onset of a chronic nosocomial infection involving
bioﬁlms of S. epidermidis.
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Supplementary information
Figure 5: Probing the cell surface of S. epidermidis strains using single-
molecule force spectroscopy (SMFS) with irrelevant BSA-modiﬁed AFM tips.
(A) Adhesion forces maps (500 nm x 500 nm) recorded on the diﬀerent strains
using BSA-tips. Percentages indicated on top of the maps correspond to the
detection frequency for every map. The data were obtained from two inde-
pendent cells for each strain. (B) Adhesion force histograms (x-axis represents
the magnitude of the binding forces while y-axis represents the percentage of
events).
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Chapter 9
Detection of surface-bound
Staphylococci
This Chapter focuses on the selective detection of bacteria by means of
an electrical biosensor. An experimental setup combines impedimetric
detection of surface adhering bacteria on micro-electrodes and optical
follow up by microscopy. The originality of this work resides in three
essential points. First, the detection principle is solely based on intrinsic
dieletric properties of bacterial cells whereas current methods involve
electrochemical reactions or cell lysis. Second, the setup combines both
electrical and optical sensing to accurately attribute electrical signals
in the light of microscopic events. Finally, a strategy is proposed that
selectively identiﬁes the genera or the species of the attached bacteria
with the help of lytic enzymes added exogenously.
The proof of concept presented here is based on the example of
bacterial detection in urine but this technique is not limited to this
particular application.
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Abstract
Point-of-care (PoC)diagnostics for bacterial detection oﬀer tremendous
prospects for public healthcare improvement. However, such tools re-
quire the complex combination of the following performances: rapid-
ity, selectivity, sensitivity, miniaturization and aﬀordability. To meet
these speciﬁcations, this paper presents a new selectivity method involv-
ing lysostaphin together with a CMOS-compatible impedance sensor for
genus-speciﬁc bacterial detection. The method enables the sample ma-
trix to be directly ﬂown on the polydopamine-covered sensor surface
without any pre-treatment, and considerably reduces the background
noise. Experimental proof-of-concept, explored by simulations and con-
ﬁrmed through a setup combining simultaneous optical and electrical
real-time monitoring, illustrates the selective and capacitive detection of
S. epidermidis in synthetic urine also containing Enterococcus faecium.
While providing capabilities for miniaturization and system integration
thanks to CMOS compatibility, the sensors show a detection limit of
ca.108 (CFU/mL).min in a 1.5 µL microﬂuidic chamber with an addi-
tional setup time of 50min. The potentials, advantages and limitations
of the method are also discussed.
Introduction
Recently brought to huge medical interest, especially in the struggle
against antibiotic resistant bacteria, lytic enzymes are molecules that
speciﬁcally digest the cell wall of most Gram-positive bacteria. They
can be produced by either bacteriophages or bacterial cells. In the ﬁrst
case, bacteriophage lytic enzymes, also called endolysins, break bonds
in the thick cross-linked peptidoglycan to enable phages to inject their
genetic material in their host to infect it [1]. In the second case, bacteria
produce their own lytic enzymes, also called autolysins, which are tightly
controlled and necessary for cell wall rearrangements during cell division.
Finally, in some cases, evolution has driven bacteria to develop lytic en-
zymes to eliminate species competing for a speciﬁc environmental niche.
This is notably the case for S. simulans, which produces lysostaphin, a
peptidoglycan hydrolase active against almost all Staphylococcus species.
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Besides their medical relevance, lytic enzymes and bacteriophages
have also proven to be powerful tools to achieve high-selective impedi-
metric detection of bacteria [2], in a growth-dependent or independent
way. In the ﬁrst case, bacterial growth monitored through ion release is
strongly aﬀected in culture media containing phages, since target bac-
teria are continuously digested [3]. In the growth-independent method,
phages are immobilized on the electrode surface and subsequently cap-
ture and digest bacteria in a selective way, releasing ions in the outer
medium that are monitored by the impedimetric sensor [4]. Another
electrochemical technique detects peptidoglycan fragments, products of
the bacterial lysis, that have speciﬁcally bound on an antibody layer
grafted on the sensor surface [5].
For Point-of-Care (PoC) diagnostics, growth-independent impedance
detection provides a lower detection time. Despite essentials for Lab-
on-Chip (LoC) systems, compactness, simplicity and autonomy remain
challenging for the following reasons. First, most studies report gold mi-
croelectrodes hardly compatible with the Complementary Metal-Oxide-
Semiconductor (CMOS) process. To beneﬁt from low-cost, system inte-
gration and miniaturization capabilities of CMOS, microelectrodes can
be patterned in the last CMOS metal layer and covered with an ∼ 0.1
µm-etched [6] [7] or ∼ µm-intact [8] [9] passivation layer. However,
this thick oxide layer causes a massive drop in sensitivity.
Secondly, grafting a biorecognition layer, e.g., lytic enzymes, bacte-
riophages or antibodies, on the sensor surface typically faces problems
such as reproducibility, uniformity and stability over time [10]. Al-
though already complex, the functionalization protocol further needs to
be adapted to every surface material and grafting molecule. In addition,
the biorecognition layer is subject to nonspeciﬁc bindings in complex
samples, requiring dedicated negative controls.
Thirdly, the largest sensitivity of bacterial impedance sensors is typ-
ically achieved in low-salt buﬀers of electrical conductivity close to 100
µS/m, such as 0.1% peptone water [11], 100 mM mannitol solution
[12] [13], or even in deionized water [14]. Resuspension of bacteria
in these buﬀers is then typically performed but requires at least three
centrifugation steps to remove most ions contained in the initial matrix.
This is time-consuming (>1 h) and requires lab equipment incompati-
ble with PoC and LoC applications. Furthermore, great care should be
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taken in the result interpretation, since observed shift s can either be due
to bacterial cells or the presence of remaining ions from the initial buﬀer.
In this paper, three notable innovations are brought together to solve
the aforementioned problems for direct and selective detection of bacte-
ria towards PoC and LoC applications. First, a new selective method
based on lytic enzymes was developed. Free of selective surface function-
alization and centrifugation steps, the whole procedure is then simple,
straightforward and reproducible. In short, once the sensor surface is
totally covered with various bacteria, sensor levels before and after the
application of speciﬁc lytic enzymes are compared; if diﬀerent, some tar-
get bacteria have been lysed and the sample can be qualiﬁed positive.
We demonstrate this concept with a selective detection of S. epidermidis
in synthetic urine, also containing Enterococcus faecium as a negative
control, to mimic urinary infections.
Second, CMOS-compatible microelectrodes, made in aluminum and
covered with a very thin layer of atomic-layer-deposited (ALD) Al2O3,
have been used. The 30 nm-thick Al2O3 layer protects the underly-
ing aluminum from corrosion and has a moderate impact on bacte-
rial sensitivity, compared to a micrometer-sized oxide layer. As a 80
nm electrochemically-anodized Al2O3 layer has previously been demon-
strated for bacterial detection in dried conditions [15], this paper extends
the use of this type of passivated electrodes to detection in liquid.
Finally, an innovative setup combining simultaneous real-time opti-
cal and electrical monitoring of sensor was built. Compared to most
studies where electrical shif ts are interpreted without optical control,
this original setup provides a way to accurately link electrical phenom-
ena to surface events such as binding of bacterial cells and considerably
decreases the risk of misinterpretations.
Materials and Methods
Micro-fabrication and encapsulation of the interdigitated
microelectrodes (IDE)
Fig. 1 sketches the process ﬂow. First, 3-in. Pyrex wafers were im-
mersed in a freshly-prepared Piranha solution (H2O2 :H2SO4, 2:5) during
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10 min for cleaning, followed by two continuously renewed immersions in
deionized (DI) water baths during 20 min. Afterwards, aluminum was
evaporated in a rotate mode to deposit a 1 µm-thick layer. A ﬁrst optical
lithography with positive photo-resist then provides ﬁnger masking dur-
ing the subsequent Al plasma etching. After removing resist, the whole
wafer was covered with 33 nm of plasma-enhanced atomic layer deposited
(ALD) Al2O3 at room temperature (RT) with trimethylaluminum and
oxygen as precursor. The argon ﬂ ow through plasma source was 200
sccm and the oxygen ﬂow for the plasma step was 30 sccm during 20 s.
Afterwards, a second optical lithography with positive photoresist was
used to deﬁne pad area and etch the subsequent Al2O3 layer after 15 s
immersion in IPA:HF 70% (3:1). Finally, a last optical lithography with
negative photoresist KMPR1025 was used to deﬁne 30 µm-thick walls to
support the microﬂuidic cap. The interdigitated microelectrodes (IDE)
are 2 µm-wide, 4 µm-spaced, 1 µm thick and deﬁne a 300 µm-diameter
circle (Fig. 2 a and b).
Figure 1: Sensor micro-fabrication steps: (1) aluminum deposition, (2) positive
optical lithography followed by aluminum plasma etching, (3) deposition of an
ALD Al2O3 layer, (4) positive optical lithography to open pads, (5) etching
Al2O3 with IPA:HF 70% (3:1), (6) positive optical lithography to deﬁne thick
KMPR walls and (7) PDMS cap pressure.
For the microﬂuidic cap, a 270 µm-thick KMPR1050 layer was pat-
terned by optical lithography on a clean 3-in. silicon wafer. This mold
was then covered with a thin hexamethyldisilazane (HMDS) layer to eas-
ily take oﬀ the polydimethylsiloxane (PDMS) cap subsequently. Inside a
Petri dish, the PDMS was then ﬂown on the mold wafer and incubated
at 60oC overnight. To ensure the watertight sealing of the system, a
transparent pressure tool was used (Fig. 2 c). As the PDMS cap is
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pressed on the chip, the whole microﬂuidic channel including inlets and
outlets is 1 mm-wide, 5 mm-long and 300 µm-thick, resulting in a total
channel volume of 1.5 µL, while the immediate volume above the 300
µm-diameter sensor is 21 nL.
Figure 2: (a) Sensor microphotograph, (b) schematic cross-section of the en-
capsulated sensor and (c) photograph of the encapsulated sensor positioned on
an inverted microscope and contacted through electrical probes.
Chemicals and reagents
Solutions and buﬀers used in this study were: TrypticSoyBroth (TSB),
Tryptic Soy Agar (TSA), Lysogeny broth (LB), synthetic urine, poly-
dopamine solution, 1 µM lysostaphin solution, 0.01 M phosphate buﬀer
saline (PBS) and PBS diluted 1:10, PBS 1:100, PBS 1:1000 by volume
in DI water, respectively. Detailed protocols to prepare these solutions
are available in Supplementary information.
Bacterial samples
S. epidermidis ATCC 35984 and E. faecium ATCC 19434 were used as
reference strains for this study. Detailed protocols for culture, resuspen-
sion and CFU counting are available in Supplementary information.
Experimental setup and impedance measurements
The device was positioned on an inverted microscope (DMI6000, Leica,
Belgium) enabling real-time imaging of the sensor surface during electri-
cal measurements (Fig. 2 c). Samples were ﬂown through the microﬂu-
idic channel by a peristaltic pump (Gilson Minipuls). An impedance an-
alyzer (LCR 4284A , Agilent, USA) was connected to electrical probes
and remotely controlled through LabVIEW®to perform an automatic
sweep from 100 Hz to 1 MHz, at voltage amplitude of 50 mV. Before
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impedance measurement, an open calibration was performed by posi-
tioning electrical probes above aluminum pads, without any electrical
contacts. Once electrical probes were put in contact with pads, the sen-
sor was ﬁrst rinsed and measured in PBS 1:1000 at 125 µL/min, during
10 min at RT. Then, the polydopamine solution was incubated during
30 min at dark condition, without ﬂow and electrical measurements. Af-
terwards, the sensor was washed with PBS 1:1000 during 5 min at 250
µL/min followed by 5 min at 125 µL/min under electrical measurements
to reach a constant value. At this point, the sensor is ready to be ex-
perimented with bacterial cells. But, as bacteria are contained in PBS
1:1000 or in synthetic urine, two diﬀerent protocols must be considered
and .
Real-time detection of S. epidermidis in PBS 1:1000
Before ﬂowing bacterial suspensions, PBS 1:100, PBS 1:10, PBS and
PBS 1:1000 solutions were successively ﬂown at 125 µL/min during 10
min and for each, reference measurements were performed. Suspensions
from 106 to 109 CFU/mL of stationary-state S. epidermidis resuspended
in PBS 1:1000 were then injected at 1 µL/ min, each followed by the
same washing procedure with sterile PBS 1:1000 as previously described.
Finally, PBS 1:100, PBS 1:10 and PBS were ﬂown again under electrical
measurements to extract shif ts in diﬀerent conditions of salinity, but
with exactly the same number of adherent S. epidermidis on the sensor
surface, as veriﬁed by our optical setup.
Selective detection of S. epidermidis in synthetic urine, in the
presence of E. faecium
For this experiment, the suspension of E. faecium (negative control)
in synthetic urine was ﬁrst introduced at 1 µL/min, followed by a 10
min wash with PBS 1:1000 as previously described. These two steps
were repeated with exponential-state S. epidermidis (target) contained
in synthetic urine, for experiments requiring both species on the sensor.
Finally, lysostaphin was incubated 30 min at 1 µL/min, followed by a ﬁ-
nal wash with sterile PBS 1:1000. To assess reproducibility, three totally
independent experiments were performed for both negative controls, i.e.
sensors with E. faecium only, and target samples, i.e. sensors with E.
faecium and S. epidermidis.
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Automatic bacterial counting algorithm
Based on microscope images, a MATLAB s program was implemented
to automatically count the number of attached bacteria on the sensor
surface. A mask was ﬁrst obtained after black and white (B&W) con-
version and electrode dilatation, compensating the blur eﬀect on IDE
edges. Using the mask, the electrode region was set to a zero value and
the whole image was converted to B&W with an optimal threshold to
distinguish bacteria. Finally, the number of pixel clusters was automat-
ically counted.
Results and Discussion
Impedance results are displayed in terms of the normalized admittance
Y/ω [F], with Y [S] the sensor admittance, i.e., the inverse of impedance,
and ω = 2pif [rad/s] the angular frequency. The capacitance denotation
is not used because the impedance phase is slightly diﬀerent from -90o.
Before analyzing selectivity to S. epidermidis in synthetic urine, real-
time detection of S. epidermidis resuspended in the low-salt buﬀer PBS
1:1000 is ﬁrst investigated to optimize sensor performances. In all exper-
iments, a polydopamine layer, known as biological glue [16] covers the
sensor surface (Al2O3) to increase and homogenize bacterial binding.
Real-time detection of S. epidermidis resuspended in PBS
1:1000
Shifts and slopes in real-time
During the initial wash of the polydopamine-covered sensor with ster-
ile PBS 1:1000, the normalized admittance Y/ω showed stability and
exhibited no drift (Fig. 3 a, ﬁrst ten minutes). Once samples of S.
epidermidis resuspended in PBS 1:1000 were ﬂown on the sensor, Y/ω
systematically increased by three successive and diﬀerent mechanisms
highlighted in Fig. 3 a. The ﬁrst is an immediate shift ∆c [F], observed
just after bacterial injection and attributed to the slight diﬀerence in
ionic content, i.e., electrical conductivity, between sterile PBS 1:1000
and bacterial resuspension in PBS 1:1000. Indeed, centrifugation steps
lead bacterial cells to release ions due to osmotic pressure and damaged
cell walls [17]. Despite its dependence on bacterial concentration, two
reasons make ∆c unsuitable for bacterial sensing. First, ∆c is strongly
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aﬀected by experimental procedures such as manipulation, contamina-
tion and temperature, all aﬀecting the baseline sample conductivity (see
the artifact on 106 CFU/mL in Fig. 3 a). The use of a reference conduc-
timeter within the micro-ﬂuidic channel could solve this problem, but
increases the system complexity. Second, ∆c is useless for real applica-
tions dealing with saline solutions, whose high electrical conductivity is
hardly impacted by bacterial ion release. For these reasons, ∆c -based
sensing should be avoided.
During the next 20 min bacterial incubation, Y/ω was shown to con-
tinuously grow with increasing bacterial surface coverage, deﬁning the
real-time slope srt = δ(Y/ω)/δt [F/min] (Fig. 3 a, dotted blue linear
curve). Thanks to simultaneous optical and electrical measurements,
the direct link between srt and the bacterial real-time binding was as-
sessed (Fig. S1a!!!). Furthermore, a linear dependence between srt and
the bacterial concentration is highlighted in Fig. 3 b. The related "real-
time shif t" ∆rt [F] was extracted as the diﬀerence between Y/ω values
after the incubation phaseand after the initial conductivity peak . Its
linear dependence on the bacterial density [number of cells/mm2] was
quantiﬁed to 319 aF per adherent bacterium, resulting from the pres-
ence of both adherent and non-adherent, but close to the sensor surface,
bacterial cells (Fig. 3 c). However, both srt and ∆rt are strongly reduced
in more saline bacterial samples for reasons described in .
After the bacterial incubation, a wash with sterile PBS 1:1000 ﬂushed
non-adherent bacteria and excessive ions away, so that Y/ω stabilized at
a lower equilibrium value (Fig. 3 a). This level minus the pre-incubation
Y/ω value in sterile PBS 1:1000 deﬁnes the "shift after wash" ∆w [F]. A
linear dependence between ∆ w and the bacterial surface coverage was
experimentally evaluated to 101 aF per adherent bacterium (Fig. 3 c)
and conﬁrmed by simulations in Fig. S1!! b [18]. In contrast to ∆rt ,
only the remaining adherent bacteria on the sensor aﬀect ∆w, justifying
its smaller value. On the other hand, ∆w is highly stable and reliable
since it purely originates from dielectric properties of bacterial cells only.
Indeed, as measured only at equilibrium and under ﬂow with sterile PBS
1:1000, ∆w is not subject to ionic release or contamination. In addition,
wash procedures can be added as using saline bacterial samples to recover
∆w. For these reasons, next discussions are only based on ∆w .
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Figure 3: (a) Real time moni-
toring of the normalized admit-
tance Y/ω at 1 M Hz as increas-
ing S. epidermidis concentra-
tions from 106 to 109 CFU/mL
in PBS 1:1000 are successively
injected. (b) Dependence of
the bacterial density measured
optically after 20 min incuba-
tion and the 1 MHz admittance
slope srt with the bacterial con-
centration. (c) Dependence of
the sensitivity, expressed as the
relative change of Y/ω in per-
cent, with the bacterial cov-
erage at 1 MHz for diﬀerent
conditions illustrated in (a).
(d) Dependence of the maximal
sensitivity and the sensitivity
maximizing the SNR with the
conductivity σsol of the buﬀer
used for measurements, for the
shift ∆w and at a ﬁxed bac-
terial coverage of 3 x 104
cells/mm2 . Error bars express
temporal noise computed from
at least 10 successive measure-
ments of corresponding shifts at
steady state.
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Limit of detection
The intrinsic limit of detection (LOD) of surface-based sensors is deﬁned
as the minimum number of adherent bacteria required on the sensor
surface to generate a signal ∆w ﬁve times larger than the noise σn. It
is possible to express the LOD in term of the bacterial concentration Cb
[CFU/mL], which can be linked to the non-saturated bacterial density Sb
[number of cells/mm2] by the following formula, for a 20 min incubation
time: log10(Sb) = -3.25 + 0.92 log10(Cb) (Fig. 3 b). As the noise source
from the electrical readout was characterized to σn = 1 fF in optimal
conditions, approximately 50 bacteria on the sensor surface are therefore
needed to have ∆w > 5. σn, corresponding to a bacterial density of 707
bacteria per mm2, i.e., 0.06% of surface coverage. From the previous
formula, the LOD is approximated to 108 (CFU/mL)*min, which means
either 108 CFU/mL within 1 min of bacterial incubation, or 107 CFU/mL
within 10 min, or equivalently 106 CFU/mL within 100 min.
Eﬀect of buﬀer salinity
To quantify sensor performance in various conditions of salinity and at
a ﬁxed bacterial density of 3.104 cells/mm2, pre- and post-incubation
washes were performed with various dilutions of PBS, whose electrical
conductivity spans from 1.4 mS/m to 1.4 S/m (see ). For each PBS
solutions, the sensitivity S(ω) = ∆w/(Y0/ω) [%] was computed from ∆w
and from the initial normalized admittance Y0/ω. Its mean S(ω) and
standard deviation σs were obtained through time averaging of at least 10
successive measurements in steady state. At the frequency maximizing
the signal-to-noise ratio SNR = 20. log10(Sω)/σs) [dB], the sensitivity
was shown to decrease from 9% to 2% as the ionic strength increases (Fig.
3 d, black bars). Indeed, the electric ﬁeld gets more conﬁned in surface
and the insulator capacitance dominates (see for more explanation).
In contrast, maximal sensitivities without SNR consideration comprise
extremely large error bars (Fig. 3 d, red bars), unsuitable for accurate
interpretation. In conclusion, the largest sensitivity is achieved with
low-salt washing solutions.
Analytical model and simulations
In absence of bacteria, the sensor impedance can be modeled with the
insulator capacitance Cins [F], the double layer (DL) capacitance CDL
[F], the solution resistance Rsol [Ω] and the solution capacitance Csol
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[F] (Fig. 4 a). Since PBS 1:1000 has electrical conductivity σsol '
1.4 mS/m and relative permittivity εr, sol = 80, the Debye length λD
is approximately 32 nm, resulting in CDL ' 10.Cins as the insulator
thickness and relative permittivity are tins = 30 nm and εr,ins = 9,
respectively. Therefore, CDL can be neglected in series and two cutoﬀ
frequencies govern, as conﬁrmed experimentally (Fig. 4 b):
fc,1 =
1
2piRsol.Cins
≈ 1
2pi
tins
d
σsol
ε0εr,ins
≈ 21kHz (1)
fc,2 =
1
2piRsol.Csol
≈ 1
2pi
σsol
ε0εr,sol
≈ 225kHz (2)
where d is the electrode gap [m] and ε0 the vacuum permittivity
[F/m]. For applied frequencies f < fc,1, Cins dominates while Csol pre-
vails at f > fc,2. Between these two cutoﬀ frequencies, the impedance is
more resistive due to Rsol dominance.
With adherent bacterial cells on the sensor surface, the global impedance
was experimentally shown to decrease, highlighting increasing capacitive
behavior especially at large frequencies where the sensitivity S(ω) was
maximized (Fig. 4 c). At such frequencies, the cytoplasm conductance
dominates the bacterial impedance Zb [Ω] and shortens electrical ﬁeld
lines, resulting in larger capacitance due to the smaller path. In con-
trast, the sensitivity is extremely small at low frequencies since Cins is
not aﬀected by bacterial cells. As shown in Fig. 4 c, these analytical
and experimental considerations were conﬁrmed by ﬁnite-element simu-
lations of the 2D-model comprising one bacterial cell (Fig. 4 a), modeled
with a Gram-positive two-shell representation whose dielectric values are
given in [19].
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Figure 4: Sensor modeling: (a) Equivalent electrical circuit including bacterial
cells, (b) experimental impedance modulus and phase in PBS 1:1000 without
bacteria versus the applied frequency and (c) comparison between experimental
and simulated sensitivity S(ω) to S. epidermidis versus the applied frequency.
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Speciﬁc detection of S. epidermidis in synthetic urine
To provide bacterial selectivity in complex samples with lytic enzymes,
our method involves ﬁve steps (Fig. 5 a). First, the matrix sample con-
taining bacterial cells is ﬂown during 20 min on the clean sensor covered
with a polydopamine layer. After that, the sensor is washed with PBS
1:1000 to fully remove non-adherent species and enable sensitive and
accurate measurements at 1 MHz (see for justiﬁcation). Then, lytic en-
zymes are ﬂown during 30 min atop the sensor and selectively lyse target
bacteria, if present on the sensor surface. Then, a second wash with PBS
1:1000 is performed to sweep enzymes away before measuring the nor-
malized admittance Y/ω again. A shift in Y/ω occurs between the two
measurements only if target bacteria, if present on the sensor surface,
have been lysed. An absence of shift means that the surface state with
adherent bacteria is unchanged, i.e., target bacteria were missing from
the sensor surface.
Fig. 5 b-c depicts the typical evolution of Y/ω at 1 MHz, for both the
negative control, i.e., synthetic urine with only E. faecium, and the test
sample, i.e., synthetic urine with both S. epidermidis and E. faecium.
Only parts in PBS 1:1000 used for wash are shown since low-sensitivity
occurs in saline solutions (see ), whose out-of-range parts do not interfere
with subsequent shifts ∆1, ∆2 and ∆3 measured at equilibrium in PBS
1:1000. As shown by ∆1 and ∆2 in Fig. 5 b-c, both adherent E. faecium
and S. epidermidis on the sensor surface strongly aﬀect the normalized
admittance thanks to their dielectric properties at 1 MHz (see ). Ab-
solute shifts ∆1 and ∆2 are signiﬁcant compared to the temporal noise
computed on at least 10 successive measurements, but vary between the
three independent sensors because of the diﬀerent numbers of adherent
bacteria (Fig. 6 a). As shifts are normalized by the number of bacteria
counted on the sensor surface, E. faecium and S. epidermidis present
reproducible normalized shifts spanning from 52 to 59 aF per bacterium
and from 77 to 97 aF per bacterium, respectively (Fig. 6 b). The larger
sensitivity to Staphylococci may be explained by their dielectric proper-
ties, probably increased by a higher ionic cytoplasmic content thanks to
the heavily cross-linked cell wall.
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Figure 5: Selectivity method: (a) principle scheme, (b) real-time evolution of
the normalized admittance Y/ω at 1 MHz for the negative control, E. faecium
in synthetic urine, and (c) for the target sample, S. epidermidis and E. faecium
in synthetic urine. The events mentioned in the timeline are: (I) washing with
PBS 1:1000, (II) incubating 5.108 CFU/mL E. faecium in synthetic urine,
(III) incubating 5.108 CFU/mL S. epidermidis in synthetic urine and (IV)
incubating lysostaphin. Shifts after wash ∆1, ∆2 and ∆3 are evaluated after
the addition of E. faecium, S. epidermidis and lytic enzymes, respectively.
After the incubation of lysostaphin, i.e., a lytic enzyme that specif-
ically digests Staphylococcus spp., sensors with only E. faecium on the
surface showed a slight decrease ∆3 ∈ [2 fF, 21 fF] of the normalized ad-
mittance, despite intact E. faecium cells as observed optically (Fig. 5 b
and 6 a). This slight drop can be attributed to enzymes binding onto the
polydopamine layer, which typically sticks any biomolecules containing
aromatic rings. On the other hand, sensors covered with S. epidermidis
showed a signiﬁcantly larger decrease ∆3 ∈ [163 fF, 299 fF] of Y/ω (Fig.
6 a), whose larger variability results from the diﬀerent amounts of lysed
S. epidermidis on the sensor surface, for each experiment. As ∆3 is di-
vided by the number of lysed bacteria, a reproducible normalized shift
spanning from 68 to 88 aF per lysed S. epidermidis is obtained. De-
spite the almost complete destruction of S. epidermidis cells, the sensor
does not recover its initial impedance value with E. faecium only. Our
interpretation is that cellular debris (DNA, proteins and peptidoglycan)
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remains on the sensor surface after cell lysis and interacts with the elec-
tric ﬁeld to cause measurable shifts in Y/ω.
Figure 6: Comparison of impedance measurements on E. faecium (negative
control) and S. epidermidis (target) at 1 MHz and for three diﬀerent sensors
in each case: (a) absolute capacitive shifts ∆C after E. faecium/S. epidermidis
binding (in black) and after enzyme incubation (in red), (b) relative capacitive
shifts normalized to the number of bound bacteria after incubation or to the
number of destroyed bacterial cells after lytic enzyme incubation. Error bars at
each block refer to temporal noise obtained after averaging at least 10 successive
temporal measurements on one sensor in a steady-state window. Translucent
boxes depict the measurement span in a given condition, whose µ corresponds
to the mean value of the 3 sensors.
Advantages and limitations
The selective method of Section presents several advantages among oth-
ers. First, the matrix can directly be ﬂown on the sensor without any
pre-treatment steps such as centrifugation or dilution. The possible pres-
ence of large cells (diameter > 10 µm) in the matrix is likely not a prob-
lem since they should be washed away by strong shear forces at ﬂow rate
of 250 µL/min, as conﬁrmed optically with large bacterial cell clusters.
A ﬁltration method, e.g., membrane at the channel inlet, could alterna-
tively be added to ﬁlter them out.
Second, in contrast to aﬃnity-based surface sensors, our selective
method does not suﬀer from background noise due to non-speciﬁc bind-
ing of biomolecules on the sensor surface, which strongly facilitates its
use in real matrix samples. Compared to antibodies, the use of lytic
enzymes can be easily extended to all Gram-positive bacteria (using en-
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dolysins) and strongly reduces cost at a large-scale production, since
peptidoglycan hydrolases can be obtained by fermentation. The risk of
false negatives due to mutation is also relatively low, because peptido-
glycan hydrolases target highly conserved bonds in the bacterial cell wall.
Third, washing with low-conductivity media enables the stable and
sensitive monitoring of intrinsic dielectric properties of adherent bac-
teria, avoiding time-consuming centrifugation required for ion release
based techniques. Furthermore, the electrical conductivity of the bacte-
rial sample does not need to be controlled, as it is preferably the case for
ion release technique.
Finally, since the electrode materials (Al/Al2O
3) are CMOS-compatible,
the method can be extended to microelectrodes patterned in the last
metal layer of a CMOS circuit, beneﬁting from system miniaturization
and low manufacturing cost, both essentials for LoC applications.
On the other hand, our method exhibits several limitations. First,
great care with PBS 1:1000 wash is needed since ionic contamination can
easily occur and provide false positives. The ﬂuidic setup must be opti-
mized to avoid any cross contamination from saline to non-saline buﬀers.
Second, osmotic-sensitive bacteria may burst during an osmotic shock.
In this case, the sensor would provide false positives during the rinsing
procedure if burst bacteria are not those targeted. Due to their thick
cell wall (∼ 30 - 50 nm), Gram-positive bacteria are less subject to this
phenomenon than Gram-negative bacteria characterized by a 2-8 nm-
thick cell wall. To resolve the two aforementioned issues, a higher ionic
medium could be used for measurements, but the electrical frequency
should be increased accordingly to keep the same sensitivity.
Third, reproducible cell adhesion on the sensor surface is crucial to
avoid false negatives, in the case bacteria do not adhere to the surface.
To address this problem, a polydopamine layer was used in this work
to improve and homogenize bacterial binding in saline and non-saline
buﬀers. Though other coatings could also provide adequate or better
results, they should be investigated in a separate study. Furthermore,
the proposed method could be combined with well-known concentration
techniques such as dielectrophoresis [12] or magnetic beads [13], to en-
hance sensitivity and decrease detection time.
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Finally, a comparison with other signiﬁcant works dealing with im-
pedimetric detection of bacteria in solution is provided in Table S1!! and
supports our conclusions.
Conclusion
In this paper, an innovative selective method for impedimetric detection
of bacterial cells was presented. It is based on the use of lytic enzymes to
selectively destroy target bacteria, anchored on the sensor surface after
the ﬂow of a treatment-free sample matrix. This principle was demon-
strated by selectively detecting S. epidermidis in synthetic urine samples
also containing E. faecium, as a model for real urinary infections. This
method is a step towards Lab-on-Chip (LoC) and Point-of-Care (PoC)
systems, since it enables the direct ﬂow of the sample matrix and the
integration with CMOS readout circuit on the same chip. Furthermore,
the selectivity principle can easily be extended to all Gram-positive bac-
teria using bacteriophage lysins, which have similar enzymatic activity
as lysostaphin used in this paper. Finally, real-time detection of S. epi-
dermidis resuspended in low-ionic buﬀer was also investigated, enabling
key comprehension for sensor optimization. All electrical interpretations
were conﬁrmed by real-time simultaneous optical monitoring of the sen-
sor surface thanks to an innovative setup.
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Supplementary Information
Protocols for chemical and reagents for section
PBS tablet, creatinine, Na2HPO4, CaCl2, dopamine hydrochloride and
lysostaphin were purchased at Sigma-Aldrich (Diegem, Belgium). Urea,
KCl, MgSO4 and Tris were purchased at Merck (Overijse, Belgium).
NaCl, NaHCO3, NaCl and glycerol were purchased at VWR (Leuven,
Belgium). (NH4)2SO4 was purchased from UCB (Brussels, Belgium).
0.01 M phosphate buﬀer saline (PBS) at pH 7.4 was obtained by
diluting one tablet in 200 mL of milliQ water. PBS 1:1000, PBS 1:100
and PBS 1:10 were prepared by adequately diluting PBS in milliQ wa-
ter by volume. PBS and all PBS dilutions were autoclaved 15 min at
121oC before use. Tryptic Soy Broth (TSB), Tryptic Soy Agar (TSA)
and Lysogeny broth (LB) were prepared standardly and autoclaved 15
min at 121oC.
Synthetic urine was made as follows (w/v): urea 2%, KCl 1.2%, cre-
atinine 0.1%, (NH4)2SO4 0.1%, Na2HPO4 0.1 %, MgSO4 0.01%, CaCl2
0.01% and NaHCO3 0.01%. These compounds were diluted in 1 L of
milliQ water, the pH was then adjusted at 7 using 1M HCl. Synthetic
urea was sterilized using 0.22 µm porosity Millipore ﬁlters in PES (Filter
service, Eupen, Belgium) before use.
A Tris-NaCl buﬀer contains Tris 50 mM, NaCl 150 mM dissolved in
milliQ water, adjusted to pH=9.2 with HCl 1 M and autoclaved prior to
use. The polydopamine solution was prepared by dissolving 4 mg/mL of
dopamine hydrochloride in the Tris-NaCl buﬀer. The solution was left 1
hour in the dark to polymerize before being injected in the microﬂuidic
channel.
Commercialized lysostaphin, sold as 1 mg powder where 55% of the
total mass is lysostaphin, was diluted in 1 mL of PBS supplemented
with 30% of glycerol, and transferred into 50 µL aliquots stored at -
20°C. Working solutions were prepared by adding 950 µL of PBS to 50
µL of stock solution (20 µM) yielding a 1µM lysostaphin.
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Protocols for bacterial strains, culture, suspension preparation
S. epidermidis ATCC 35984 and E. faecium ATCC 19434 (both pur-
chased from LGC standards, Molsheim, France) were used as reference
Gram-positive bacteria in this study. Following overnight culture on
TSA plates at 37oC, liquid cultures were performed in 250 mL Erlen-
meyer ﬂasks containing 50 mL of TSB. Stationary phase cultures were
obtained after overnight incubation at 37oC at 120 RPM.
Two 2mL tubes of stationary phase culture of E. faecium were cen-
trifuged 10 min at RT at 5500 g. The supernatant was then discarded and
both pellets were resuspended in 1 mL of synthetic urine. The centrifu-
gation, supernatant removal and resuspension steps were repeated twice
for both tubes. Suspensions from both tubes were pooled and the optical
density (OD600nm) was adjusted to OD600nm=1 ( 5x10
8 CFU/mL). For
stationary-state S. epidermidis, the same protocol was used but adjusted
to OD600nm = 3 (∼ 109 CFU/mL) to OD600nm = 0.003 ( 106 CFU/mL),
by adequately diluting the concentrated suspension in PBS 1:1000.
For exponential-state S. epidermidis, an exponential phase culture
was obtained by inoculating 50 mL of fresh medium with 500 µL of
the stationary phase culture and incubating at 37oC, 120 RPM until an
OD600nm of 0.5 was reached. One 50 mL tube was then centrifuged 10
min at 4oC, 5500 g and the pellet was resuspended in 2 mL of synthetic
urine. This step was repeated two times in two 2 mL tubes. The sus-
pension was adjusted to an OD600nm=1 ( 5x10
8 CFU/mL) in order to
be injected into the setup.
The bacterial concentration was determined by plate count technique
and expressed in colony forming units per milliliter (CFU/mL).
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Simultaneous electrical and optical monitoring
As shown in Fig. S1 a, the simultaneous and real-time optical and elec-
trical monitoring of surface events demonstrates a linear correlation be-
tween the bacterial surface coverage [number of cells/mm2] and the nor-
malized admittance Y/ω [pF]. 3D simulations performed in [18] conﬁrm
this linear correlation, as shown in Fig. S1 b.
Figure S1: (a) Experimental simultaneous electrical and optical monitoring of
S. epidermidis binding in real-time on the sensor surface. The events A and
B correspond to the start and the end of the 109 CFU/mL ﬂow on the sen-
sor surface, respectively. (b) Simulated sensitivity versus the bacterial surface
coverage [18].
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Chapter 10
Ionic strength dependent
aggregation of Staphylococci
In this chapter, a yet unreported type of aggregation of Staphylococci is
presented. Several strains of S. aureus and S. epidermidis displayed fast
and reversible intercellular adhesion that solely depends on the ionic
strength of the external medium. Interestingly, an optimal ionic strength
could be identiﬁed for each strain. These experiments demonstrate
that Staphylococci can react to small variations of salt concentration in
their environment. Besides, this ionic-strength dependent aggregation
has been shown to signiﬁcantly accelerate bioﬁlm formation of S.
aureus. Plausible mechanisms leading to aggregation are also discussed
here. Finally, the Biostream device, a ﬂow cell that was developed
during this PhD thesis (see Appendix B), was used to highlight the con-
sequence of the aggregative phenotype on bioﬁlm formation by S. aureus.
An interesting question raised by this work is whether the observed
phenomenon has an evolutionary purpose or if it is the undesired conse-
quence of the composition of the bacterial cell wall.
* This work was submitted for publication on April 2015 :
Thomas Vanzieleghem, Numa Couniot, Philippe Herman, Denis Flan-
dre, Yves F. Dufrêne, Jacques Mahillon, Come together: ionic strength
modulates cell aggregation and bioﬁlm formation in Staphylococci.
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Abstract
Cell aggregation plays a key role in bioﬁlm formation and pathogenesis of
Staphylococcus species. Bacterial aggregates and bioﬁlms are more resis-
tant than isolated planktonic cells to antibiotics, disinfectants and host
immune system. While the molecular basis of aggregation in Staphy-
lococci has already been extensively investigated, the inﬂuence of envi-
ronmental factors, like ionic strength, remains poorly understood. In
this paper, we report a new type of cellular aggregation of Staphylococci
that depend solely on ionic strength with a strain-dependent optimum.
Seven strains out of 14, all belonging to Staphylococcal species, formed
large cell clusters within minutes in buﬀers of ionic strength ranging from
1.5 to 50 mM whereas three other isolates belonging to Gram-positive
species did not show the same phenotype. The optimal ionic strength for
aggregation was found to be strain-dependent but in all cases, bacterial
aggregates formed at an ionic strength of 1.5-50 mM were immediately
dispersed in a solution of higher ionic strength, indicating reversibility of
the cell aggregation process. In addition, this phenotype was shown to
signiﬁcantly promote bioﬁlm formation. Indeed, S. aureus ATCC6538, a
strain displaying the aggregative phenotype, displayed enhanced ability
to form bioﬁlms when grown in a medium (50 mM) rather than high
(150 mM) ionic strength, indicating that ionic strength-dependent ag-
gregation promotes bioﬁlm formation. These ﬁndings suggest that some
staphylococcal isolates can respond to ionic strength as an external stim-
ulus to trigger rapid cell aggregation and bioﬁlm formation in a way that
has not yet been reported.
Importance
Staphylococci are amongst the leading pathogens causing nosocomial in-
fections. During the development of such infections, these bacteria rely
upon cell aggregation and bioﬁlm formation to increase their virulence
and especially their persistence inside the host. Understanding how en-
vironmental factors inﬂuence these processes is crucial to apprehend the
behavior of the pathogens. In this work, we highlight the dramatic im-
pact of ionic strength on intercellular adhesion in Staphylococci and its
consequences on bioﬁlm formation. At optimal ionic strength staphylo-
coccal cells rapidly aggregate and revert back to a dispersed state as the
ionic strength is modiﬁed. This suggests that the mechanism involves
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electrostatic interactions between cell surfaces and not direct genetic
regulation. The unique aggregative phenotype reported here provides an
ecological advantage to Staphylococci as they would signiﬁcantly accel-
erate the formation of mature bioﬁlms.
Introduction
Staphylococcus spp. is a group of commensal bacteria colonizing animal
skin and mucosa [1], among which the two notorious pathogens S. au-
reus and S. epidermidis. While the former is mainly responsible for acute
infections [2] and wound inﬂammation [3], the latter, along with other
coagulase negative Staphylococci, is often involved in nosocomial diseases
associated with implanted devices [4], such as intravascular and urinary
catheters [5] [6] or prostheses [7] [8]. In many cases, Staphylococci form
bioﬁlms, a lifestyle that increases their persistence in the host [9] [10].
Indeed, bioﬁlms eﬀectively shield bacteria from threats such as the host
immune system [11] [12], antimicrobial peptides [13] or antibiotics [14].
Cell aggregation, whether reversible or irreversible, is crucial in the
process of building up micro- and macro-colonies during bioﬁlm forma-
tion [15]. Cell aggregation can be mediated by surface proteins that are
involved in ligand-receptor recognition or in homophilic interactions be-
tween molecules present on the surface of two bacteria. For example,
SasG and Aap proteins have been found to be responsible for Zn2+-
dependent intercellular aggregation by forming dimers of ﬁbrils bridging
two bacterial cells in S. aureus [16] and S. epidermidis [17] [18], respec-
tively. Also, in S. aureus, the clumping factor A (ClfA) has been shown
to trigger agglutination by catalyzing the transformation of ﬁbrinogen
into ﬁbrin upon which bacterial cells aggregate in large clusters [19].
In addition, non-speciﬁc intercellular adhesion can also occur through
attractive electrostatic or hydrophobic interactions, or through macro-
molecular bridging associated with cell surface polymers. The intercel-
lular adhesin, also called PIA (Polysaccharide Intercellular Adhesin or
poly-N-acetylglucosamine) has been shown to increase cell-cell stickiness
and make cell aggregation irreversible [20] [21]. Another example is the
S. aureus Bioﬁlm-Associated Protein (Bap) and its homolog Bhp of S.
epidermidis, a cell surface protein that plays a key role in the formation
of bioﬁlm in PIA deﬁcient strains [22] [23].
163
Although progress has been made in unraveling the molecular basis
of cell aggregation of Staphylococci, the impact of environmental param-
eters on intercellular adhesion remains largely unknown. In this pa-
per, we report a novel phenomenon in staphylococcal cell aggregation in
which ionic strength tightly modulates the aggregation phenotype. Sev-
eral strains belonging to the Staphylococcus genus readily formed large
cell clusters in response to changes in NaCl concentration. This aggrega-
tive phenotype was found to be reversible in a short time scale as the ionic
strength was increased, pointing towards an electrostatic origin for the
intercellular aﬃnity. As a consequence, bioﬁlms were found to develop
signiﬁcantly faster and displayed a more complex three-dimensional ar-
chitecture. The impact of our ﬁndings on the development of nosocomial
infections associated with implanted medical devices is also discussed.
Materials and Methods
Buﬀers
Cell aggregation experiments were conducted in Tris 0.1 mM (pH 7.4)
with increasing concentrations in NaCl to obtain buﬀers with ionic strengths
ranging from 0.1 to 150 mM. The buﬀer conductivity and pH were mea-
sured before performing the experiments as a control of the ionic strength
and pH of the solutions, respectively.
Bacterial strains and culture
The bacteria used in this study were the reference strains S. aureus
ATCC 6538, S. epidermidis ATCC 12228, S. epidermidis ATCC 35984,
S. epidermidis HB [24], Enterococcus faecium ATCC 19434, and Strepto-
coccus salivarius subsp. thermophilus ATCC 19258. The clinical strains
S. aureus MRSA1, MRSA2 and MRSA3, S. epidermidis C1, C2, C3 and
Staphylococcus warneri C4 were isolated from positive blood cultures
(Brussels Saint-Luc University hospital, UCL, Woluwé-Saint-Lambert,
Belgium). Three environmental isolates, all identiﬁed by 16S DNA se-
quencing, were also used in this study: S. aureus strains E1 and E2,
both found in food products, Staphylococcus hominis E3 and Micrococ-
cus luteus E4 originating from air sampling.
All strains were plated on Tryptic Soy Agar (TSA, BioRad) from frozen
stock kept at -80oC and incubated at 37oC for 24 h. Liquid cultures were
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carried out in 100 ml Erlenmeyer ﬂasks containing 20 ml TSB (BioRad)
inoculated from the plates and placed in a shaker-incubator at 37oC and
120 rpm for 16 h.
Quantiﬁcation of cell aggregation by spectrophotometry
Cell aggregation was assessed by measuring the Optical Density at 600
nm (OD600) of bacterial suspensions prepared in buﬀers with increasing
ionic strength. A total of 7 ml of an overnight culture were recovered
in 2 ml Eppendorf tubes after centrifugation at 4oC, 5000 g for 5 min.
The successive supernatants were discarded and the pellets were resus-
pended in 1 ml of appropriate buﬀer. Centrifugation and resuspension
steps were carried out three times to remove most components of the
initial culture medium. The seven bacterial suspensions in the buﬀers of
increasing ionic strength were transferred into PMMA cuvettes (VWR)
and the OD600 was recorded using a spectrophotometer (Ultrospec 2100
pro). The cuvettes were incubated at 30 oC for 90 min and OD600 was
measured again. This protocol was conducted in triplicates for the sev-
enteen strains using independent overnight cultures.
The ratio R was deﬁned as follows:
R = OD600(t=90min)OD600(t=0min)
While a ratio of 1 (no visible aggregation) indicates the stability of the
bacterial suspension, its reduction assesses the sedimentation of aggre-
gated bacteria in the suspension. For strain ATCC 12228 of S. epi-
dermidis, the kinetics of the aggregation phenomenon was followed by
measuring OD600 every 10 min. This experiment was repeated three
times with independent cultures.
Cell aggregation in parallel plate ﬂow chamber
In order to assess the reversibility of the aggregative phenotype under
changing ionic strength, ﬂow cell experiments were carried out.
For these experiments, two bacterial suspensions of S. epidermidis
ATCC 12228 were prepared in the following buﬀers: Tris 0.1 mM, NaCl
5 mM and in Tris 0.1 mM, NaCl 150 mM. Their bacterial concentrations,
assessed by plate count of serial dilutions on TSA, were estimated to be
ca. 5*108 CFU/ml.
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A sterilized parallel plate ﬂow cell (Biostream [25]) of 16 mm x 45
mm x 1 mm in size featuring a culture treated PolyStyrene (PS) slide
was mounted on an inverted microscope (Leica DMI6000) at room tem-
perature. Images of the surface of the PS slide were taken by a 40 x long
working distance objective (numerical aperture=0.6, Fluotar, Leica) and
a sensitive 1.4 MP cooled CCD B/W camera (Leica DFX 365). The ﬂow
cell system was ﬁlled with a Tris 0.1 mM, NaCl 150 mM buﬀer, using a
peristaltic pump (Minipuls, Gilson) to remove the air from the tubing.
To conduct the experiment, the higher ionic strength inoculum was
ﬁrst injected for 5 min at a ﬂow rate of 20 ml/h and a hydraulic retention
time (Volume of the ﬂow chamber [mm3]/Flow rate [mm3/s]) of 1.5 min.
Rinsing was performed during 10 min with Tris 0.1 mM, NaCl 150 mM.
Then, the lower ionic strength inoculum was injected in the ﬂow cell,
also for 5 min according to the same procedure. Loosely bound bacteria
were removed by rinsing 10 min with the Tris 0.1 mM, NaCl 5 mM buﬀer
at the same ﬂow rate. Finally, the higher ionic strength Tris 0.1 mM,
NaCl 150 mM buﬀer was ﬂowed again in the ﬂow cell for 10 min without
changing the ﬂow rate.
Atomic Force Microscopy (AFM)
The surface of the S. epidermidis strain ATCC 12228 was probed by
AFM with a negatively charged tip in order to highlight the amount and
the repartition of positive charges on the bacterial cell surface.
For chemical force microscopy (CFM) analyses, carboxyl-terminated
AFM tips were prepared by immersing gold-coated cantilevers (OMCL-
TR4, Olympus Ltd., Tokyo, Japan; nominal spring constant ∼0.02 N
m−1) for 12 h in ethanol solutions containing 1 mM of (16-mercaptohexa-
decanoic acid) (Sigma) and (11-mercapto-1-undecanol) (Sigma) at a mo-
lar ratio of 10:90, and then rinsed with ethanol and ﬁnally dried with
N2. CFM measurements were performed at room temperature (20
oC),
in TRIS buﬀer at three increasing ionic strengths (0.1, 5 and 150 mM
NaCl), using a Nanoscope VIII Multimode AFM from Bruker Corpora-
tion (Santa Barbara, CA). The spring constants of the cantilevers were
measured using the thermal noise method. Cells from the S. epider-
midis strain ATCC 12228 were immobilized by mechanical trapping into
porous polycarbonate membranes (Millipore, Billerica, MA) with a pore
size similar to the cell size [26]. After ﬁltering a cell suspension, the ﬁlter
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was gently rinsed with buﬀer, carefully cut (1 cm x 1 cm), attached to
a steel sample puck using a small piece of double face adhesive tape,
and the mounted sample was transferred into the AFM liquid cell while
avoiding de-wetting. Single cells were ﬁrst localized using a bare tip,
after which the tip was replaced with a carboxyl-terminated tip for force
measurements. Force maps of 32 x 32 force-distance curves were recorded
on areas of 1 µm2 with a maximum applied force of 500 pN, a contact
time of 100 ms, and an approach and retract tip velocity of 1,000 nm
s−1. Adhesion maps and histograms were obtained by calculating the
largest adhesion force for each force curve.
Bioﬁlm formation in parallel plate ﬂow chamber
Bioﬁlm formation of S. aureus strain ATCC 6538 was assessed in two
media, with distinct ionic strengths but equal amount of nutrients. The
tests were conducted in two Biostream ﬂow cells, run in parallel, contain-
ing culture-treated PS slides (Ted Pella, Inc.). Media were prepared by
diluting TSB 3-fold either with Tris 0.1 mM or Tris 0.1 mM, NaCl 150
mM, displaying conductivities of ca. 5.5 and 15.5 mS/cm, respectively.
Two inocula were prepared by diluting bacterial suspensions, prepared in
Tris 0.1 mM, 50 mM NaCl and Tris 0.1 mM, 150 mM NaCl, 100-fold in
the same buﬀers. The conductivities of inocula were of ca. 5.5 and 15.5
mS/cm, respectively. The bacterial concentration of the inocula was ca.
5*107 CFU/ml, as estimated by plate count of serial dilutions on TSA.
The two Biostream ﬂow cell systems were put at 37oC and ﬁrst ﬁlled
with the buﬀer of appropriate ionic strength before the inocula were in-
jected for 10 min at a ﬂow rate of 20 ml/h. Then, the media were ﬂowed
each in one of the ﬂow chambers for 6 h. To representatively assess
bioﬁlm growth, the surface of the PS slide was imaged in 6 randomly
chosen zones in both ﬂow cells, after 2, 4 and 6 h. After 4 h, the max-
imum height of micro-colonies, further referred to as bioﬁlm thickness,
was measured using the Z-stack function on the dedicated microscope
software (Leica LAS AF). After 6 h, the ﬂow of media was stopped and
both ﬂow cells were rinsed with Tris 0.1 mM, NaCl 150 mM for 15 min at
the same ﬂow rate. A 125 µg/ml solution of Concanavalin A coupled to
AlexaFluor350 (Invitrogen Life Technologies) was injected in both ﬂow
cells. This lectin marks polysaccharides of the bioﬁlm EPS. The lectin
stain was left to incubate without ﬂow at room temperature, in the dark,
for 15 min. A rinsing step of 15 min at a ﬂow rate of 20 ml/h with a Tris
0.1 mM, NaCl 150 mM buﬀer was then performed. Finally, the ﬂow cell
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surfaces on which the bioﬁlms grew were observed in bright-ﬁeld, as well
as in ﬂuorescence microscopy with a 40 x long working distance objective,
a metal-halide lamp for excitation, ﬁlters tailored for DAPI ﬂuorescence
(Leica A4 ﬂuorescence cube). These experiments were repeated three
times, with inocula prepared from independent cultures.
Statistical analysis
Standard deviation was computed for all data. When relevant, Stu-
dent T-tests were performed to assess whether two mean values were
signiﬁcantly diﬀerent, assuming normal distribution of our data and ho-
mogeneity of variance.
Results
NaCl concentration induces fast intercellular aggregation
of some staphylococcal isolates
As shown in Fig. 1a, two suspensions of S. epidermidis ATCC 12228
after 90 min of incubation at 30 oC displayed strikingly diﬀerent sedi-
mentation depending on the ionic strength of the buﬀer. In the Tris 0.1
mM supplemented with 5 mM NaCl buﬀer, the suspension has signiﬁ-
cantly cleared and an accumulated biomass, referred to as pellet in Fig.
1, is visible at the bottom of the cuvette, whereas the suspension in the
150 mM NaCl buﬀer remained homogeneously dispersed. The kinetics
of this behavior is shown in Fig. 1b, where the evolution of the OD600
of S. epidermidis ATCC 12228 in Tris 0.1 mM buﬀers with 0, 5 and 150
mM of NaCl is reported. While the suspension in Tris 0.1 mM buﬀer
with 5 mM NaCl started to clear after 20 min and continued until 90
min, the two other suspensions remained stable. The rapid clearance re-
sults from the formation of large cell clusters sedimentation, as observed
microscopically with S. epidermidis ATCC 12228 suspensions (data not
shown). Large aggregates of staphylococcal cells could be seen in the 5
mM NaCl buﬀer after 30 min whereas the cells in 150 mM remained well
separated.
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Figure 1: Macroscopic observation of the ionic strength (I) dependent ag-
gregative phenotype. (a) The cuvettes contain S. epidermidis ATCC 12228
suspended in 0.1 mM Tris buﬀer with 5 mM NaCl (I = 5 mM, left) and in 0.1
mM Tris with 150 mM NaCl (I = 150 mM, right), respectively. Suspensions
were initially adjusted to the same optical density and the images were taken
after 90 min of incubation at 30oC. The suspension in the 5 mM NaCl buﬀer
has sedimented, forming a 2 mm thick pellet at the bottom (arrows). On the
contrary, on the right, the suspension in 150 mM NaCl remains homogenously
dispersed. (b) The OD600 of three suspensions of S. epidermidis ATCC 12228,
in I = 0.1 mM (red line), I = 5 mM (blue line) and I = 150 mM (black line)
buﬀers, were monitored every 10 min for 90 min. Turbidity of the suspension
in I = 5 mM rapidly decreased unlike the suspensions in 0.1 mM and 150 mM.
Error bars express the standard deviation obtained from the results of three
independent experiments.
Occurrence of the ionic strength dependent cell aggrega-
tion
The occurrence of the observed aggregative phenotype was determined
on a panel of 17 strains including: six S. aureus, four S. epidermidis,
four other coagulase negative Staphylococci, one E. faecium, one M. lu-
teus and one S. salivarius. Suspensions were prepared from stationary
phase cultures, in seven Tris 0.1 mM buﬀers with ionic strength of 0.1,
0.5, 1.5, 5, 15, 50 and 150 mM (NaCl). The OD600 of these suspensions
were measured when they were prepared (t = 0) and after 90 min of
incubation at 30 oC. The results are expressed as a ratio R obtained by
dividing the OD600 after 90 min by the initial OD600 of the suspension.
All strains were tested in triplicates. Fig. 2a presents a graph of R mea-
sured for strain S. epidermidis ATCC 12228 in all seven Tris 0.1 mM
buﬀers with increasing ionic strengths. The curve presents an optimum
of ionic strength, at which R achieves a minimum value. At this opti-
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mal ionic strength, intercellular aggregation took place and pellets could
systematically be observed at the bottom the cuvettes (see Fig. 1a). At
both high and low ionic strengths, R values were close to 1, meaning that
the suspensions were stable and that only slow sedimentation occurred,
with no or few cell aggregation.
In order to quantitatively assess the occurrence of the aggregative
phenotype, two criteria were deﬁned. The ﬁrst is the range of ionic
strengths in which aggregation is the most pronounced. It was deﬁned
as the ionic strengths in which minimal R values were noticed. In other
words, this range corresponds to the spread of the minima in experimen-
tal curves, as shown in Fig. 2a. The second is the maximal amplitude
(1-R) of the OD600 drop after 90 min within the range of ionic strength
previously deﬁned. Fig 2b and 2c display the range of ionic strengths and
the amplitude, respectively, for the seventeen strains tested in this study.
Out of a total of seventeen strains, seven strains (three S. aureus,
three S. epidermidis and one coagulase-negative Staphylococcus - CoNS)
were shown to dramatically aggregate at some ionic strengths. For these
seven strains, an optimal ionic strength where aggregation occurs could
always be identiﬁed. In buﬀers of 150 and 0.1 mM ionic strength, sus-
pensions of these seven strains remained well dispersed as indicated by
the R values close to 1, i.e. amplitude values close to 0.
The seven other isolates belonging to Staphylococcus spp., represent-
ing 50 % of staphylococcal strains tested in this work did not aggregate
in these conditions. Three other Gram-positive cocci were also tested
(E. faecium, M. luteus and S. salivarius) but did not present any sign
of aggregation, in any of the buﬀers.
Amongst the seven staphylococcal isolates that positively reacted to
the test, two facts can be noticed. First, all three S. epidermidis isolates
signiﬁcantly aggregate in a broad range of ionic strengths whereas the
S. aureus and the CoNS strains were characterized by a single point
minimum at which aggregation is optimal (Fig. 2b). Secondly, S. aureus
ATCC 6538 showed an optimal aggregation in the buﬀer containing 50
mM NaCl, an ionic strength close to that of physiological buﬀers.
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Figure 2: Dependence of the
aggregative phenotype on the
ionic strength. (a) Plot of
the ratio R = OD600 (t = 90
min)/OD600 (t = 0 min) mea-
sured for suspensions of the
strain S. epidermidis ATCC
12228 in seven buﬀers of in-
creasing ionic strength, rang-
ing from 0.1 to 150 mM.
An ionic strength optimum of
aggregation, characterized by
low R values after 90 min,
is present on the experimen-
tal curve. The maximal am-
plitude (1-R) and the opti-
mal range of ionic strength in
which the aggregation was the
strongest have been deﬁned as
two relevant parameters. 16
other strains were tested ac-
cording to the same proto-
col as S. epidermidis ATCC
12228, the amplitude of the
phenotype for each strain is
presented in (b). Error bars
represent standard deviation
(n=3). All strains displaying
amplitude lower than 0.1 can
be considered as not aggre-
gating. For the seven strains
that present signiﬁcant ampli-
tude values, the optimal ionic
strength at which this ampli-
tude was measured is plotted
in (c).
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Cell aggregation is reversible under changing NaCl con-
centration
Flow cell experiments were designed to assess whether the cell aggrega-
tion was reversible when the ionic strength was modiﬁed. Practically, a
suspension of S. epidermidis ATCC 12228 in Tris 0.1 mM, NaCl 150 mM
was ﬁrst ﬂowed in the chamber and then rinsed with the same buﬀer.
Only single cells were immobilized on the PS surface. A suspension of
the same strain in Tris 0.1 mM, NaCl 5 mM was then injected and rinsed
with the same buﬀer. In this case, large bacterial aggregates were ob-
served to bind to the surface. These aggregates remained fastened on the
surface under ﬂow until a Tris 0.1 mM, NaCl 150 mM buﬀer was ﬂowed
in the chamber again. At this moment, the immediate change in NaCl
concentration caused the bacterial aggregates to be instantaneously dis-
persed and a massive release of separated cells was then observed, some
of which adhering on the surface. Time-lapse images of this experiment
were recorded and a representative selection is presented in Fig. 3.
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Figure 3: Reversible intercellular aggregation in real-time ﬂow cell experi-
ments. These experiments were performed with S. epidermidis ATCC 12228
during 27 min. In (a), a bacterial suspension ( 5*108 CFU/ml) in Tris buﬀer
of 150 mM ionic strength was injected in the ﬂow cell and the same buﬀer was
used to rinse oﬀ the excess of unbound bacteria. Bound bacteria are visible
as dark dots on the image. In (b), the surface of the ﬂow cell is represented
after that the same procedure as described for (a) was performed but with a
buﬀer at I = 5 mM. Large cell clusters of aggregated bacteria are visible. In
(c), the 150 mM buﬀer was ﬂowed again and the aggregates were dispersed,
as indicated by the increased density of adherent single cells. The transition
from (b) to (c) is detailed in (d) to (h), zoomed images taken every 12 sec.
Increasing ionic strength induces the immediate and massive release of single
cells from the aggregates.
This experiment demonstrates the reversibility of the reported ag-
gregative phenotype. Since the transition from the aggregated to the
dispersed state occurred instantaneously, the cell-cell aﬃnity is likely to
be mediated by electrostatic interactions.
Inﬂuence of ionic strength on the bacterial cell surface
charge
The results of the ﬂow cell experiment described above led us to postulate
the involvement of electrostatic forces in the ionic strength-dependent ag-
gregation of Staphylococci. To investigate the eﬀect of ionic strength on
the cell surface charge, S. epidermidis ATCC 12228 were probed using
atomic force microscopy (AFM) with chemically-functionalized probes.
In this modality, known as chemical force microscopy (CFM, [27] [28] [29]
[30]), the AFM probe is modiﬁed with hydrophobic or charged chem-
ical groups, thereby enabling to probe cell surface hydrophobicity or
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charge on the nanoscale. Fig. 4 shows the adhesion force maps, adhe-
sion force histograms and representative force curves recorded at three
ionic strength using COOH-terminated probes. At low ionic strength
(Fig. 4a, 4d), most force curves (79 %) featured single adhesion force
peaks of 205 ± 121 pN magnitude (mean ± s. d. from 4 x 1024 curves
obtained on 4 diﬀerent cells). As the probe is negatively charged at pH
7.4 (COO−), these adhesion events were attributed to electrostatic at-
tractive forces between the negative charges on the probe and positive
charges on the cell surface. Adhesion maps revealed homogeneous dis-
tribution of adhesion events, without any evidence for clusters. Remark-
ably, increasing the ionic strength to 5 mM dramatically decreased the
adhesion frequency and adhesion force (Fig. 4b, 4e), an eﬀect that could
be attributed to the screening of the probe and cell surface charges by
surrounding ions. The same trend was observed at 150 mM (Fig. 4c, 4f).
The AFM experiments conﬁrmed the impact of ionic strength on the
presence of positive charges on the cell surface of S. epidermidis ATCC
12228. However, the data collected in the buﬀer of 5 mM ionic strength
could not give additional insights on the reason for the rapid aggregation
of cells in these conditions.
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Figure 4: Probing of the bacterial cell surface of S. epidermidis ATCC 12228
with negatively charged AFM probes. (a - c). Adhesion force maps (500
nm x 500 nm; z range = 500 pN; bright pixels correspond to binding events).
(d - f) Adhesion force histograms, and representative force curves obtained
by recording spatially-resolved force curves on the cell surface using COOH-
terminated probes (n = 1024 curves for each cell) in buﬀer at 0.1 mM (d), 5
mM (e) and 150 mM (f). All curves were obtained using a contact time of 100
ms, a maximum applied force of 250 pN, and approach and retraction speeds
of 1,000 nm s−1. Examples of a force-distance retraction curve recorded as the
tip was being withdrawn are overlaid on histogram.
The aggregative phenotype has a major inﬂuence on bioﬁlm
formation
Intercellular aggregation is essential at all stages of the development of
mature bioﬁlms [6] [31]. To test whether the aggregative phenotype re-
ported in this paper impacts the early stages of bioﬁlm formation, the
strain S. aureus ATCC 6538, known to be a strong bioﬁlm former [32]
[33] [34], was cultivated in ﬂow cells during 6 h. Two experiments were
conducted in parallel, the only diﬀerence being the ionic strength of the
growth media. Both were prepared with a base of TSB diluted three-
fold, one was diluted in Tris 0.1 mM buﬀer to obtain a medium with a
conductivity corresponding to the optimal ionic strength for S. aureus
ATCC 6538 aggregation (i.e. 50 mM, see Fig. 2b), the other in Tris
0.1 mM, NaCl 150 mM. Flow cells were inoculated for 10 min with two
inocula of the same bacterial charge (ca. 5*107 CFU/ml) but suspended
in 0.1 mM Tris buﬀer 50 and 150 mM NaCl, respectively. Then, the
media were ﬂowed in ﬂow cells for 6 h at 37 oC to allow bioﬁlm growth.
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The surface of ﬂow cells were imaged in 6 positions, right after the in-
oculation and after 2, 4 and 6 h. Representative time-lapse pictures are
presented in Fig. 5a.
Strinkingly, the initial cell clumps were larger in the 50 mM ionic
strength medium. That observation was also made for micro-colonies at
every time points during growth (after 2, 4 and 6 h). In the more saline
medium, bacterial development occurred horizontally as micro-colonies
spread on the surface of the ﬂow cell. In the medium of lower ionic
strength, bacteria grew both vertically and horizontally to form denser
aggregates. To quantitatively evaluate the bioﬁlm development in these
two media, the maximal height of micro-colonies (i.e. the bioﬁlm thick-
ness) after 4 h of growth in ﬂow cells was recorded for three independent
experiments (Fig. 5b). In the low salinity nutritive medium, micro-
colonies were signiﬁcantly thicker than those grown in the high salinity
medium, reaching maximal mean height of 27.5 and 14.3 µm, respec-
tively. These results conﬁrmed the qualitative analysis of microscopic
images that underlined the structural diﬀerences between bioﬁlms of the
same strain grown in media diﬀering only by their ionic strength.
Additionally, at the end of 6 h of growth, both ﬂow cells were rinsed
with Tris 0.1 mM, NaCl 150 mM for 15 min. No signiﬁcant morpho-
logical change could be observed in the bioﬁlm grown in the medium of
lower ionic strength, showing that the aggregation induced at a deﬁned
NaCl concentration is no more reversible after 6 h of growth. To as-
sess the presence of the characteristic matrix of Extracellular Polymeric
Substances (EPS) of a bioﬁlm in the micro-colonies, both bioﬁlms were
stained with a ﬂuorescent conjugate of Concanavalin A, a lectin that
speciﬁcally binds polysaccharides (Fig. 5a, last micrographs). The in-
tensity and the localization of the ﬂuorescence in the bioﬁlm grown with
the medium of lower ionic strength indicate the presence of EPS located
inside the well-developed micro-colonies. Using identical imaging param-
eters, the bioﬁlm fed with the more saline medium displayed a weaker
ﬂuorescent signal (Fig. 5c). More abundant EPS in the micro-colonies
is indicative of advanced maturity of the bioﬁlm grown in the medium
with a lower NaCl concentration.
Taken together, the experimental evidences presented here demon-
strate the large inﬂuence of growth medium salinity on the bioﬁlm devel-
opment process. The reversible aggregative phenotype seems to enable
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a fast buildup of micro-colonies and notably reduces the time needed
to build a structured three dimensional bioﬁlm. During bioﬁlm forma-
tion, the secretion of the EPS matrix engulfs the bacterial cells together
irreversibly.
Figure 5: Early bioﬁlm growth of S. aureus ATCC 6538 in ﬂow cells in TSB-
based media characterized by ionic strength of 50 mM and 150 mM. (a) Time
lapse microscopic pictures of bioﬁlms growing in the two media, only diﬀering
by their ionic strength, were taken 0, 2, 4 and 6 h after the inoculation. The
far right images represent overlay of bright-ﬁeld and ﬂuorescence microscopy to
image the presence of polysaccharides belonging to EPS by means of a tagged
lectin (Concanavalin A). (b) A plot of the bioﬁlm thickness versus the ionic
strength of the medium in which the bioﬁlms were grown. Bioﬁlm thickness
was assessed by measuring the height of micro-colonies after 4 h recorded by
microscopy in 6 positions in ﬂow cells. Error bars represent standard deviation
computed on three independent experiments. (c) A graph of the intensity of
ﬂuorescence on lectin-marked bioﬁlms recorded after 6 h. The y-axis represents
the frequency (number of pixels at a given intensity/total number of pixels in
the image) at which pixels of deﬁned intensity (x -axis) occur in three images for
both media. Pixel intensity scale ranges from 0 to 255, but was limited to 100
in the Figure to improve readability. Each condition represented by the three
independent curves presents diﬀerent shapes indicating that bioﬁlms grown in
50 mM ionic strength medium contains signiﬁcantly more EPS.
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Discussion
In the present study, we demonstrated that the ionic strength directly
modulates the intercellular aggregation of some S. aureus, S. epidermidis
and one S. warneri. Several strains belonging to these species formed
large cell clusters within minutes when they were suspended in buﬀers
with ionic strengths ranging from 1.5 to 50 mM. In high (150 mM) and
low ionic strength (0.1 mM) buﬀers however, these bacteria remained
homogeneously dispersed in suspension. Within the 14 staphylococcal
strains tested in this study, seven were shown to aggregate and were all
clinical isolates. Amongst the strains that did not react to changes in
ionic strength, four were also of clinical origin and three were collected
in the environment or in food products. The absence of aggregation in
strains of E. faecium, S. salivarius and M. luteus indicates that the phe-
notype could be limited to species of the Staphylococcus genus, though
further investigations would be needed to conﬁrm that the ionic strength
aggregation is speciﬁc to Staphylococci and to analyze the distribution
of this phenotype amongst this genus.
The intercellular aggregation observed in intermediate ionic strength
buﬀers (i.e. 5 mM) was proved to be reversible on a short time scale
in ﬂow cell experiments. Indeed, bacterial aggregates were immediately
dispersed as a high ionic strength buﬀer was injected (see Fig. 2). These
results suggest that the forces involved in this particular type of aggrega-
tive phenotype are electrostatic. In general, the cell surface of bacteria
is negatively charged at physiological pH [35].
In low ionic strength media, AFM results showed that forces retain
a negatively charged tip on the bacterial cell surface, showing the pres-
ence of positive charges. However, in the same conditions, bacterial cells
remained well dispersed in suspension, indicating that bacteria were at
least non-attractive or even repulsive towards one another. Two phe-
nomena could explain these contradictory results. First, in AFM, the
tip is brought in contact with the surface without taking into account
the electrostatic repulsion barrier. Our experimental setup does not give
any information on the balance between positive and negative charges
on the cell surface. In this case, we suggest that some proteins with
an isoelectric point well above 7.4 and/or positively charged cell sur-
face polymers, such as partially deacetylated PIA, could be responsible
for this attractive interaction with the negatively charged probe. These
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polymers harboring positive charges sensed by AFM could represent a
minor percentage compared to negative ones. Second, due to the low con-
centration of ions in solution, the double ionic layer surrounding the cell
is large, implying that the electrostatic repulsion between two globally-
negative charged cells operates at larger distances from the cell wall.
Besides, in these conditions, the cell wall anchored polymers are fully
extended towards the external medium generating a soft layer at the cell
surface. This was conﬁrmed by AFM, the cell surface appeared granular
as the cells were probed with a bare tip (data not shown). This layer of
extended polymers accentuates the range of the electrostatic repulsion
exerted between two bacterial cells. As a consequence, two approaching
bacteria of net negative charge would repel one another before any con-
tact could happen.
At high ionic strength, ions present in abundance in solution shield
the electrostatic interactions between two cell surfaces. The thickness of
the double layer is minimal, around a couple of tenth of nm [35]. Hence,
the topographical smoothness of the cell surface upon probing with a
bare AFM tip (result not shown) indicates that the soft layer of poly-
mers around the bacteria is not forming. In these conditions, bacteria in
suspension would remain dispersed as the electrostatic interactions are
strongly dimmed by surrounding ions.
Concerning the cell aggregation occurring at intermediate ionic strength,
we hypothesized that localized positively charged polymers (proteins
with a high isoelectric point or PIA) interact with negatively charged
polymers on the surface of another bacterium to induce cell aggrega-
tion. Such phenomena have already been highlighted among colloids
with montmorillonite particles (negatively charged clay) that aggregate
upon addition of polycations. In this case, the polycations form clusters
at the surface of the clay and ﬂocculation is mediated by electrostatic
interactions [36]. As bacteria are diﬀerent from mineral particles, two
conditions should be met for this type of interaction to take place be-
tween bacterial cells: the soft layer of surface polymers should be moder-
ately expanded and the shielding eﬀect of ions forming the double layer
should not be too pronounced. Both require moderate ionic strengths,
where clusters of positive charges can eﬃciently interact with negative
charges located on surface of other cells to cause cell aggregation. Clus-
ters of charged polymer may result from deﬁned sorting and anchorage
of proteins on the cell surface [37] [38]. It is tempting to speculate that
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a particular, strain dependent organization of the polymers on the bac-
terial cell surface is responsible for the ionic strength dependent cell
aggregation. Unfortunately, AFM results collected in the 5 mM ionic
strength buﬀer did not reveal any speciﬁc organization of charges upon
the probed bacterial surface, which represents less than 10 % of the total
bacterial surface.
Alternatively, conformational changes in cell surface proteins and
other polymers can be induced by ionic strength [39] [40] [41] leading
to modify some properties of bacterial surfaces. For example, it has
been shown that cell hydrophobicity of Lactobacillus acidophilus and
Lactococcus casei is higher at low ionic strength and reverted to a more
hydrophilic state at high ionic strength [42]. Based on this study re-
sults, the reversibility of the aggregation observed in speciﬁc ranges of
ionic strength could also be the result of a reaction of cell surface poly-
mers to a sudden modiﬁcation of NaCl concentration. The instantaneous
reversibility of cell aggregation observed in ﬂow cell experiments is com-
patible with the time scale of rearrangements in polymer conformation
which can be extremely short, down to sub-milliseconds [43].
The aggregation of Staphylococci reported in this paper can have
important consequences on the development of nosocomial infections.
Indeed, in complex system such as body ﬂuids, the electrical conductiv-
ity and the ionic strength are not linked by a simple relationship as it
is the case for simple buﬀers, e.g. Tris-NaCl buﬀers. The presence of
macromolecules or even cells strongly aﬀects the electrical conductivity
while the ionic strength remains constant. This has been illustrated for
blood in which the presence of erythrocytes caused a drop in electrical
conductivity proportional to their abundance. Visser has measured the
conductivity of stationary blood plasma at around 15 mS/cm whereas
the same blood plasma containing a normal quantity of 45 % of haema-
tocrit (volume occupied by erythrocytes when these cells are separated
from plasma by centrifugation in Ficoll) was found to have an electrical
conductivity of 0.55 S/m. Furthermore, in the same study, the electrical
conductivity of ﬂowing blood was shown to be lower by up to 30 % than
that of stationary blood [44]. This ﬂowing blood electrical conductivity
approximately corresponds to a solution at 50 mM ionic strength, i.e. the
optimal condition in which the strain S. aureus ATCC 6538 aggregates.
In this work, the impact of ionic strength and conductivity could not be
clearly discriminated but it can be hypothesized that body ﬂuids present
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favorable conditions for the aggregation of Staphylococci to happen.
Staphylococcal bioﬁlms are the most frequent cause of chronic in-
fections related to implantable devices [45] [46]. The development of
bioﬁlms on surfaces highly depends on the ability of bacterial cells to pro-
mote intercellular aggregation, in order to ensure the cohesion of these
sessile communities. To date, several molecules have been shown to play
a key role in this process, including notably the PIA [20], and proteins
such as Aap (or its homolog SasG) [47], Bap [22] and Embp [48]. We
report that the ionic strength dependent cell aggregation phenomenon
highlighted in this study impacts bioﬁlm formation of S. aureus ATCC
6538 in terms of thickness, three dimensional development and EPS
production, reducing the time needed to develop a structured bioﬁlm.
Mechanisms such as modulation of quorum sensing (QS) system, gener-
ally recognized to govern the genetic switch towards the bioﬁlm lifestyle
in Staphylococci, in particular by regulating the production of EPS [49],
could be one of the reasons leading to a more structured bioﬁlm at some
given ionic strengths. Rapidly forming large aggregates in challenging
environments would enable Staphylococci to fast track the formation of
bioﬁlms and decrease their vulnerability.
Based on our observations, the importance of the ionic strength of
growth media and buﬀers used to develop bioﬁlms of Staphylococci in
vitro should not be overlooked. To date, most laboratory media feature
a conductivity of about 15 mS/cm, equivalent to the ionic strength of a
150 mM NaCl solution, i.e. physiological solutions.
In conclusion, we report a novel phenomenon of staphylococcal inter-
cellular aggregation that exclusively depends on ionic strength. Strains
of the two notorious pathogens S. aureus and S. epidermidis displayed
rapid and reversible cell aggregation on initially dispersed planktonic
cells. For surface bound bacteria, intercellular aggregation induced faster
and more structured bioﬁlm formation. Bioﬁlms are known to be the
root cause of persistent infection on indwelling medical devices, notably
thanks to host immune system evasion and increased tolerance to an-
tibiotics. The mechanism underlying this aggregative phenomenon is
yet unknown though evidences point towards electrostatic interactions.
Further work is needed to elucidate the molecular determinants of this
particular aggregative mechanism.
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Chapter 11
Challenging bioﬁlms with
enzymes
This chapter brings up the issue of the control of mature bioﬁlms. Given
the increasing number of resistance to antibiotics and disinfectants,
bioﬁlms remain diﬃcult to eradicate and novel strategies are needed to
cope with them. Hereafter are presented the results of bioﬁlm removal
assays with several enzymes with lytic and matrix degrading activities.
A statistical method called response surface methodology was chosen
to assess the eﬀect of individual enzymes as well as their potential
synergies and inhibitions on mature bioﬁlms of S. epidermidis. The
enzymes displayed promising anti-bioﬁlm properties that could prove
useful in the management of staphylococcal bioﬁlms.
* This work has been prepared for publication:
T. Vanzieleghem, F. Vande Cappelle, M. Schmelcher, M. Loessner,
and J. Mahillon. Enzymatic degradation of Staphylococcus epidermidis
bioﬁlms.
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Abstract
S. epidermidis is a major nosocomial pathogen. This species ranks ﬁrst
in the causes of chronic infections associated with certain types of in-
dwelling devices, especially catheters. The major reason why S. epider-
midis is successful as a pathogen is its ability to develop bioﬁlms. These
surface-associated microbial communities provide improved resilience for
bacteria in challenging environments, notably towards antibiotics and
the host immune system. As a consequence, bioﬁlms are diﬃcult to
treat with classical therapies and the need for alternatives to success-
fully eradicate them is present. This study provides demonstration that
three lysins (peptidoglycan hydrolases) including lysostaphin, a bacte-
rial exolysin originally isolated from Staphyococcus simulans, lysin K
and Twort, two phage endolysins, and dispersin B analog degrade ma-
ture in vitro bioﬁlms of S. epidermidis. In addition to the removal of
the bioﬁlms, lysostaphin and lysin K signiﬁcantly lysed bioﬁlm-resident
cells during a 2 h treatment. The cumulated eﬀect of bioﬁlm removal
and cell lysis yields an eﬀective eradication of established bioﬁlms. In
the quest for novel anti-bioﬁlm therapies, lysins and matrix-degrading
enzymes represent interesting alternatives to antibiotics.
Introduction
Commensal bacteria of human skin and mucosa, S. epidermidis is now
regarded as an opportunistic pathogen, encountered in about 5 % of all
healthcare associated infections [1]. It is also the most frequently iso-
lated pathogen in infection involving indwelling medical devices [2] [3]
[4]. The virulence of this species is primarily due to its bioﬁlm-forming
ability [5] [6]. Bioﬁlms continuously release planktonic cells, therefore
causing acute infections [7]. Besides, these sessile communities display
very little sensitivity to antibiotics as Minimal Bioﬁlm Eradiction Con-
centration (MBEC) concentrations can be up to 100 to 1,000 times higher
than the Minimal Inhibitory Concentration (MIC) established for plank-
tonic cells [8] [9]. Even in synergy, antibiotics could reveal ineﬀective.
Two phenomena may explain the increased tolerance of bioﬁlms towards
antibiotics. The ﬁrst is the limitation of mass transfer in the core of
bioﬁlms due to the exopolymeric matrix. The second is the presence of
persister cells, slow growing bacteria able to tolerate antibiotics [7] [10]
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[11] [12]. This therapeutic dead-end underlines the need for novel strate-
gies to tackle the issue of bioﬁlm-related infections.
Currently, two main approaches can be distinguished: preventive
strategies to avoid bioﬁlm development and curative ones, designed to
eradicate mature, well-established bioﬁlms. On the one hand, preven-
tion is primarily set up thanks to modiﬁed surfaces that aim to reduce
bacterial adhesion and/or kill bacteria upon contact and best practices
in hygiene [13] [14] [15] [16] [17]. On the other hand, the main cura-
tive strategies currently used rely on antibiotics. Given their limitations
in combatting bioﬁlms, new approaches have emerged. Firstly, nanoan-
tibiotics (e.g. coated nano-particles or nano-encapsulated bactericidal
molecules) could prove useful to improve the delivery of antibiotics in
the core of bioﬁlms [18] [19]. However, the question of nano-particles
toxicity remains present and should be carefully considered [20]. Other
leads include Anti-Microbial Peptides (AMP) and quorum sensing in-
hibitors also called quorum quenchers. Antimicrobials peptides, of natu-
ral or synthetic origin, selectively permeabilize bacterial membranes, and
induce membrane depolarization, cell leakage, and eventually death [21]
[22]. However, events of bioﬁlms tolerance or resistance to AMP have
been reported [5] [23] [24]. Although the inhibition of QS systems may
lead to a physiological shift towards less virulence and impaired bioﬁlm
formation [25], in Staphylococci, activation of the Agr (Accessory gene
regulator) QS system notably decreases production of adhesins and fa-
vors the expression of virulence factors [26] [27]. Eradication of bioﬁlms
has already been performed in vitro by activating Agr [28] [29]. However,
this strategy could be detrimental in vivo regarding the release of plank-
tonic cells and the enhancement of the expression of virulence factors [30].
So far, there is thus no panacea to prevent or treat bioﬁlm-associated
infections. In that sense, enzymatic control through the concerted ac-
tion of lysins (peptidoglycan (PG) hydrolases) and enzymes targeting the
bioﬁlm matrix is a promising strategy in both preventive and curative
treatments. PG hydrolases include bacterial lysins (exolysins, autolysins
and lysozymes) and endolysins from phages [31]. Lysins can lyse Gram-
positive bacteria when added exogenously to the medium due to the
large osmotic pressure (up to 50 atm) of their cytosol compared to the
environment [32] [33]. Besides, due to the variations in PG structure
from one bacterial species to another [34], speciﬁc species can be tar-
geted by using a dedicated lysin as bactericidal agent [35], avoiding the
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disadvantages of the usual broad range antibiotics [36]. Concerning po-
tential resistances, several mechanisms of resistance have been identiﬁed
for bacterial lysins and lysozymes [37] [38] [39] but there is no report of
resistance to phage endolysins [31]. Previous studies have shown that
lysins (e.g. lysostaphin, LysK and LysH5) were able to remove staphylo-
coccal bioﬁlms in vitro [40] [41] and lysostaphin in particular was able to
eradicate bioﬁlm developed on catheterized mice [42] [43]. In addition,
synergies between PG hydrolases and antimicrobial agents have also been
reported [44].
In this study, the eﬀect of a dispersin B analog (a β-hexaminidase,
hereafter referred to as Dsp B*), lysostaphin (LST), and two lysins (PG
hydrolases) from phages Twort and K (Tw and LysK) were tested on both
bioﬁlm removal and cell lysis activity within bioﬁlms. All four enzymes
proved eﬃcient at degrading mature S. epidermidis bioﬁlms although
Tw and Dsp B* were inhibiting each other. Of interest, LST and LysK
also displayed a lytic activity against bioﬁlm-dwelling bacteria. These
enzymes are thus promising candidates as anti-bioﬁlm agents in the eﬀort
to control infectious bioﬁlms.
Materials and Methods
Bacterial strains and cultures
The strain S. epidermidis ATCC 35984, known to be a strong bioﬁlm
former [45], was used in this study. The strain was plated from frozen
stock (-80 oC) on Tryptic Soy Agar (TSA) plates and incubated at 37
oC for 24 h. The cultures were carried out in 250 ml Erlenmeyer ﬂasks
ﬁlled with 50 ml of Tryptic soy Broth (TSB) at 37 oC under 120 rpm
agitation overnight.
For enzyme puriﬁcations, Escherichia coli XL1-Blue MRF' strains
bearing constructs on plasmid pQE30 for the N-terminally His-tagged
versions of lysin K (LysK) and Twort (Tw) were used as recently reported
by Schmelcher and colleagues [46].
Enzymes
Four enzymes were used in this work: lysostaphin (LST, lyophilized pow-
der, ≥ 500 units/mg protein, Sigma), an analog of dispersin B (DspB*),
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and two endolysins from the staphylococcal phages Twort and K (Tw and
LysK, respectively). The last three enzymes were puriﬁed as His-tagged
versions from the E. coli strains carrying the appropriate constructs. The
induction and puriﬁcation procedures described in [46] were followed, ex-
cept for the following steps: sonication was performed for 5 min (0.5 sec
pulse and 0.5 sec rests) at 35 % of the maximal power of the sonicator
(Sonopuls HD 2200, Bandelin) with HD73 probe, and puriﬁcation was
done in immobilized metal ion aﬃnity columns (Ni-NTA Superﬂow 12.5
ml, QIAGEN). After ﬁltration on 0.22 µm, the purity of the eluate was
assessed by SDS-PAGE using Amersham ECL gels (GE Healthcare Life
Sciences) according to manufacturer instructions. The amount of pro-
teins was measured with the Nanodrop (Thermo Scientiﬁc) by recording
the absorbance at 280 nm and transformed into mg/ml as previously
reported [46].
Standardisation of lysins activity
The bacteriolytic activity of LST, Tw and LysK were assessed on suspen-
sion of S. epidermidis ATCC 35984. Exponential phase cultures at an
optical density at 600 nm of about 0.5 were stopped on ice for 30 min then
centrifuged at 5,000 g for 5 min at 4 oC. The supernatant was removed
and the pellet was resuspended in PBS (Tablets, pH 7.4, Sigma) to ob-
tain a suspension at an optical density at 600 nm of 0.25. Lysins were
added to the bacterial suspensions in PMMA cuvettes (Brand, VWR)
and the optic density was recorded 10 min after the addition of enzymes.
One unit of activity (U) is deﬁned as the amount of enzyme necessary to
cause a 50 % reduction of the optical density at 600 nm of a suspension
from 0.25 to 0.125 in 10 min, assumed to be the result of cell lysis [47].
The following concentrations of lysins were determined as equivalent to
1 activity unit (U): lysostaphin, 10 nM, LysK, 2.5 nM and Tw, 7.5 nM.
Bioﬁlm development in 96-well plates
Static bioﬁlms were grown in culture-treated PolyStyrene (PS) 96-well
plates (CellStar, Greiner Bio-One) according to the protocol described
by [48]. Brieﬂy, 190 µl of TSB were added to the wells of the multiwell
plates and inoculated with 10 µl of an overnight culture of S. epidermidis
ATCC 35984. The 96-well plates were then sealed with paraﬁlm and
incubated at 37 oC for 24 h.
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Enzymatic treatment of mature bioﬁlms and spectropho-
tometric quantiﬁcation
Bioﬁlms were rinsed twice with sterile PBS. Meanwhile, the enzymes
mixes were prepared according to the indications summarized in Tables
1 and 2 by diluting enzyme stocks into PBS to reach the appropriate
concentrations. These mixes were then transferred in the wells; each
was tested four times in independent wells. The bioﬁlms were incubated
with enzymes during 2 h at 37 oC. After incubation, the Optic Den-
sity at 595 nm (OD595) was recorded to quantify the extent of cell lysis
in the bioﬁlms. Then, the enzymes mixes were removed and the wells
were rinsed once with sterile PBS. Subsequently, a staining procedure
with safranin was used in order to quantify the biomass remaining in
the bioﬁlm after the 2h enzymatic treatment. Safranin was preferred
to crystal violet for reproducibility reasons. The staining procedure was
performed according to the protocol recently described by Wu et al. [49].
Brieﬂy, the wells were incubated 1 h at room temperature with HCl 0.1
M, then with safranin 0.1 % w/v for 45 min. The excess of dye was
thoroughly rinsed with sterile PBS. Finally, 100 µl of NaOH 0.2 M were
transferred in the wells and the 96-well plates were incubated at 57 oC
for at least 1 h. During this time, the NaOH solution solubilizes the
stained remnants of bioﬁlms. The contents of the wells were then trans-
ferred to a new 96-well plate for measurement of A540 to quantify the
amount of bioﬁlm that remained in the wells after treatment with enzy-
matic cocktails. The results were expressed in percentage of reduction
(% reduction) compared to untreated control bioﬁlms.
Response surface methodology
In this work, a Response Surface Methodology (RSM) was applied, us-
ing an orthogonal Central Composite Design. The trials were deﬁned
by the statistical software JMP (SAS ) and the experimental design is
shown in Table 1. In the 30 trials, three types can be distinguished: 16
factorial points (from 1 to 16), 6 central points (from 17 to 22) and 8
star points (from 23 to 30). The factorial points allowed determining the
eﬀect of each enzyme individually and in combination with the others,
two by two. The central points are replicated to assess the variability
of the experiments. Finally, the star points indicate if the enzymes have
a linear or quadratic dose-response eﬀect on bioﬁlms. The trials were
split in three blocks, each corresponding to a 96-well plate. Each trial
was repeated four times in diﬀerent wells with the same enzyme mix.
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The analyses were split in three blocks, each corresponding to a single
96-well plate. The "block" parameter allows taking into account the
intra-experimental variability. This analysis is made possible because
the 2 central points are repeated in each 96-well plate (i.e. block). In
this case, possible slight loss of enzymatic activity occurring during the
preparation of enzymatic cocktails are detected and accounted for in the
equation of the regression model. The mean values of the four replicates
of A540 and OD595 measured for the 30 trials (displayed in Table 1) were
used to compute two multiple regressions, one for each experimental re-
sponse. The multiple regression models should be validated according
to four criteria. First, R2 should be close to 1. Then, the p-value of the
ANOVA test should be below 0.05, indicating that the model accounts
for the variability in the data. Third, there should not be a "lack of ﬁt",
i.e. a lack of accordance between the multiple regression model and the
experimental data. Finally, the residues (i.e. the diﬀerence between the
values predicted by the model and the experimental values) should follow
a normal distribution. The four criteria were veriﬁed for both models
and are summarized in Fig. S1.
Results
Enzymatic degradation of mature S. epidermidis bioﬁlms
Mature bioﬁlms of S. epidermidis, grown in 96-well plates were chal-
lenged for 2 h at 37 °C with enzyme cocktails according to the trials
indicated in Table 1, as deﬁned by the central composite design. Two
parameters were measured: OD595 at the end of the enzymatic treatment
and A540 after a safranin staining protocol according to [49]. These data
(Table 1) quantify the extent of the cell lysis in bioﬁlms and the biomass
remaining (i.e. bioﬁlm) in the wells, respectively. A multiple regression
analysis was performed on the results with the statistical software JMP
and the results, the eﬀect of each enzyme and their interactions on both
responses (A540 and OD595), are displayed in Table 3. The signiﬁcance
of the eﬀects was classiﬁed in three levels according to the p-values.
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Table 1 - Trials of the response surface methodology to assess the bioﬁlm
degradation activity of the four enzymes Tw, LST, DspB* and LysK. The
concentrations are represented by ranges from -2 to 2 for which Table 2 gives
the corresponding concentrations in nM. The column Pattern is a symbolic
representation of each combination, "a" refers to -2, "-" to -1, "0" to 0, "+"
to 1 and "A" to 2. The "Block" column, from 1 to 3, indicates in which of the
three 96-well plates the trial was performed. The results for A540 and OD595
are presented in absolute values and in % of reduction compared to untreated
controls in the far right columns. Mean values of A540 and OD595 are reported
in the last line for the controls (n=12).
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Table 2 - Concentration ranges (in nM) used for LST, Tw, LysK and DspB*
in the response surface methodology trials reported Table 1.
Table 3 - The parameters of the multiple regressions for A540 and OD595.
They are classiﬁed in four categories: the eﬀect of the enzymes alone, the
quadratic terms that reﬂect the non-linearity of the dose-response curves in
Fig. 1, the interactions, i.e. synergies or inhibitions, and ﬁnally the block
eﬀects that relate to the use of three distinct 96-well plates to perform the
experiments. The p-values below 0.0001 were considered highly signiﬁcant
(***), between 0.0001 and 0.05, very signiﬁcant (**), between 0.05 and 0.1,
signiﬁcant (*). NS stands for Not Signiﬁcant. The following interactions were
deemed NS for both A540 and OD595 and were eliminated from the regressions:
TW x LysK, DspB x LysK, LST x DspB*, Block x DspB* and Block x Tw.
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Bioﬁlm removal
Table 3 shows that all four enzymes, LST, Tw, LysK and DspB*, were each
active against mature S. epidermidis as determined by the associated p-values
below 0.05. The slopes of the curves shown in Fig. 1 indicate the degree of
activity of each enzyme. At ﬁrst glance, LST, DspB* and LysK seem to remove
bioﬁlms better than Tw. A further analysis using Table 2 (concentrations of
enzymes used in the experiments) shows that DspB* is active at subnanomolar
concentrations, LST is most eﬃcient around 50 nM while LysK is active only
from several hundred nM, up to 1 µM. The slope of the curves in Fig. 1 should
thus be interpreted carefully, in light of the concentrations used.
Also in the curves of Fig. 1, it appears that LST, LysK and DspB* are
characterized by non-linear dose-responses. This originates from the signiﬁ-
cance of the quadratic terms: LST2, LysK2 and DspB2 in the regression model
(see Table 3). Signiﬁcant quadratic terms imply that the bioﬁlm removal activ-
ity is saturating at a certain level of concentration. In this case, the increment
of bioﬁlm removal provided by the addition of enzyme is dependent on the
amount of enzyme already present. Of note, this eﬀect is less marked for Tw,
as conﬁrmed by the signiﬁcance of Tw2 in Table 3.
Figure 1: Prediction of the eﬀect of Tw, LST, DspB* and LysK enzymes alone
on the experimental responses represented on the y axes: % reduction in A540
(a) and % reduction in OD595 (b) (compared to untreated controls). Thick lines
indicate the predicted eﬀect of each enzyme on both experimental responses.
Dotted lines represent the conﬁdence intervals at 95 % computed by the model.
The x axes indicate the concentration of all enzymes; please refer to Table 2
for the actual molar concentrations.
Finally, Fig. 2 (a, b) shows that DspB* and Tw negatively cross-inﬂuence
one another. Indeed, in Fig. 2 (a), the bioﬁlm degrading eﬀect of Tw is clearly
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marked when DspB* is present in low concentration (-1) while the presence of
the highest concentration in DspB* (+1) annuls it, the curve is signiﬁcantly
ﬂattened. The same goes for DspB* that has a strong bioﬁlm removal activity
in the presence of lower amounts of Tw whereas it shows no eﬀect at all when
Tw is present at high concentration (+1) as shown in Fig. 2(b). In the model,
these eﬀects translate in the signiﬁcance of the interaction occurring between
Tw and DspB* (Tw x DspB*, see Table 3). However, in this case, it is likely
that this interaction appears signiﬁcant due to saturation in the experimental
response. Indeed, in the presence of a large concentration of Tw or DspB*,
A540 has already reached its minimal value and cannot be inﬂuenced by the
addition of Tw or DspB*. Therefore, the nature of the interaction between Tw
and DspB* is probably not an inhibition.
Figure 2: Interaction plots. The graphs display the inﬂuence of an enzyme
(indicated in the top right corner) on the eﬀect of another enzyme (x axis) on
the bioﬁlm removal (% reduction in A540) or cell lytic activities (% reduction
in OD595) (left y axis) (a) Impact of DspB* on the bioﬁlm removal eﬀect of Tw;
(b) Inﬂuence of Tw on DspB* bioﬁlm removal activity; (c) Impact of LysK on
the cell lysis caused by LST; (d) Inhibiting eﬀect of LST on the lytic activity
of LysK.
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Cell lysis of bioﬁlm-dwelling S. epidermidis cells
The cell lysis in bioﬁlms after treatment with the enzymes was quantiﬁed by
recording the OD595. Fig. 1(b) indicates that LST and LysK are able to
markedly lyse bioﬁlm-dwelling S. epidermidis cells. These two enzymes are
also classiﬁed as signiﬁcant according to the multiple regression model (Table
3). Surprisingly, despite its lytic activity on S. epidermidis cells in suspension,
Tw does not seem to participate to cell lysis, i.e. reduction of OD595. This
can be seen by the ﬂatness of the curve in Fig. 1(b) as well as in Table 3, in
which Tw appears as non-signiﬁcant. Finally, DspB* does not play any role
in cell lysis as expected from its enzymatic activity, i.e. N-acetylglucosamine
hydrolase.
Also in Table 3, the interaction term involving both LysK and LST ap-
pears signiﬁcant. Fig. 2 shows that LST and LysK interact in an inhibitive-
competitive way. Indeed, Fig. 2(c) indicates a loss in LST lysis activity when
LysK is present in higher concentration (+1). On the other hand, in a situa-
tion in which LysK is present in smaller amounts (-1), LST causes a decrease
in OD595. The cell lysis activity of LST is therefore strongly inﬂuenced by the
presence of LysK in the medium. Similarly, Fig. 2(d) shows that LysK activity
is impaired in the presence of larger amounts of LST. These results indicate
that both enzymes inhibit each other in cell lysis.
Finally, as for bioﬁlm removal, LST and LysK cell lytic activity do not
follow a linear dose-response relationship. Instead, both are characterized by
quadratic curves as conﬁrmed by the signiﬁcance of LST2 and LysK2 in Table
3.
Optimization of cell lysis and removal of bioﬁlms
The regression model computed from the experimental data allows to predict
how the enzymes LST, Tw, LysK and DspB* act on cell lysis and bioﬁlm degra-
dation for a 2 h treatment at 37 oC. Because of the particular geometry of the
original composite central design, the domain of forecast is a sphere that ex-
pands from -1 to +1 for each enzyme (see Table 2 for concentrations in nM).
Outside this sphere, the predictions would be inaccurate, even though the star
points of the central composite design include concentration ranging from -2 to
+2.
In Fig. 3, contour plots display the impact of varying concentrations of
LST and LysK for deﬁned quantities of DspB* and Tw (-1, 0, +1) on % re-
duction in A540 (red lines) and % reduction in OD595 (blue lines). The colored
areas represent the zones in which prediction reduction in A540 and in OD595
are respectively above 85 and 80 %. These values correspond to experimen-
tal observations of an almost total degradation of the bioﬁlm and a signiﬁcant
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clearance of the turbidity in the wells (i.e. an extensive cell lysis).
Figure 3: Optimization of Tw, LST, LysK and DspB* activity on mature
S. epidermidis bioﬁlms. Nine plots display areas in which more than 85 %
reduction in A540 (in red) and 80 % reduction in OD595 (in blue) was achieved,
for all concentrations of LST and LysK and for 3 ﬁxed amounts of Tw (top x
axis) and DspB* (left y axis). The overlap of blue and red zones represent the
optimal combinations of LysK, LST, Tw and DspB*. Refer to Table 2 for the
signiﬁcance of -1, 0 and 1 in terms of concentrations (in nM).
Of note, the size and position of the blue zone, indicating the concentrations
of LysK and LST at which cell lysis is optimal, is not signiﬁcantly changing.
This conﬁrms that Tw and DspB* play a minor role in cell lysis within the
bioﬁlm, as monitored by the reduction of OD595 (see Table 3). On the con-
trary, the size and position of the red zone on the graph is strongly inﬂuenced
by the concentration of Tw and DspB* that signiﬁcantly aﬀect A540 by remov-
ing the bioﬁlm.
The main information indicated by these contour plots can be found in the
overlap of the ﬁlled red and blue zones. These zones represent the numerous
combinations of LST, Tw, LysK and DspB* concentrations that produce opti-
mal levels of bioﬁlm removal and cell lysis, i.e. 85 % reduction in A540 and 80
% reduction in OD595 compared to untreated control bioﬁlms.
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Discussion
With the intrinsic tolerance of bioﬁlms to classical therapies and cleaning pro-
cedures it becomes urgent to develop new strategies to cope with bioﬁlms that
represent a threat to public health. In this article, the potential anti-bioﬁlm
activity of four enzymes, including three lysins (one bacterial and two from
phages) and one matrix-degrading enzyme, was tested against bioﬁlms grown
in static conditions. The bioﬁlm removal (A540) and cell lysis (OD595) activ-
ities of these enzymes were both monitored. Bioﬁlm removal activity coupled
with extensive cell lysis would provide an eﬃcient way to eradicate bioﬁlms.
In this work, a response surface methodology was implemented in order
to assess the potential interactions between LST, LysK, Tw and DspB* on
bioﬁlms. It consists of a canonical set of experiments providing results that can
be optimally treated with statistical models. Indeed, response surface method-
ology provides a predictive model that accounts for the eﬀect of individual
enzymes, as well as synergies. Such approaches have become increasingly pop-
ular for screening and optimization procedures in life sciences, notably because
of the quantity of information gathered from the experiments [50]. For a review
of advantages and limitations in using RSM for such purpose, see the work of
Bas and co-authors [51].
Experimentally, the bioﬁlms grown in 96-well plates were challenged for 2
h at 37 oC with cocktails of enzymes that are listed in Table 1 and 2. The
choice was made to expose the bioﬁlms for a relatively short period of time to
avoid any growth to happen. After enzymatic treatment, a staining of bioﬁlm
remnants was performed with safranin, which was preferred to crystal violet
for reproducibility reasons.
The interpretation of the results showed that LST and LysK were good
candidates to remove S. epidermidis bioﬁlms and lyse cells. However, if used
together in a cocktail, they tend to inhibit each other with regard to their cell
lysis activity. Tw was eﬃcient at degrading bioﬁlms but was found to be sur-
prisingly inactive at lysing bioﬁlm-dwelling cells. It is likely that the cell surface
properties of S. epidermidis cells in bioﬁlms impair the peptidoglycan hydrolase
activity of Tw, resulting in protection from lysis. Also, this endolysin could be
more sensitive to inactivation or denaturation by proteases or inhibitors present
in the EPS matrix of bioﬁlms or released by the lysis of other cells. Finally,
DspB* was found to have a marked bioﬁlm removal activity at subnanomolar
concentrations, most probably by degrading the main component of the EPS
matrix, poly-N-acetylglucosamine chains. Unfortunately, the lack of positive
synergies involving DspB* with LST, LysK or Tw indicates that it does not
facilitate the cell lysis of bioﬁlm-dwelling S. epidermidis of these lysins.
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The analysis also revealed an inhibition between LST and LysK on cell
lysis activity. This observation is not in accordance with previous works that
reported a synergistic action of these two enzymes to lyse Staphylococci in sus-
pensions [52]. It seems that bioﬁlm embedded cells do not favor a cooperative
action of LysK and LST, despite the fact that they harbor distinct cut sites
[31]. The bioﬁlm lifestyle may induce protective modiﬁcations on the cell sur-
face of S. epidermidis that hamper the activity of lysins.
Based on the results presented in this study, it was also possible to identify
combinations of the four enzymes that maximize both the bioﬁlm removal and
cell lysis (see Fig. 3). It appeared that LST and LysK were good candidates
for bioﬁlm degradation that can be helped by either Tw or DspB* to achieve
bioﬁlm eradication.
These conclusions should however be put in perspective with the culture
conditions in vitro. Indeed, the composition of bioﬁlms can be strongly inﬂu-
enced by environmental factors such as, for instance, the presence of various
carbon sources or ﬂuid ﬂow [53] [54]. Also, the presence of distinct species can
have a dramatic inﬂuence on the structure and composition of the bioﬁlms.
In particular, the ratio between bacterial cells and EPS matrix as well as the
proportions of the polymers in the matrix may vary [55]. As a result, the bal-
ance of each enzyme needed to eﬀectively remove bioﬁlms could be diﬀerent
from the combinations identiﬁed here. Further work to challenge the activity of
LST, LysK, Tw and DspB* on multi-species bioﬁlms grown in diﬀerent condi-
tions would provide additional insights on their potential as anti-bioﬁlm agents.
This work provides direct demonstration that phage endolysins are a promis-
ing class of enzymes to combat bacterial bioﬁlms. Two of these enzymes were
found to actively degrade in vitro bioﬁlms of S. epidermidis. Given the large
pool of phages in nature [56] and the diversity of catalytic domains and struc-
ture of endolysins [31], there is a large untapped reservoir of potent active
principle to target bacterial bioﬁlms.
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Supplementary information
Figure S1 - Validation criteria for the two multiple regressions computed for
A540 (a) and OD595 (b). From top to bottom, the following items are presented:
the experimental values are plotted according to the predicted regression model,
R2, ANOVA, lack of ﬁt and the distribution of the residues. See text for further
explanation.
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12.1 The onset of bioﬁlm-associated nosocomial
diseases : prevention and detection
Is S. epidermidis the next superbug?
The standards of modern medicine regarding hygiene in healthcare has
led to the extensive use of disfectants and antibiotics in hospitals. Over
the years, these facilities have become very harsh environments for
microorganisms to thrive in. The high selective pressure in hospitals
results in only the ﬁttest micro-organisms survive. For bacteria,
evolution and adaptation to changing conditions can occur fast, through
various mechanisms (Chapter 2). Challenging conditions can also
be seen as opportunities to invade a niche in which the competitive
microﬂora is considerably reduced. The past 70 years of antibiotics
use in healthcare are the best illustration of this. Leading nosocomial
pathogens such as S. aureus and S. epidermidis have been responding
to each novel antibiotic molecules (penicillin, methicillin or vancomycin)
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with resistance or tolerance mechanisms, acquired either by mutations,
or through HGT. Besides antibiotic resistance, the ability of bacteria
to develop in the form of bioﬁlms also allow them to increase their
resilience in healthcare facilities.
In this work, the focus was set on S. epidermidis, a ubiquitous
bacterium in environments frequented by humans. For S. epidermidis,
bioﬁlm formation is recognized as a virulence factor [Otto 2009]
[Christner 2010]. We questioned whether the bioﬁlm forming ability
could be inﬂuenced by exposure to clinical settings. In Chapter 7, a
collection of 134 S. epidermidis strains originating both from the envi-
ronment and hospitals (samples were taken from inert surfaces in rooms
as well as from patients) was tested by PCR for the presence/absence
of genes known to be involved in bioﬁlm development. The functions
include adhesion, aggregation, dispersal, QS (Agr) and IS elements
that participate in the regulation of bioﬁlm formation. These data
were processed with a hierarchical clustering algorithm using the Ward
method that provided a dendrogram (see Fig. 7.1).
Collectively, these results support the hypothesis that S. epidermidis
reacts to the selective pressure omnipresent in hospitals by favoring the
acquisition or retention of genes important for bioﬁlm formation and
antibiotic resistance. Besides, the strains isolated from infected patients
appear to cluster apart from the majority of the strains collected
from inert surfaces in hospitals, indicating that dwelling in patients
body accentuates the need for bacteria to keep, maintain or acquire
bioﬁlm-related genes. These conclusions are in line with previous
observations [Rohde 2004] [Kozitskaya 2004] [Schoenfelder 2010].
Despite the apparent lack of bona ﬁde virulence factors, S. epider-
midis relies on bioﬁlm formation to invade the host, notably to hide from
immune system [Fey 2010]. The mortality resulting from these diseases
can greatly vary according to the patients age and the site of infection but
is estimated to be between 1 - 25 % [Raad 2007] [O'Grady 2002]. These
infections tend to leave medical staﬀs without options but to remove
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implants or adopt long term antibiotic treatments. For these reasons,
S. epidermidis has become a prominent cause of nosocomial, chronic in-
fections on indwelling devices. It reaches about 0.1 % of the population
in developed countries [Rogers 2009], representing a major burden for
healthcare systems and a threat to patient safety [Otto 2012].
On the importance of bacterial adhesion to biomaterials
In the development of implant associated infections, the impor-
tance of bacterial adhesion to biomaterials is now widely accepted
[Pavithra 2008] [Rodrigues 2011]. For example, it has been shown
that bacteria adhering on the surface of biomaterials are already less
susceptible to antibiotics and the immune system of the host com-
pared to planktonic cells [Arciola 2001] [Arciola 2002] [Muszanska 2012].
The surface bound state, as recently proposed by Busscher and
colleagues, can be delimited in three regimes [Busscher 2012]. The
ﬁrst is the lack of adhesion, when bacteria remain in planktonic state
close to the surface. It is notably the case for surfaces coated with
hydrophilic polymer brushes on which bacterial adhesion is compro-
mised [Kaper 2003]. On the contrary, when bacteria bind the surface
with intense forces, i.e. a negatively charged bacterium encounters
a positively charged surface (for example coated with quaternary
ammonia), excessive forces are exerted on the cell envelop causing cell
death [Tiller 2001]. In the last regime, the interaction regime, bacteria
adhere and thrive on the surface. In this conﬁguration, a series of
changes in the physiology of bacteria occur. These adaptations favor
bioﬁlm formation and strongly inﬂuence the fate of bacteria in the host
[de la Fuente-Núñez 2013].
In the case of S. epidermidis, its ability to adhere massively to PDMS
has been shown in static conditions in Chapter 8 and dynamic conditions
in Appendix C. These results conﬁrm previous reports of adhesion to
a wide range of biomaterials such as silicone, polyethylene tereph-
thalate (PET), PTFE and polyurethanes [Patel 2007] [Linnes 2012]
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[Abusalim 2013]. However, these materials are readily coated by plasma
proteins when implanted in the body, therefore changing their surface
properties. The results of this study demonstrated the inhibiting eﬀect
of an adsorbed protein layer on bacterial adhesion of single cells and
whole populations.
The inhibiting eﬀect of adsorbed proteins can be explained by the
DLVO theory [Hermansson 1999]. Indeed, on hydrophobic materials,
adhesive hydrophobic forces occur between the bare material and
the bacterial cell surface. Adhesion is therefore a thermodynamically
favored event. However, a ﬁlm of adsorbed proteins, most of which are
negatively charged at physiological pH, tend to repel bacteria through
repulsive electrostatic forces [Bos 1999]. In this case, the adhesion
event is not thermodynamically favored, notably because the free
energy of hydrophobic surfaces in contact with water has already been
reduced by the proteins. To compensate for the absence of non-speciﬁc
interactions with protein covered surfaces, S. epidermidis possesses
several cell surface proteins, belonging to a class called MSCRAMMs
[Clarke 2006]. They can mediate speciﬁc interactions with host factors.
These molecules are thought to act as harpoons to fasten bacteria on
surfaces on which they would not adhere if only non-speciﬁc interactions
are at play. An example of MSCRAMM is SdrF, a surface protein that
binds to Type I collagen in a ligand-receptor fashion [Arrecubieta 2007].
In this study, the interaction between SdrG, another member of
MSCRAMMs family, and Fg (Chapter 8, sections 8.1 and 8.2) has been
investigated. The binding mechanism of SdrG to Fg according to a
"dock, lock and latch" model was elucidated some years ago. It involves
a 15 amino-acid long peptide sequence in the Fg molecule, Fg(β6-20).
This peptide chain is stabilized between the N2 and N3 domains of SdrG
by numerous hydrogen bonds [Ponnuraj 2003]. The dissociation rate
of the SdrG-Fg interaction has been shown to be low, indicating that
the bond is stable in time [Herman 2014]. The force that characterizes
the SdrG-Fg bond was found to be about 2 nN [Herman 2014] and
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conﬁrmed in the results shown in Chapter 8. The magnitude of this
force is unusually large, indicating the level of adaptation of SdrG to its
substrate. As a comparison, speciﬁc interactions between human IgG
and rat anti-IgG have been reported to be around 0.8 nN [Lv 2010], less
than twice the force of SdrG-Fg binding. In the same vein, the results
of this study also showed that a single SdrG-Fg interaction is stronger
that the binding of whole S. epidermidis cells to a bare silicone surface,
observed to be between 0.5 and 1.5 nN as a result of hydrophobic
interactions.
An hypothesis for such a large force uniting SdrG to Fg could lie
in the necessity for a bacterium to secure its adhesion to surface, even
under high shear stresses, as they can be encountered in blood vessels
[Papaioannou 2005]. It is critical for bacterial cells to ensure a lasting
anchorage on the surface on which it thrives to avoid being removed.
Detachment of S. epidermidis in a hostile context such as in the host
(e.g. blood stream) would undoubtedly impair bioﬁlm development and
compromise its survival [Schoenfelder 2010].
In addition to these observations, the importance of SdrG abundance
on the bacterial cell surface in the adhesion to Fg coated surfaces was
investigated. Cell surfaces of four S. epidermidis strains were mapped
by AFM with Fg-modiﬁed tips to highlight the presence of SdrG. It
appeared that not all tested staphylococcal isolates displayed SdrG on
their surface. SdrG was detectable in two strains and HB displayed
signiﬁcantly more SdrG on the cell surface than ATCC 12228. Despite
the fact that it carries the fbe gene, encoding the SdrG protein, strain
ATCC 35984 did not harbor any detectable amount of active SdrG
molecules on its cell surface. It is likely that the fbe gene in the strain
ATCC 35984 does not produce a fully functional SdrG adhesin. This
hypothesis is based on the comparison of fbe genes in genomes of many
S. epidermidis strains including those of ATCC 12228 and ATCC
35984 that revealed signiﬁcant discrepancies in the length of the protein
and the size of the SD (Ser-Asp) repeats (data not shown). Indeed,
mutations, deletions or insertion in the sequence could have altered
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the tertiary structure of the resulting SdrG. The spatial arrangement
of N2 and N3 domains of SdrG, essential to the binding mechanism,
could therefore be modiﬁed in this strain. Another possibility is that
the expression of fbe is submitted to complex regulations, probably
strain-dependent. Also, the in vitro conditions may not have favored
the expression of SdrG. This is supported by reports that fbe expression
increased after exposure to in vivo environments [Sellman 2008], indi-
cating that the cells react to deﬁned stimuli to trigger SdrG production.
However, the mechanisms governing the genetic regulation of fbe remain
still largely unknown.
To evaluate the impact of the bacterial surface density of SdrG on the
adhesion to Fg-coated surfaces, adhesion assays were performed. They
revealed a positive correlation between SdrG density on the cell surface
and increased adhesion to Fg. That was shown both for single cells as
well as for whole populations (Chapter 8, section 8.2). These results
lead to believe that it is advantageous for S. epidermidis to massively
express SdrG at its cell surface in order to maximize its chances to ad-
here to surfaces coated by Fg. This assumption is probably also valid for
other MSCRAMMs that speciﬁcally recognize other host ligands such
as ﬁbronectin, vitronectin, elastin or collagen. It is reasonable to in-
fer that, in vivo, the cell surface of S. epidermidis undergoes dramatic
modiﬁcations in order to favor its adhesion to host tissues and coated
biomaterials.
Approaches to tackle the issue of implant-associated infec-
tions
The incidence of nosocomial infections has diminished in the period
2002-2012 in the US, as estimates went from 1.7 million to 700.000 cases
[Klevens 2007] [CDC 2014]. This is the result of several complementary
strategies that are currently employed: best practises in hygiene,
modiﬁed biomaterials (detailed in Chapter 4, section 4.1) or pressurized
surgical rooms. But there is no silver bullet to completely avoid the risk
of implant-associated infection to occur and despite these advances, the
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matter of Healthcare Associated Infections (HAI) has become a priority
for the World Health Organization (WHO) [Benedetta Allegranzi 2013].
The need for supplementary means of prevention is clearly present.
From this work, two possible leads can be developed.
The ﬁrst is based on the inhibition of S. epidermidis adhesion to
Fg thanks to SdrG. As already mentioned, the expression of SdrG
is dependent on environmental cues, probably sensed by a signalling
pathway governing the expression of the fbe gene. Further work on
the pathways involved in the expression of SdrG could lead to the
identiﬁcation of possible drug targets to limit its abundance on the
bacterial cell surface. As it was shown in this work, S. epidermidis
adhesion on biomaterials coated by plasma proteins would therefore be
impaired. Bacteria unable to adhere on surfaces in the host would be
more susceptible to antibiotics and to the immune system, limiting the
risk of infection development. This type of strategy could also be used
against other MSCRAMMs.
A second strategy consists in the development of a method for
sensing bacteria on surfaces by means of impedance spectroscopy
(Chapter 9). Brieﬂy, micrometer wide interdigitated electrodes are
submitted to a signal of low amplitude (50 mV) oscillating at a chosen
frequency, ideally around 1 MHz. Bacterial adhesion on the area
between electrodes modiﬁes the properties of the electric ﬁeld which
translates in a change of impedance. This work was primarily focused
on PoC applications, notably the detection of bacteria in a liquid
but sensing surfaces could be integrated on the surface of implants to
detect the adhesion and the proliferation of contaminating bacteria
in real-time. Such smart implants would provide unique insights into
the early stages of implant contamination, therefore decrease the time
to diagnosis. [Paredes 2014]. However much eﬀort and clinical trials
are required to bring such smart implants on the market, the proof of
concept shown in this work could be used to such purposes.
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The prevention of HAIs requires multidisciplinary approaches that
take into account the complexity of bacterial adhesion and bioﬁlm devel-
opment. Novel strategies will complement the measures already in place
to tackle the issue and will hopefully diminish the risk for patients to
acquire HAIs.
12.2 On the inﬂuence of the environment on
bioﬁlm formation by Staphylococci
Throughout the development of bioﬁlms, from the initial adhesion to
the dispersal phase, bacteria respond to environmental cues in order
to adapt their physiological and metabolical states (for a complete
review, see [Karatan 2009]). Such processes are essential to maintain
ﬁtness in changing environments. In the case of S. epidermidis, these
gene regulations involve, for example, the production of EPS in the
presence of glucose [Mack 2007], the response to ﬂuid ﬂow or shear
stresses [Weaver 2012] or the modulation of expression of speciﬁc genes
as previously mentioned for SdrG [Sellman 2008] (for more details, see
Chapter 3, section 3.5).
Ionic strength has been reported to have major, though ambiva-
lent, inﬂuences on bioﬁlm formation in several bacterial species. In
Salmonella enterica serovar Typhymurium, high salt concentration
inhibits bioﬁlm formation by downregulating csgD, a central regulator
of bioﬁlm related genes [Romling 1998]. The same eﬀect was observed
in E. coli for curli genes, known as virulence factor involved in the
adhesion to surfaces [Jubelin 2005]. On the other hand, high salt
concentration has also been shown to promote bioﬁlm formation by
upregulating genes encoding PNAG production in E. coli through the
activation of a cation responsive protein NhaR [Goller 2006]. In S.
epidermidis and S. aureus, the transcriptional regulator rbf was found
to induce bioﬁlm formation in high salt and glucose concentration but
in an ica-independent manner [Lim 2004].
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In Chapter 10, ionic strength was found to play an important role
in intercellular adhesion in Staphylococci. In fact, at an optimal salt
concentration, that was shown to be strain-dependent, self-aggregation
of S. aureus, S. epidermidis and one other CoNS (i.e. S. warneri) could
be observed. The auto-aggregative phenotype was noticed in 50 % of the
strains tested indicating that it is not a general feature of Staphylococci.
Besides, isolates from three other Gram-positive species did not display
this phenotype.
This phenomenon happens rapidly as large cell clumps can be wit-
nessed only a couple of minutes after the ionic strength of a suspension
was modiﬁed. Interestingly, reverting back to high ionic strength (0.15
M) induced the immediate dispersion of cell clusters. Taken together,
these results, and especially the time scale, led us to suggest that the
impact of ionic strength in this phenomenon is not related to genetic
regulation. The pursued hypothesis rather involves surface charges
and the conformation and repartition of polymers on the bacterial cell
surface (for complete discussion, see Chapter 10).
Aggregation plays a key role throughout the life cycle of bioﬁlms
and the direct consequence of the ionic strength dependent aggregation
on bioﬁlm formation was also demonstrated on one S. aureus strain. At
optimal ionic strength, S. aureus ATCC 6538 developed signiﬁcantly
more structured micro-colonies and produced EPS faster than in an
equally nutritive medium at a higher ionic strength. Interestingly, after
6 hours of growth in nutritive medium, the aggregation reaction was
not reversible anymore, most likely due to the presence of EPS that
engulfs bacteria in micro-colonies. These evidences show that some
staphylococcal strains might have found an elaborated way to make use
of changes in the external medium to increase cell-cell stickiness and
accelerate their bioﬁlm development.
Self-aggregation of Staphylococci was previously reported in a test
referred to as the Salt Aggregation Test (SAT). Brieﬂy, bacterial cells
are suspended in 0.02 M phosphate buﬀer at pH 6.8 and mixed with
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portions of solutions containing large concentrations of ammonium
sulfate to achieve ionic strength from 0.3 M to 6 M. In conditions
of increasing salt concentration, the cell surface of bacteria was
progressively dehydrated as the salts aﬀect the availability of water
molecules [Hermansson 1999]. The addition of ammonium sulfate to
a bacterial suspension was therefore used as a method to assess the
surface hydrophobicity of bacterial cells, quantiﬁed by the extent of self-
aggregation occurring in the suspension [Jonsson 1984] [Rozgonyi 1985].
The SAT employs solutions at very high ionic strength, from 0.3 M up to
6 M. In the present work, self-aggregation happened in a range of ionic
strength comprised between 0.0004 M to 0.15 M, closer to physiologi-
cal conditions and well below the ionic strength used to perform the SAT.
The reported phenotype of self-aggregation is most likely part of a
broader strategy used by Staphylococci to modulate the degree of inter-
cellular aggregation depending on the situation the bacteria ﬁnd them-
selves in. At the initial adhesion step, intercellular cohesion should be
maximized to favor the development of the community. In the disper-
sion phase however, aggregation should be more ﬁnely controlled or even
abolished to allow the bioﬁlm to release planktonic cells, also called col-
onizers.
12.3 What ways around the failure of antibiotics
to eradicate bioﬁlms?
The major reason why HAIs are such a burden for healthcare systems
is the inability to properly treat the majority of them once they are
diagnosed. The root cause of chronic HAIs are, in most cases, bioﬁlms
[Bryers 2008]. These are diﬃcult to eradicate with classical antibiotic
therapies. Indeed, bioﬁlms are resilient and regrow, usually causing the
symptoms to reappear shortly after the antibiotic treatment is stopped
(see Fig. 3.9 for illustration).
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Several factors explain the resilience of bioﬁlms. First, as previously
discussed, most bacteria causing HAIs display an arsenal of antibiotic
resistance genes. The second is the presence of persister cells, toler-
ant to cidal antibiotics because they happen to be in a metabolical
state close to dormancy. They are stochastically present in bioﬁlms
[Lewis 2005]. Then the EPS matrix plays an important role of passive
protection by slowing down mass transfer to and from the bioﬁlm.
As a result, the diﬀusion of bactericidal molecules in the core of the
bioﬁlm is hampered, and the exposition of bacteria signiﬁcantly reduced
[Stewart 2008] [Flemming 2010]. The synergistic eﬀect of these three
distinct phenomena justiﬁes the increased persistence of bioﬁlms.
From a therapeutic point of view, there are often few options left but
to act surgically, either by removing the medical device if there is one
or cure the infected zone. To bring alternative solution to the problem,
novel strategies have been explored, many of them have been described
in Chapter 4. In this work, the use of matrix degrading and cell-lytic
enzymes to degrade bioﬁlms has been examined.
Enzymes as means to control mature bioﬁlms
Four enzymes were selected for bioﬁlm removal assays. The ﬁrst is
an analog of DspB, an endoglucanase cleaving the bond between two
N-acetylglucosamine residues of the PNAG. PNAG is the major com-
ponent of the matrix in the bioﬁlm formed by strains of S. epidermidis
that carry the ica locus.
The second and third are two phage endolysins, lysin K (LysK)
and Twort (Tw) as a reference to the phage they were isolated from
[Schmelcher 2014]. LysK and Tw are both composed of three modular
domains, each having their own catalytic activity. In the laboratory,
they have been puriﬁed from E. coli strains bearing a construct with a
copy of the gene and a His-tag. Phage lysins are primarily used by bac-
teriophages to inject their DNA/RNA in the host cell and to trigger the
release of viral particles at the end of the lytic cycle [Borysowski 2006].
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Such enzymes have also the property to lyse Gram-positive bacteria
from outside the cells, for example when they are added exogenously to
a medium [Nelson 2012]. The susceptibility of Staphylococci to lysis by
phage lysins is species- and sometimes even strain-dependent (data not
shown).
The last enzyme used in this study is lysostaphin (LST), a bacterial
lysin, also called exolysin, discovered several decades ago in Staphylo-
coccus simulans [Sschindler 1964]. It is a glycyl-glycin endopeptidase,
cleaving the interpeptide bridge of Staphylococcus peptidoglycan (PG).
The ability of LST to degrade staphylococcal bioﬁlms has already been
reported elsewhere [Wu 2003] [Kokai-Kun 2009]. In this work, the focus
was set on showing potential interactions between LST and the three
other enzymes described above.
The eﬀect of these enzymes on bioﬁlms grown in 96-well plates were
assessed with two parameters: ﬁrst, after the enzymatic treatment,
the optical density at 595 nm (OD595) of the wells was measured,
as an indicator of cell lysis in the bioﬁlm. The second measurement
relates to the quantity of bioﬁlm remaining in the wells after the
treatment. It is a way to quantify the bioﬁlm removal activity of
enzymes. Experimentally, the absorbance at 540 nm (A540) was
recorded after a staining procedure with safranin was performed.
Though crystal violet was initially chosen to stain bioﬁlms, the pro-
tocol proposed by [Wu 2014] was found to provide more accurate
results and less variability. The combination of these two measurements
oﬀers more insights on the way enzymes degrade S. epidermidis bioﬁlms.
The results displayed in Chapter 11 were obtained by using a
Response Surface Methodology (RSM). Brieﬂy, this methodology
propose a canonical sets of experiments to analyse the eﬀect of several
factors on deﬁned responses, in this case the bioﬁlm removal and cell
lysis (see Chapter 11 for complete design). The four factors of this work
were the enzymes described above. The results were analysed with a
statistical software (JMP, SAS) by means of multiple regression and
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validated according to deﬁned criteria (Chapter 11). The bioﬁlm de-
grading eﬀect of enzymes alone and in synergy could then be determined.
The interpretation of the results for the removal of mature S.
epidermidis bioﬁlms grown in static conditions from a surface indicate
that all four enzymes, LST, Tw, LysK and DspB analog (DspB*),
were able to signiﬁcantly remove bioﬁlms. The dose-response eﬀects
of LST and LysK, and to a lesser extent of DspB*, were found to be
non linear (quadratic). This observation can be partly attributed to a
saturation in the experimental response (A540) from certain levels of
enzyme concentrations.
For the results of cell lysis within the bioﬁlms, the analysis revealed
that LST and LysK were the only two active enzymes. As for the bioﬁlm
removal activity, their eﬀect was found to be quadratic. Interestingly,
Tw, that was eﬀective at killing exponentially growing S. epidermidis
cells in suspension, appeared not to be signiﬁcantly contributing to cell
lysis within the bioﬁlm. This ﬁnding is particularly unsettling since
Tw and LysK belong to the same group of endolysins, featuring the
same type of catalytic domains. Besides, as mentioned above, they have
the same molecular weight. The reason for this lack of activity might
result from particular cell wall properties of S. epidermidis in bioﬁlms.
Also, it is possible that Tw diﬀuses more slowly into the core of the
bioﬁlm, due to apparent charge or hydrophobicity. For instance, charged
nanoparticles (NPs) have been shown to diﬀuse much more slowly into
bioﬁlms that neutral NPs of the same size [Forier 2013]. Finally, the
enzymes may display diﬀerential sensitivities to proteases in the matrix
of the bioﬁlms, causing a loss of activity over time.
Concerning the interactions between each of the four enzymes tested
in this work, a negative synergistic eﬀect of Tw and the analog of
DspB on bioﬁlm removal was noticed. Similarly, lysostaphin with LysK
were cross-inﬂuencing one another cell lysis activity, contrary to other
reports [Becker 2008]. On top of the evaluation of the interactions
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of several compounds, RSM allowed the prediction of cell lysis and
bioﬁlm removal of the tested enzymes. Indeed, multiple combinations of
enzymes concentrations that yield an optimal eﬀect could be deduced
from the multiple regression model.
Of note, the conclusions drawn from this study are only valid in the
conditions in which it was performed. In this work, S. epidermidis ATCC
35984 bioﬁlms were grown in static conditions (96-well plates). Bioﬁlms
of the same S. epidermidis strain grown in the Biostream ﬂow cells (see
Appendix B for description) were challenged with the optimal mix of
enzymes predicted by the model. The cocktail failed to signiﬁcantly
remove the bioﬁlm (data not shown), indicating that ﬂow cell bioﬁlms are
more resistant to these enzymes than the ones grown in 96-well plates.
It is likely that dynamic conditions provided by the Biostream setup
had a major inﬂuence on the proportion of cells and EPS in bioﬁlms
compared to the situation in bioﬁlms grown under static conditions. This
underlines the importance of the experimental model chosen to perform
screening experiments. In any case, the development of (combination of)
anti-bioﬁlm compounds should be confronted to an experimental model
as close as possible from the real conditions in which bioﬁlm thrive.
Because such models may be costly and time consuming (i.e. ﬂow cells,
batch reactors or murine models) [Coenye 2010], experimental designs
could prove useful to optimize screening procedures.
Pros and cons of using enzymes as means to eradicate
bioﬁlms
The use of enzymes to combat bioﬁlms involved in speciﬁc types of
HAIs is a promising strategy. Enzymes degrading the matrix of EPS
of bioﬁlms, for example DNAses or hexaminidases, could enhance the
action of anti-microbial agents such as antibiotics by increasing the ex-
posure of bacterial cells. On the other hand, they also induce a massive
release of bacteria in the surroundings of the bioﬁlm. In case of HAIs, a
dissemination of planktonic cells from a bioﬁlm would considerably aug-
ment the risk of developing secondary infections and potentially worsen
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the situation [McDougald 2012]. For that reason, the use of matrix
degrading enzymes is to be coupled with potent anti-microbial agents
to kill bacteria liberated from the bioﬁlm. These anti-microbial agents
could be lytic enzymes, notably phage endolysins. Endolysins have been
reported to signiﬁcantly degrade bioﬁlms of S. aureus [O'Flaherty 2005]
[Sass 2007] [Kokai-Kun 2009] and more recently of S. epidermidis (see
results in Chapter 11) [Gutiérrez 2014]. Even persister cells should
be lysed by endolysins, although this has never been speciﬁcally reported.
The use of enzymes as potential therapeutic agents is not new and
some successful examples have been reported, notably in the treatment
of cancers [Holcenberg 1977]. However, each enzyme bound to become
a drug has to go through clinical trials. Due to their proteinaceous
nature, they could be eliciting adverse immune response from the
patient, including the production of antibodies that could block their
activity [Borysowski 2006]. Preliminary tests on murine models with a
pneumococcal endolysin Cpl-1 indicated that mice produced antibodies
against the enzyme but did not display any visible sign of anaphylaxis
or adverse side eﬀect. In the same work, the mice that were previously
injected with Cpl-1 and control (naive) mice were challenged with
pneumococci intravenously. The bacteremic titers (number of live
pneumococci cells per blood volume) decreased about 2-3 logs shortly
after both populations of mice were treated intravenously with 200 µg
of Cpl-1. These results show that Cpl-1 was still active in vivo despite
the presence of anti-Cpl-1 antibodies [Loeer 2003].
The potential to develop endolysin-based anti-bioﬁlm drugs is enor-
mous, given the diversity of phages and lysins in nature [Clokie 2011].
Besides, reports of bacterial resistance to endolysins are still rare
[Nelson 2012], partially owing to the fact that these enzymes target
highly conserved bonds in the PG. For the above cited reasons, endolysins
with conﬁrmed anti-bioﬁlm potential might be part of the solution for
HAIs that cannot be healed with currently available therapeutics.

Chapter 13
Conclusion and perspectives
S. epidermidis has, over the last twenty years, emerged as a leading
opportunistic pathogen. The success of S. epidermidis as a nosocomial
pathogen is intimately linked to the increasing use of implantable medi-
cal devices. These provide an opportunity for this ubiquitous colonizer
of human skin to settle in the host, and thrive in the form of bioﬁlms. In
most cases, it aﬀects fragile people such as the neonates and the elderly
who generally are immunocompromised. Recent statistics indicate
that S. epidermidis ranks ﬁrst in encountered pathogens in infections
associated with central venous catheters, peritoneal dialysis catheters,
neurosurgical devices (e.g. shunts and pressures devices), vascular grafts
and prosthetic joints [Piette 2009]. Such chronic infections are very
diﬃcult to treat with antibiotics for two main reasons. First, bioﬁlms
are intrinsically tolerant to antibiotics due to the presence of persisters
[Lewis 2010]. Second, most strains of S. epidermidis isolated in clinical
settings carry various genes of resistance to commonly used antibiotics
[Diekema 2001]. Besides, bioﬁlms are known as "hot spots" for HGT,
especially conjugation involving plasmids that carry antibiotic resistance
genes [Savage 2013]. The clinical consequences of these nosocomial
infections include signiﬁcantly lengthened hospital stays, increased
patient morbidity and mortality, usually resulting from septicaemia
[Eiﬀ 2002].
This work was motivated by the crucial need to improve the under-
standing of the mechanisms underlying bioﬁlm formation and to develop
adequate strategies to control bioﬁlms. Since for S. epidermidis, bioﬁlm
development is a major virulence factor, it was chosen as experimental
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model.
The focus was ﬁrst set on studying adhesion of S. epidermidis on
surfaces coated with proteins and particularly Fg, a plasma protein that
is notably involved in blood clotting and platelets recruitment. The spe-
ciﬁc role of SdrG, an adhesin described some years ago [Hartford 2001],
has been questioned. At the beginning of this work, the mechanism
by which SdrG is able to bind to Fg was known [Ponnuraj 2003]
but the characteristics of the binding event were not yet elucidated.
In particular, the extent of the force involved in the SdrG-Fg bond
remained unclear. AFM force spectroscopy allowed to reveal that the
binding strength of SdrG to its substrate was unusually large (about 2
nN). Also, it was shown to be inﬂuenced by contact time: the longer the
two proteins were in contact, the more intense the force (see Chapter 8).
Further work highlighted a correlation between the surface abundance
of SdrG on the bacterial cell surface and the ability of individual cells
to adhere to Fg-coated surfaces. Trends for whole bacterial populations
adhesion levels were matching those of single cells, indicating that SdrG
surface density directly inﬂuences the immobilization of S. epidermidis
on surfaces covered with Fg.
In vivo, reports of increased expression of fbe to crowd the cell sur-
face with SdrG [Sellman 2008] indicate that the opportunistic pathogen
S. epidermidis tries to favor its establishment on implants or devices.
Once bound to a surface, several lines of evidence suggest that bacteria
undergo a physiological switch towards a so-called "surface-bound
state". In this condition, bacteria "sense" that they are interacting with
a substratum [Busscher 2012] and, through a network of regulatory
pathways, induce the development of a bioﬁlm [Hall-Stoodley 2004]
[Mack 2007].
Given the likely importance of SdrG in the infective strategy of S.
epidermidis, the quest for new strategies to prevent infections should
focus on the genetic regulation of fbe expression or on blocking the
ability of SdrG to bind to Fg, for example thanks to a synthetic
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peptide that interferes with the "dock, lock and latch" mechanism. The
idea of prophylactic vaccines targeting SdrG have also been proposed
[Sellman 2008] but may not be well-suited since many of patients
contracting such chronic infections are immunocompromised.
Several other MSCRAMMs and other cell surface polymers have
been identiﬁed as key elements that facilitates the adhesion of S.
epidermidis to various types of surfaces. For example, the protein Bhp
has been shown to mediate binding on hydrophobic surfaces, teichoic
acids can attach to ﬁbronectin and SdrF can speciﬁcally recognize type
I collagen [Otto 2012]. It is not likely that therapeutic agents silencing
the functions of these polymers can easily be found and used in clinical
settings to prevent the onset of indwelling device associated infec-
tions. Based on the ﬁndings reported in Chapter 9, another approach
based on biosensors could be proposed. It involves the detection of
surface-adhering bacteria using impedance spectroscopy. The developed
biosensors are of small size (about 300 µm in diameter), a feature that
would allow their integration on the surface of implants. So-called
"smart" implants could provide a way to follow the contamination
of device in a non-invasive fashion. Potential advantages of such
devices are, among others, faster diagnosis (early detection of bioﬁlms)
and follow-up of the eﬀect of therapeutic treatments on the bioﬁlm.
Incomplete eradication of bioﬁlms could therefore be spotted early on,
avoiding the reappearance of patients symptoms.
Beside the critical importance of bacterial adhesion, the development
of bioﬁlms relies heavily on intercellular adhesion, or aggregation. In
fact, while growing, the lone surface-bound bacterial cells tend to form
micro-colonies that are held together by several mechanisms including
the production of an EPS matrix and the speciﬁc interaction of cell
surface proteins (e.g. Aap for S. epidermidis). Alternatively, bacteria
may also form cell clumps in suspension that can then adhere on a
surface, partially short-cutting the formation of micro-colonies. The
process of aggregation is known to be the second phase of bioﬁlm
formation. It is notably inﬂuenced by both active (e.g. genetic) and
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passive (e.g. environmental inﬂuence) responses triggered by various
stimuli such as the concentration of glucose, temperature, the presence
of calcium or ethanol [Hall-Stoodley 2004].
In Chapter 10, the involvement of ionic strength in a yet unreported
type of aggregation of Staphylococci was investigated. Indeed, several
staphylococcal strains belonging to S. aureus, S. epidermidis and S.
warneri species, were shown to rapidly form large cell clumps at an
optimal ionic strength. In the experiments, the ionic strength was solely
brought by NaCl which is not likely to induce aggregation in the way
divalent ions such as calcium can. The reversibility of the aggregative
phenotype led us to propose an hypothesis that involves electrostatic
interactions of bacterial cell surface charges and deployment of cell
surface polymers. Brieﬂy, at an optimal ionic strength, the cell surface
polymers are suﬃciently contracted to diminish the repulsive radius
of two negatively charged cells and allow localized positive charge
clusters to interact with negative charges on another cell. Higher ionic
strength would shield almost all electrostatic interactions and annul
the phenomenon. AFM experiments gave indications that electrostatic
interactions are at play but failed to fully validate the proposed hypoth-
esis. Further work would be necessary to identify the root cause of this
phenomenon. For instance, AFM force spectroscopy performed with tips
displaying diﬀerent chemistry, such as positive charges or hydrophobic
groups (e.g. -CH3 terminated groups) may reveal complementary
information on the origin of the mechanism. Also, a comparison of
the electrophoretic mobility of strains that aggregate and those that
do not may give interesting hints related to surface potential of these
strains. Alternatively, proton titration of bacterial suspension can also
be performed to get additional insights [Poortinga 2002].
The impact of the ionic strength-dependent self-aggregation on
bioﬁlm formation of a S. aureus reference strain was demonstrated in
vitro, in ﬂow cells (see Chapter 10) and in microtiter plates (data not
shown). This raise the question of the culture conditions of staphylo-
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coccal bioﬁlms in vitro. Indeed, the results presented in this study show
that the structures of the bioﬁlms grown at diﬀerent ionic strength
but with the same amount of nutrients are markedly distinct. This is
to be put in perspective with other ﬁndings reported by [Lim 2004]
that increased salt concentration, in combination with glucose, increase
bioﬁlm formation by inducing the production of PNAG. Ionic strength
must now be considered as a parameter of importance of laboratory
medium dedicated to bioﬁlm growth. The impact of culture parameters
on the properties and composition of mature bioﬁlms should therefore
not be overlooked.
Bioﬁlms that have reached a certain degree of maturity display
typical characteristics, notably provided by the presence of the EPS
matrix and the various physiological states of the bacterial cells. One of
their key features is the resilience in harsh environments, for instance
in the presence of oxidative stresses, UV, dry conditions or high
concentrations of antibiotics. Bioﬁlms as bacterial communities make
the most of unity and cooperation to survive threats that planktonic
populations might not have withstood [Jeﬀerson 2004]. This is one of
the main reasons why they cause such troubles in the industry and in
hospitals. In this study (Chapter 11), the potential of enzymes for the
degradation of mature S. epidermidis bioﬁlms was investigated. Four
enzymes, including lysostaphin, Tw and LysK, two phage lysins, and
an analog of DspB, were tested for anti-bioﬁlm activity. The analog
of DspB, an N-acetylglucosamine, displayed a strong bioﬁlm removing
eﬀect and, as expected from its enzymatic activity, did not provoke cell
lysis. On the contrary, both lysostaphin and LysK were deemed eﬃcient
at removing bioﬁlm and killing bacteria. On the other hand, Tw, an
endolysin of the same family as LysK, with a similar structure, did
remove bioﬁlm signiﬁcantly but failed to lyse the cells in the bioﬁlms.
Preliminary tests with other phage endolysins (80α and SH2) were not
conclusive as they were not able to remove any bioﬁlm and did not cause
any detectable cell lysis. The anti-bioﬁlm potential of phage endolysins
thus does not seem to be a general characteristic of these enzymes.
However, given the diversity of phages available in nature, carrying
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endolysins with various features [Nelson 2012], this class of enzymes can
still provide a largely untapped pool of anti-bioﬁlm compounds.
In view of the development of potential therapeutic agents to
target bioﬁlms, it is essential to carefully choose the experimental
model. Indeed, bioﬁlms grown in diverse conditions, for instance in
in vitro ﬂow cells, or in in vivo murine models, will display diﬀerent
characteristics, notably in terms of proportions of EPS matrix and
cells. This undoubtedly aﬀects the potency of the active principle that
degrade bioﬁlms and lyse cells within these.
Controlling bacteria is a challenge. Nearly a century of struggle has
taught us that the use of single anti-bacterial treatments almost always
leads to the appearance of resistance mechanisms. In most cases, these
resistance genes can be shared amongst bacterial populations and spread
worldwide rapidly. A solution to counter this is to use combinations of
two or more compounds to eradicate bacteria or bioﬁlms. In this way,
the likelihood for micro-organisms to survive becomes really low. In
addition, one can also beneﬁt from the synergistic action of the anti-
bacterial principles. However, correctly determining the interactions,
positive or negative, between the compounds can be time-consuming
and diﬃcult to properly quantify. In this study, RSM was implemented
to this extent. These approaches are already used in analytical chem-
istry and tend to become more and more popular in biotechnological
ﬁelds of research, for instance to assess the impact of temperature, pH
and NaCl concentration on the activity of peptidases or the optimal
culture conditions of Streptomyces spp. for the production of chitinase
[Ba³ 2007]. These tools can be advantageous to spot the synergies
between compounds that have proven eﬃcient at degrading bioﬁlms
in order to propose potentially successful combinatory treatment of
bioﬁlms.
In conclusion, this work provides comprehensive insights in the
bioﬁlm formation process of S. epidermidis, in connection with the prob-
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lem of device-related nosocomial infections. To tackle this issue, several
leads for the development of preventive and curative strategies have also
been proposed, including sensing surfaces and enzymatic control of ma-
ture bioﬁlms.
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Appendix B
Biostream Patent
In this work, an eﬃcient ﬂow cell device was needed. Biostream
was invented in order to respond to this demand. The UCL
has pursued a patent application for this invention. The latter
was published on the 13th of March 2014 under the publication
number WO/2014/037479. A condensed version of the docu-
ment with only the front page and the claims is presented in
the next pages. A full version is freely accessible online on Es-
pacenet : http://worldwide.espacenet.com/publicationDetails/
originalDocument?CC=WO&NR=2014037479A1&KC=A1&FT=D&ND=3&date=
20140313&DB=worldwide.espacenet.com&locale=fr_EP.
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Appendix C
Adhesion of S. epidermidis
in ﬂow cells
C.1 Aim
One of the main focus of this work is bacterial adhesion to surfaces.
In this context, the adhesion of S. epidermidis strains in dynamic con-
ditions was investigated on PDMS coated or not with proteins. The
results presented in this Appendix were used to validate a model based
on probabilities that accounts for bacterial adhesion under ﬂow that is
not presented in this work.
C.2 Material and methods
Bacterial strains and culture
Six S. epidermidis strains were used in this study: ATCC 12228, ATCC
35984, HB ([Nilsson 1998]), HB SdrG(-) in which the gene SdrG has
been knocked out ([Hartford 2001]), DS1 and Bo19, two strains isolated
from Mont-Godinne hospital in 2012, identiﬁed by 16S DNA sequencing
or MALDI-TOF IVD (Bruker).
Bacteria were streaked on TSA plates from frozen stock and incu-
bated for 24 h at 37oC. Liquid cultures were carried out in 250 ml Erlen-
meyers containing 50 ml of TSB, incubated at 37oC for 16 h under 120
RPM agitation.
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Preparation of bacterial suspension
Overnight cultures were centrifuged at 5000g for 15 min. The super-
natant was removed and the pellet was resuspended in 20 ml of sterile
PBS. The resulting suspension was ﬁltered on 5 µm to remove any large
aggregates. OD at 600 nm of the suspension diluted 10 times in PBS
was adjusted to 0.4 to obtain a bacterial charge of ca. 1.5*109 CFU/ml.
Plates counts of serial dilutions were performed on TSA to assess the
number of CFU/ml in bacterial suspensions.
Spin coating of PDMS on glass surfaces
Glass coverslips (24 x 60 mm, 0.17 mm thick, Menzel Glazer) were
cleaned in piranha (H2SO4:H2O2 3:1 v:v) and thoroughly rinsed with
distilled water at least ﬁve times. The clean coverslips were dried under
a ﬂow of gazeous nitrogen and placed in the spin coater (Laurell Tech-
nologies, model: WS-400B-6NPP/Lite). One ml of a previously prepared
1:2 solution of PDMS (Dow Corning, Sylgard 184) in hexane (VWR) was
deposited on the glass surface and a cycle of 1 min at 3000 RPM was
performed in the spin coater. After that, the PDMS coated slides were
cured at 95oC for 1 h. The surfaces were kept in a sealed Petri dish until
use.
Flow cell setup
Biostream ﬂow cells (see Appendix B for detailed description of the de-
vices) were assembled using PDMS coated slides. The input of each ﬂow
cell was connected to three recipients and the output to a waste bottle
by 1.6 mm (inner diameter) silicone tubes. The whole system was auto-
claved for 15 min at 121oC. Under a sterile a tmosphere, PBS was added
to the ﬁrst recipient connected to ﬂow cells input, a coating solution to
the second and the bacterial suspension to the third. The coating solu-
tions used were TSB, a solution of Fg (0.5 mg/ml in PBS, ﬁlter sterilized
on 0.22 µm) or a solution of bovine serum diluted 10 times in PBS, ﬁlter
sterilized on 0.22 µm.
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Adhesion of S. epidermidis under ﬂow
Adhesion experiments were performed at 37oC according to the following
scheme. PBS was ﬁrst ﬂown in the ﬂow cells for 10 minutes. Then,
the coating solution was injected during 20 min at a ﬂow rate of 0.5
ml/min, that was conserved for the whole experiment. Flow cells were
rinsed with PBS for 20 min. To proceed to the adhesion experiment,
bacterial suspensions were pumped through the ﬂow cells for 20 min.
A ﬁnal rinsing step of 45 min with PBS was performed to remove any
unbound or loosely bound bacteria.
Each strain was tested in triplicate on bare PDMS and on each coat-
ing.
Quantiﬁcation of bacterial adhesion
Micrographs of the PDMS surfaces inside the ﬂow cells were then taken
in 2 rows, 7 positions in each row (a total of 14), using a 40x long working
distance objective (0.6 numerical aperture, Fluotar, Leica) mounted on
an inverted microscope (DMI 6000, Leica) equipped with a sensitive
CCD black and white 1.4 MP camera (DFX365, Leica). The number
of bacteria per image were determined with ImageJ using the 'Analyze
particles' after a basic thresholding had been applied. Bacterial counts
were converted to densities of adherent bacteria per square millimeter
(bacteria/mm2).
Statistical analysis
An ANOVA was performed on the data of densities of adherent bacteria
using JMP (SAS). Subsequently, a Tukey HSD (Honestly Signiﬁcant Dif-
ference) was performed on the ANOVA results to discriminate the mean
value of bacterial density on each coating for each strain. This test is
conservative and assesses the diﬀerence between two values on the basis
of the variance of the experiments provided by the ANOVA.
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C.3 Results
Fig. C.3 presents the results of ﬂow cell adhesion experiments. Globally,
adhesion to PDMS was eﬀective for all tested strains, only minor dif-
ferences could be noticed for ATCC 12228 and HB. Interestingly, these
two strains were the ones that showed signiﬁcant adherence to Fg coated
PDMS. These results are line with those presented in Chapter 8, section
8.2. The other strains displayed a low aﬃnity for Fg coated PDMS. On
serum coated PDMS, the strains HB and ATCC 35984 stick out while
the adhesion of the rest of the strains was weak. Yet, the level of adhe-
sion to the coating of bovine serum is clearly inferior to that of ATCC
12228 and HB on Fg. Finally, a coating of TSB does not impair bacte-
rial adhesion to the same extent as bovine serum coating. The reference
strains seemed slightly more aﬀected than the other strains.
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Figure C.1: Plot of the log10 of densities of adherent bacteria of six S. epi-
dermidis strains on PDMS and PDMS coated with TSB, Fg and bovine serum.
Two bars that are not connected by the same letter have been deemed signiﬁ-
cantly diﬀerent by the Tukey HSD test.
C.4 Discussion
Hydrophobic PDMS surfaces promoted adhesion of all the strains tested
in this study. According to the extended DLVO theory, it is likely that
a sum of hydrophobic forces (attractive Lewis acid-base interactions)
mediated by cell surface polymers strongly anchors S. epidermidis on
PDMS [Hermansson 1999].
Bovine serum coated PDMS inhibited bacterial adhesion signiﬁ-
cantly. Albumin is the major compound present in bovine serum, it is
likely that it accounts for the vast majority of the coating. Albumin
is not recognized by speciﬁc MSCRAMMs, unlike Collagen or Fg, but
has been shown to inhibit adhesion of S. epidermidis [Linnes 2012].
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Our result are in line with this hypothesis. The strains ATCC 35984
adheres better than the other strains. This is probably the result of
speciﬁc recognition of plasma proteins present in the coating, such as
vitronectin or elastin. Indeed, genes coding for adhesins binding these
proteins are present in the genome of S. epidermidis, notably in the
strain ATCC 35984.
On TSB-coated PDMS, bacterial adhesion was globally reduced
compared to bare surfaces but not to the extent of bovine serum
coated PDMS. XPS analysis revealed that the surface conditioning
layer forming in contact with TSB was less dense than that formed
upon deposition of bovine serum. Water contact angle measurements
conﬁrmed that the drop in hydrophobicity compared to bare PDMS
was far less than with bovine serum (Michel Thiel, Master thesis,
June 2013). Our hypothesis is that adsorbed peptides from TSB were
displaced by biopolymers of S. epidermidis cell surface upon adhesion.
The surface aﬃnity of larger biopolymers is often larger compared
to peptides, notably thanks to conformational changes that occur to
maximize the polymer-surface interactions.
Finally, on Fg-coated PDMS, two strains, ATCC 12228 and HB
adhered signiﬁcantly more than the other strains. In Chapter 8, the
AFM results show that these two strains display SdrG in its active
form on their surface while the mutant deﬁcient for sdrG and the strain
ATCC35984 did not. AFM analyses were not performed for DS1 and
Bo19 but it is reasonable to believe that they harbor low amounts of
SdrG on their cell surface, it at all.
Overall, these results conﬁrm the trends presented in Chapter
8 and several reports in the literature [Linton 1999] [Patel 2006]
[Heilmann 2011].
